id	sid	tid	token	lemma	pos
iajs-2916	1	1	ihjpas	ihjpas	PROPN
iajs-2916	1	2	.	.	PUNCT
iajs-2916	2	1	53	53	NUM
iajs-2916	2	2	(	(	PUNCT
iajs-2916	2	3	4)2022	4)2022	NOUN
iajs-2916	2	4	194	194	NUM
iajs-2916	3	1	this	this	DET
iajs-2916	3	2	work	work	NOUN
iajs-2916	3	3	is	be	AUX
iajs-2916	3	4	licensed	license	VERB
iajs-2916	3	5	under	under	ADP
iajs-2916	3	6	a	a	DET
iajs-2916	3	7	creative	creative	ADJ
iajs-2916	3	8	commons	common	NOUN
iajs-2916	3	9	attribution	attribution	NOUN
iajs-2916	3	10	4.0	4.0	NUM
iajs-2916	3	11	international	international	ADJ
iajs-2916	3	12	license	license	NOUN
iajs-2916	3	13	.	.	PUNCT
iajs-2916	4	1	evaluation	evaluation	NOUN
iajs-2916	4	2	of	of	ADP
iajs-2916	4	3	insulin	insulin	NOUN
iajs-2916	4	4	resistance	resistance	NOUN
iajs-2916	4	5	and	and	CCONJ
iajs-2916	4	6	glutathione	glutathione	NOUN
iajs-2916	4	7	-	-	PUNCT
iajs-2916	4	8	s	s	NOUN
iajs-2916	4	9	-	-	NOUN
iajs-2916	4	10	transferase	transferase	NOUN
iajs-2916	4	11	in	in	ADP
iajs-2916	4	12	iraqi	iraqi	ADJ
iajs-2916	4	13	patients	patient	NOUN
iajs-2916	4	14	with	with	ADP
iajs-2916	4	15	type	type	NOUN
iajs-2916	4	16	2	2	NUM
iajs-2916	4	17	diabetes	diabetes	NOUN
iajs-2916	4	18	mellitus	mellitus	NOUN
iajs-2916	4	19	and	and	CCONJ
iajs-2916	4	20	diabetic	diabetic	ADJ
iajs-2916	4	21	peripheral	peripheral	ADJ
iajs-2916	4	22	neuropathy	neuropathy	ADJ
iajs-2916	4	23	abstract	abstract	ADJ
iajs-2916	4	24	diabetes	diabetes	NOUN
iajs-2916	4	25	mellitus	mellitus	NOUN
iajs-2916	4	26	type	type	VERB
iajs-2916	4	27	2	2	NUM
iajs-2916	4	28	(	(	PUNCT
iajs-2916	4	29	t2	t2	NOUN
iajs-2916	4	30	dm	dm	NOUN
iajs-2916	4	31	)	)	PUNCT
iajs-2916	4	32	is	be	AUX
iajs-2916	4	33	a	a	DET
iajs-2916	4	34	metabolic	metabolic	NOUN
iajs-2916	4	35	disorder	disorder	NOUN
iajs-2916	4	36	that	that	PRON
iajs-2916	4	37	influences	influence	VERB
iajs-2916	4	38	above	above	ADP
iajs-2916	4	39	450	450	NUM
iajs-2916	4	40	million	million	NUM
iajs-2916	4	41	individuals	individual	NOUN
iajs-2916	4	42	around	around	ADP
iajs-2916	4	43	the	the	DET
iajs-2916	4	44	world	world	NOUN
iajs-2916	4	45	.	.	PUNCT
iajs-2916	5	1	type	type	NOUN
iajs-2916	5	2	2	2	NUM
iajs-2916	5	3	diabetes	diabetes	NOUN
iajs-2916	5	4	is	be	AUX
iajs-2916	5	5	a	a	DET
iajs-2916	5	6	lack	lack	NOUN
iajs-2916	5	7	of	of	ADP
iajs-2916	5	8	insulin	insulin	NOUN
iajs-2916	5	9	due	due	ADP
iajs-2916	5	10	to	to	ADP
iajs-2916	5	11	pancreatic	pancreatic	ADJ
iajs-2916	5	12	β	β	NOUN
iajs-2916	5	13	-	-	NOUN
iajs-2916	5	14	cell	cell	NOUN
iajs-2916	5	15	malfunction	malfunction	NOUN
iajs-2916	5	16	and	and	CCONJ
iajs-2916	5	17	insulin	insulin	NOUN
iajs-2916	5	18	resistance	resistance	NOUN
iajs-2916	5	19	.	.	PUNCT
iajs-2916	6	1	this	this	DET
iajs-2916	6	2	study	study	NOUN
iajs-2916	6	3	aimed	aim	VERB
iajs-2916	6	4	to	to	PART
iajs-2916	6	5	detect	detect	VERB
iajs-2916	6	6	insulin	insulin	NOUN
iajs-2916	6	7	resistance	resistance	NOUN
iajs-2916	6	8	using	use	VERB
iajs-2916	6	9	homeostasis	homeostasis	NOUN
iajs-2916	6	10	model	model	NOUN
iajs-2916	6	11	assessment	assessment	NOUN
iajs-2916	6	12	(	(	PUNCT
iajs-2916	6	13	homa	homa	PROPN
iajs-2916	6	14	ir	ir	PROPN
iajs-2916	6	15	)	)	PUNCT
iajs-2916	6	16	and	and	CCONJ
iajs-2916	6	17	determined	determine	VERB
iajs-2916	6	18	the	the	DET
iajs-2916	6	19	correlation	correlation	NOUN
iajs-2916	6	20	with	with	ADP
iajs-2916	6	21	glutathione	glutathione	NOUN
iajs-2916	6	22	-	-	PUNCT
iajs-2916	6	23	s	s	NOUN
iajs-2916	6	24	-	-	PUNCT
iajs-2916	6	25	transferase	transferase	NOUN
iajs-2916	6	26	(	(	PUNCT
iajs-2916	6	27	gst	gst	NOUN
iajs-2916	6	28	)	)	PUNCT
iajs-2916	6	29	activity	activity	NOUN
iajs-2916	6	30	in	in	ADP
iajs-2916	6	31	t2	t2	NOUN
iajs-2916	6	32	dm	dm	PROPN
iajs-2916	6	33	and	and	CCONJ
iajs-2916	6	34	neuropathy	neuropathy	ADJ
iajs-2916	6	35	patients	patient	NOUN
iajs-2916	6	36	as	as	ADP
iajs-2916	6	37	a	a	DET
iajs-2916	6	38	predictor	predictor	NOUN
iajs-2916	6	39	of	of	ADP
iajs-2916	6	40	oxidative	oxidative	ADJ
iajs-2916	6	41	stress	stress	NOUN
iajs-2916	6	42	,	,	PUNCT
iajs-2916	6	43	which	which	PRON
iajs-2916	6	44	occurs	occur	VERB
iajs-2916	6	45	when	when	SCONJ
iajs-2916	6	46	the	the	DET
iajs-2916	6	47	oxidation	oxidation	NOUN
iajs-2916	6	48	-	-	PUNCT
iajs-2916	6	49	antioxidant	antioxidant	NOUN
iajs-2916	6	50	equilibrium	equilibrium	NOUN
iajs-2916	6	51	is	be	AUX
iajs-2916	6	52	disrupted	disrupt	VERB
iajs-2916	6	53	.	.	PUNCT
iajs-2916	7	1	reactive	reactive	ADJ
iajs-2916	7	2	oxygen	oxygen	NOUN
iajs-2916	7	3	species	specie	NOUN
iajs-2916	7	4	causes	cause	VERB
iajs-2916	7	5	vascular	vascular	ADJ
iajs-2916	7	6	injury	injury	NOUN
iajs-2916	7	7	and	and	CCONJ
iajs-2916	7	8	a	a	DET
iajs-2916	7	9	series	series	NOUN
iajs-2916	7	10	of	of	ADP
iajs-2916	7	11	inflammation	inflammation	NOUN
iajs-2916	7	12	.	.	PUNCT
iajs-2916	8	1	in	in	ADP
iajs-2916	8	2	the	the	DET
iajs-2916	8	3	present	present	ADJ
iajs-2916	8	4	study	study	NOUN
iajs-2916	8	5	,	,	PUNCT
iajs-2916	8	6	the	the	DET
iajs-2916	8	7	results	result	NOUN
iajs-2916	8	8	show	show	VERB
iajs-2916	8	9	there	there	PRON
iajs-2916	8	10	is	be	VERB
iajs-2916	8	11	no	no	DET
iajs-2916	8	12	significant	significant	ADJ
iajs-2916	8	13	difference	difference	NOUN
iajs-2916	8	14	in	in	ADP
iajs-2916	8	15	diabetic	diabetic	ADJ
iajs-2916	8	16	patients	patient	NOUN
iajs-2916	8	17	(	(	PUNCT
iajs-2916	8	18	dm	dm	NOUN
iajs-2916	8	19	)	)	PUNCT
iajs-2916	8	20	and	and	CCONJ
iajs-2916	8	21	neuropathy	neuropathy	ADJ
iajs-2916	8	22	patients	patient	NOUN
iajs-2916	8	23	(	(	PUNCT
iajs-2916	8	24	nu	nu	NOUN
iajs-2916	8	25	)	)	PUNCT
iajs-2916	8	26	versus	versus	ADP
iajs-2916	8	27	healthy	healthy	ADJ
iajs-2916	8	28	people	people	NOUN
iajs-2916	8	29	in	in	ADP
iajs-2916	8	30	insulin	insulin	NOUN
iajs-2916	8	31	resistance	resistance	NOUN
iajs-2916	8	32	(	(	PUNCT
iajs-2916	8	33	p	p	X
iajs-2916	8	34	>	>	X
iajs-2916	8	35	0.05	0.05	NUM
iajs-2916	8	36	)	)	PUNCT
iajs-2916	8	37	.	.	PUNCT
iajs-2916	9	1	gst	gst	NOUN
iajs-2916	9	2	activity	activity	NOUN
iajs-2916	9	3	significantly	significantly	ADV
iajs-2916	9	4	differs	differ	VERB
iajs-2916	9	5	between	between	ADP
iajs-2916	9	6	the	the	DET
iajs-2916	9	7	patients	patient	NOUN
iajs-2916	9	8	and	and	CCONJ
iajs-2916	9	9	healthy	healthy	ADJ
iajs-2916	9	10	groups	group	NOUN
iajs-2916	9	11	(	(	PUNCT
iajs-2916	9	12	p≤0.05	p≤0.05	NOUN
iajs-2916	9	13	)	)	PUNCT
iajs-2916	9	14	.	.	PUNCT
iajs-2916	10	1	moreover	moreover	ADV
iajs-2916	10	2	,	,	PUNCT
iajs-2916	10	3	this	this	DET
iajs-2916	10	4	study	study	NOUN
iajs-2916	10	5	has	have	AUX
iajs-2916	10	6	reported	report	VERB
iajs-2916	10	7	an	an	DET
iajs-2916	10	8	improvement	improvement	NOUN
iajs-2916	10	9	in	in	ADP
iajs-2916	10	10	insulin	insulin	NOUN
iajs-2916	10	11	resistance	resistance	NOUN
iajs-2916	10	12	and	and	CCONJ
iajs-2916	10	13	high	high	ADJ
iajs-2916	10	14	activity	activity	NOUN
iajs-2916	10	15	of	of	ADP
iajs-2916	10	16	gst	gst	NOUN
iajs-2916	10	17	in	in	ADP
iajs-2916	10	18	the	the	DET
iajs-2916	10	19	patient	patient	NOUN
iajs-2916	10	20	's	's	PART
iajs-2916	10	21	group	group	NOUN
iajs-2916	10	22	as	as	ADP
iajs-2916	10	23	a	a	DET
iajs-2916	10	24	warning	warning	NOUN
iajs-2916	10	25	sign	sign	NOUN
iajs-2916	10	26	of	of	ADP
iajs-2916	10	27	excessive	excessive	ADJ
iajs-2916	10	28	oxidative	oxidative	ADJ
iajs-2916	10	29	stress	stress	NOUN
iajs-2916	10	30	.	.	PUNCT
iajs-2916	11	1	there	there	PRON
iajs-2916	11	2	was	be	VERB
iajs-2916	11	3	no	no	DET
iajs-2916	11	4	evidence	evidence	NOUN
iajs-2916	11	5	revealing	reveal	VERB
iajs-2916	11	6	a	a	DET
iajs-2916	11	7	link	link	NOUN
iajs-2916	11	8	between	between	ADP
iajs-2916	11	9	insulin	insulin	NOUN
iajs-2916	11	10	resistance	resistance	NOUN
iajs-2916	11	11	and	and	CCONJ
iajs-2916	11	12	gst	gst	NOUN
iajs-2916	11	13	.	.	PUNCT
iajs-2916	12	1	the	the	DET
iajs-2916	12	2	present	present	ADJ
iajs-2916	12	3	study	study	NOUN
iajs-2916	12	4	has	have	AUX
iajs-2916	12	5	demonstrated	demonstrate	VERB
iajs-2916	12	6	that	that	SCONJ
iajs-2916	12	7	homa	homa	NOUN
iajs-2916	12	8	-	-	PUNCT
iajs-2916	12	9	ir	ir	PROPN
iajs-2916	12	10	had	have	VERB
iajs-2916	12	11	a	a	DET
iajs-2916	12	12	positive	positive	ADJ
iajs-2916	12	13	relationship	relationship	NOUN
iajs-2916	12	14	with	with	ADP
iajs-2916	12	15	fasting	fast	VERB
iajs-2916	12	16	blood	blood	NOUN
iajs-2916	12	17	sugar	sugar	NOUN
iajs-2916	12	18	and	and	CCONJ
iajs-2916	12	19	insulin	insulin	NOUN
iajs-2916	12	20	in	in	ADP
iajs-2916	12	21	the	the	DET
iajs-2916	12	22	neuropathy	neuropathy	ADJ
iajs-2916	12	23	group	group	NOUN
iajs-2916	12	24	and	and	CCONJ
iajs-2916	12	25	diabetic	diabetic	ADJ
iajs-2916	12	26	group	group	NOUN
iajs-2916	12	27	and	and	CCONJ
iajs-2916	12	28	a	a	DET
iajs-2916	12	29	negative	negative	ADJ
iajs-2916	12	30	relationship	relationship	NOUN
iajs-2916	12	31	with	with	ADP
iajs-2916	12	32	high	high	ADJ
iajs-2916	12	33	-	-	PUNCT
iajs-2916	12	34	density	density	NOUN
iajs-2916	12	35	lipoprotein	lipoprotein	ADJ
iajs-2916	12	36	(	(	PUNCT
iajs-2916	12	37	hdl	hdl	NOUN
iajs-2916	12	38	)	)	PUNCT
iajs-2916	12	39	.	.	PUNCT
iajs-2916	13	1	keywords	keyword	NOUN
iajs-2916	13	2	:	:	PUNCT
iajs-2916	13	3	type	type	NOUN
iajs-2916	13	4	2	2	NUM
iajs-2916	13	5	diabetes	diabetes	NOUN
iajs-2916	13	6	mellitus	mellitus	NOUN
iajs-2916	13	7	(	(	PUNCT
iajs-2916	13	8	t2	t2	NOUN
iajs-2916	13	9	dm	dm	PROPN
iajs-2916	13	10	)	)	PUNCT
iajs-2916	13	11	,	,	PUNCT
iajs-2916	13	12	diabetic	diabetic	ADJ
iajs-2916	13	13	peripheral	peripheral	ADJ
iajs-2916	13	14	neuropathy	neuropathy	ADJ
iajs-2916	13	15	(	(	PUNCT
iajs-2916	13	16	dpn	dpn	PROPN
iajs-2916	13	17	)	)	PUNCT
iajs-2916	13	18	,	,	PUNCT
iajs-2916	13	19	oxidative	oxidative	ADJ
iajs-2916	13	20	stress	stress	NOUN
iajs-2916	13	21	(	(	PUNCT
iajs-2916	13	22	ox	ox	NOUN
iajs-2916	13	23	)	)	PUNCT
iajs-2916	13	24	,	,	PUNCT
iajs-2916	13	25	glutathione	glutathione	NOUN
iajs-2916	13	26	-	-	PUNCT
iajs-2916	13	27	s	s	NOUN
iajs-2916	13	28	-	-	PUNCT
iajs-2916	13	29	transferase	transferase	NOUN
iajs-2916	13	30	(	(	PUNCT
iajs-2916	13	31	gst	gst	NOUN
iajs-2916	13	32	)	)	PUNCT
iajs-2916	13	33	.	.	PUNCT
iajs-2916	14	1	article	article	NOUN
iajs-2916	14	2	history	history	NOUN
iajs-2916	14	3	:	:	PUNCT
iajs-2916	14	4	received	receive	VERB
iajs-2916	14	5	26	26	NUM
iajs-2916	14	6	june	june	PROPN
iajs-2916	14	7	2022	2022	NUM
iajs-2916	14	8	,	,	PUNCT
iajs-2916	14	9	accepted	accept	VERB
iajs-2916	14	10	21	21	NUM
iajs-2916	14	11	august	august	PROPN
iajs-2916	14	12	2022	2022	NUM
iajs-2916	14	13	,	,	PUNCT
iajs-2916	14	14	published	publish	VERB
iajs-2916	14	15	in	in	ADP
iajs-2916	14	16	october	october	PROPN
iajs-2916	14	17	2022	2022	NUM
iajs-2916	14	18	.	.	PUNCT
iajs-2916	15	1	hadel	hadel	PROPN
iajs-2916	15	2	khalid	khalid	PROPN
iajs-2916	15	3	jaid	jaid	PROPN
iajs-2916	15	4	departmentof	departmentof	PROPN
iajs-2916	15	5	chemistry/	chemistry/	NUM
iajs-2916	15	6	college	college	PROPN
iajs-2916	15	7	of	of	ADP
iajs-2916	15	8	science	science	NOUN
iajs-2916	15	9	for	for	ADP
iajs-2916	15	10	women/	women/	NUM
iajs-2916	15	11	university	university	NOUN
iajs-2916	15	12	of	of	ADP
iajs-2916	15	13	baghdad/	baghdad/	NUM
iajs-2916	15	14	baghdad/	baghdad/	NUM
iajs-2916	15	15	iraq	iraq	PROPN
iajs-2916	15	16	hadeel.khaled1205a@csw.uobaghdad.edu.iq	hadeel.khaled1205a@csw.uobaghdad.edu.iq	PROPN
iajs-2916	15	17	doi	doi	PROPN
iajs-2916	15	18	:	:	PUNCT
iajs-2916	15	19	10.30526/35.4.2916	10.30526/35.4.2916	PROPN
iajs-2916	15	20	ibn	ibn	NOUN
iajs-2916	15	21	al	al	PROPN
iajs-2916	15	22	haitham	haitham	PROPN
iajs-2916	15	23	journal	journal	PROPN
iajs-2916	15	24	for	for	ADP
iajs-2916	15	25	pure	pure	ADJ
iajs-2916	15	26	and	and	CCONJ
iajs-2916	15	27	applied	applied	ADJ
iajs-2916	15	28	sciences	sciences	PROPN
iajs-2916	15	29	journal	journal	PROPN
iajs-2916	15	30	homepage	homepage	NOUN
iajs-2916	15	31	:	:	PUNCT
iajs-2916	15	32	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	PROPN
iajs-2916	15	33	fayhaa	fayhaa	PROPN
iajs-2916	15	34	muqdad	muqdad	PROPN
iajs-2916	15	35	khaleel	khaleel	PROPN
iajs-2916	15	36	department	department	PROPN
iajs-2916	15	37	of	of	ADP
iajs-2916	15	38	chemistry/	chemistry/	NUM
iajs-2916	15	39	college	college	NOUN
iajs-2916	15	40	of	of	ADP
iajs-2916	15	41	science	science	NOUN
iajs-2916	15	42	for	for	ADP
iajs-2916	15	43	women/	women/	NUM
iajs-2916	15	44	university	university	NOUN
iajs-2916	15	45	of	of	ADP
iajs-2916	15	46	baghdad/	baghdad/	NUM
iajs-2916	15	47	baghdad/	baghdad/	NUM
iajs-2916	15	48	iraq	iraq	PROPN
iajs-2916	15	49	.	.	PUNCT
iajs-2916	16	1	fayhaamk_chem@csw.uobagdad.edu.iq	fayhaamk_chem@csw.uobagdad.edu.iq	PROPN
iajs-2916	16	2	isam	isam	PROPN
iajs-2916	16	3	noori	noori	PROPN
iajs-2916	16	4	salman	salman	PROPN
iajs-2916	16	5	the	the	DET
iajs-2916	16	6	national	national	ADJ
iajs-2916	16	7	diabetes	diabetes	NOUN
iajs-2916	16	8	center	center	NOUN
iajs-2916	16	9	,	,	PUNCT
iajs-2916	16	10	mustansiriyah	mustansiriyah	NOUN
iajs-2916	16	11	university	university	PROPN
iajs-2916	16	12	/	/	SYM
iajs-2916	16	13	baghdad	baghdad	PROPN
iajs-2916	16	14	/	/	SYM
iajs-2916	16	15	iraq	iraq	PROPN
iajs-2916	16	16	.	.	PUNCT
iajs-2916	17	1	esamnoori61@gmail.com	esamnoori61@gmail.com	X
iajs-2916	17	2	baydaa	baydaa	PROPN
iajs-2916	17	3	ahmed	ahme	VERB
iajs-2916	17	4	abd	abd	PROPN
iajs-2916	17	5	the	the	DET
iajs-2916	17	6	national	national	ADJ
iajs-2916	17	7	diabetes	diabetes	NOUN
iajs-2916	17	8	center	center	NOUN
iajs-2916	17	9	/	/	SYM
iajs-2916	17	10	mustansiriyah	mustansiriyah	NOUN
iajs-2916	17	11	university	university	PROPN
iajs-2916	17	12	/	/	SYM
iajs-2916	17	13	baghdad	baghdad	PROPN
iajs-2916	17	14	/	/	SYM
iajs-2916	17	15	iraq	iraq	PROPN
iajs-2916	17	16	baydaaahmed@yhoo.com	baydaaahmed@yhoo.com	X
iajs-2916	18	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-2916	18	2	mailto:hadeel.khaled1205a@csw.uobaghdad.edu.iq	mailto:hadeel.khaled1205a@csw.uobaghdad.edu.iq	PROPN
iajs-2916	18	3	mailto:fayhaamk_chem@csw.uobagdad.edu.iq	mailto:fayhaamk_chem@csw.uobagdad.edu.iq	VERB
iajs-2916	18	4	mailto:esamnoori61@gmail.com	mailto:esamnoori61@gmail.com	X
iajs-2916	18	5	mailto:baydaaahmed@yhoo.com	mailto:baydaaahmed@yhoo.com	PROPN
iajs-2916	18	6	ihjpas	ihjpas	PROPN
iajs-2916	18	7	.	.	PUNCT
iajs-2916	19	1	53	53	NUM
iajs-2916	19	2	(	(	PUNCT
iajs-2916	19	3	4)2022	4)2022	NOUN
iajs-2916	19	4	195	195	NUM
iajs-2916	19	5	1	1	NUM
iajs-2916	19	6	.	.	PUNCT
iajs-2916	20	1	introduction	introduction	NOUN
iajs-2916	20	2	people	people	NOUN
iajs-2916	20	3	with	with	ADP
iajs-2916	20	4	diabetes	diabetes	NOUN
iajs-2916	20	5	mellitus	mellitus	NOUN
iajs-2916	20	6	have	have	VERB
iajs-2916	20	7	a	a	DET
iajs-2916	20	8	metabolic	metabolic	NOUN
iajs-2916	20	9	disease	disease	NOUN
iajs-2916	20	10	that	that	PRON
iajs-2916	20	11	lasts	last	VERB
iajs-2916	20	12	the	the	DET
iajs-2916	20	13	rest	rest	NOUN
iajs-2916	20	14	of	of	ADP
iajs-2916	20	15	their	their	PRON
iajs-2916	20	16	lives	life	NOUN
iajs-2916	20	17	[	[	X
iajs-2916	20	18	1	1	NUM
iajs-2916	20	19	,	,	PUNCT
iajs-2916	20	20	2	2	NUM
iajs-2916	20	21	]	]	PUNCT
iajs-2916	20	22	.	.	PUNCT
iajs-2916	21	1	hyperglycemia	hyperglycemia	NOUN
iajs-2916	21	2	brought	bring	VERB
iajs-2916	21	3	on	on	ADP
iajs-2916	21	4	by	by	ADP
iajs-2916	21	5	issues	issue	NOUN
iajs-2916	21	6	with	with	ADP
iajs-2916	21	7	insulin	insulin	NOUN
iajs-2916	21	8	secretion	secretion	NOUN
iajs-2916	21	9	,	,	PUNCT
iajs-2916	21	10	insulin	insulin	NOUN
iajs-2916	21	11	function	function	NOUN
iajs-2916	21	12	,	,	PUNCT
iajs-2916	21	13	or	or	CCONJ
iajs-2916	21	14	a	a	DET
iajs-2916	21	15	combination	combination	NOUN
iajs-2916	21	16	of	of	ADP
iajs-2916	21	17	these	these	DET
iajs-2916	21	18	issues	issue	NOUN
iajs-2916	21	19	characterizes	characterize	VERB
iajs-2916	21	20	it	it	PRON
iajs-2916	21	21	[	[	X
iajs-2916	21	22	3	3	NUM
iajs-2916	21	23	]	]	PUNCT
iajs-2916	21	24	.	.	PUNCT
iajs-2916	22	1	hba1c	hba1c	PROPN
iajs-2916	22	2	is	be	AUX
iajs-2916	22	3	a	a	DET
iajs-2916	22	4	reliable	reliable	ADJ
iajs-2916	22	5	diabetes	diabetes	NOUN
iajs-2916	22	6	diagnostic	diagnostic	ADJ
iajs-2916	22	7	tool	tool	NOUN
iajs-2916	22	8	that	that	PRON
iajs-2916	22	9	was	be	AUX
iajs-2916	22	10	initially	initially	ADV
iajs-2916	22	11	used	use	VERB
iajs-2916	22	12	in	in	ADP
iajs-2916	22	13	diabetes	diabetes	NOUN
iajs-2916	22	14	treatment	treatment	NOUN
iajs-2916	22	15	in	in	ADP
iajs-2916	22	16	1985	1985	NUM
iajs-2916	22	17	[	[	X
iajs-2916	22	18	4	4	NUM
iajs-2916	22	19	]	]	PUNCT
iajs-2916	22	20	.	.	PUNCT
iajs-2916	23	1	in	in	ADP
iajs-2916	23	2	march	march	PROPN
iajs-2916	23	3	2009	2009	NUM
iajs-2916	23	4	,	,	PUNCT
iajs-2916	23	5	who	who	PRON
iajs-2916	23	6	convened	convene	VERB
iajs-2916	23	7	and	and	CCONJ
iajs-2916	23	8	placed	place	VERB
iajs-2916	23	9	hba1c	hba1c	PROPN
iajs-2916	23	10	as	as	ADP
iajs-2916	23	11	a	a	DET
iajs-2916	23	12	diagnosis	diagnosis	NOUN
iajs-2916	23	13	of	of	ADP
iajs-2916	23	14	diabetes	diabetes	NOUN
iajs-2916	23	15	based	base	VERB
iajs-2916	23	16	on	on	ADP
iajs-2916	23	17	available	available	ADJ
iajs-2916	23	18	evidence	evidence	NOUN
iajs-2916	23	19	[	[	X
iajs-2916	23	20	5	5	NUM
iajs-2916	23	21	]	]	PUNCT
iajs-2916	23	22	.	.	PUNCT
iajs-2916	24	1	type	type	NOUN
iajs-2916	24	2	ii	ii	PROPN
iajs-2916	24	3	dm	dm	PRON
iajs-2916	24	4	usually	usually	ADV
iajs-2916	24	5	develops	develop	VERB
iajs-2916	24	6	gradually	gradually	ADV
iajs-2916	24	7	because	because	SCONJ
iajs-2916	24	8	of	of	ADP
iajs-2916	24	9	obesity	obesity	NOUN
iajs-2916	24	10	and	and	CCONJ
iajs-2916	24	11	other	other	ADJ
iajs-2916	24	12	comorbidities	comorbiditie	NOUN
iajs-2916	24	13	that	that	PRON
iajs-2916	24	14	induce	induce	VERB
iajs-2916	24	15	cells	cell	NOUN
iajs-2916	24	16	to	to	PART
iajs-2916	24	17	become	become	VERB
iajs-2916	24	18	resistant	resistant	ADJ
iajs-2916	24	19	to	to	ADP
iajs-2916	24	20	insulin	insulin	NOUN
iajs-2916	24	21	's	's	PART
iajs-2916	24	22	hormonal	hormonal	ADJ
iajs-2916	24	23	activity	activity	NOUN
iajs-2916	24	24	[	[	X
iajs-2916	24	25	6	6	NUM
iajs-2916	24	26	]	]	PUNCT
iajs-2916	24	27	.	.	PUNCT
iajs-2916	25	1	insulin	insulin	NOUN
iajs-2916	25	2	resistance	resistance	NOUN
iajs-2916	25	3	was	be	AUX
iajs-2916	25	4	characterized	characterize	VERB
iajs-2916	25	5	by	by	ADP
iajs-2916	25	6	lower	low	ADJ
iajs-2916	25	7	responsiveness	responsiveness	NOUN
iajs-2916	25	8	of	of	ADP
iajs-2916	25	9	tissues	tissue	NOUN
iajs-2916	25	10	targeted	target	VERB
iajs-2916	25	11	by	by	ADP
iajs-2916	25	12	insulin	insulin	NOUN
iajs-2916	25	13	stimulation	stimulation	NOUN
iajs-2916	25	14	.	.	PUNCT
iajs-2916	26	1	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-2916	26	2	is	be	AUX
iajs-2916	26	3	a	a	DET
iajs-2916	26	4	condition	condition	NOUN
iajs-2916	26	5	that	that	PRON
iajs-2916	26	6	occurs	occur	VERB
iajs-2916	26	7	when	when	SCONJ
iajs-2916	26	8	insulin	insulin	NOUN
iajs-2916	26	9	resistance	resistance	NOUN
iajs-2916	26	10	is	be	AUX
iajs-2916	26	11	accompanied	accompany	VERB
iajs-2916	26	12	by	by	ADP
iajs-2916	26	13	abnormal	abnormal	ADJ
iajs-2916	26	14	insulin	insulin	NOUN
iajs-2916	26	15	production	production	NOUN
iajs-2916	26	16	after	after	ADP
iajs-2916	26	17	a	a	DET
iajs-2916	26	18	meal	meal	NOUN
iajs-2916	26	19	.	.	PUNCT
iajs-2916	27	1	long	long	ADJ
iajs-2916	27	2	-	-	PUNCT
iajs-2916	27	3	term	term	NOUN
iajs-2916	27	4	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-2916	27	5	,	,	PUNCT
iajs-2916	27	6	interestingly	interestingly	ADV
iajs-2916	27	7	,	,	PUNCT
iajs-2916	27	8	causes	cause	VERB
iajs-2916	27	9	ir	ir	NOUN
iajs-2916	27	10	to	to	PART
iajs-2916	27	11	be	be	AUX
iajs-2916	27	12	worse	bad	ADJ
iajs-2916	27	13	[	[	X
iajs-2916	27	14	7	7	NUM
iajs-2916	27	15	]	]	PUNCT
iajs-2916	27	16	.	.	PUNCT
iajs-2916	28	1	the	the	DET
iajs-2916	28	2	ensuing	ensue	VERB
iajs-2916	28	3	insulin	insulin	NOUN
iajs-2916	28	4	-	-	PUNCT
iajs-2916	28	5	resistant	resistant	ADJ
iajs-2916	28	6	condition	condition	NOUN
iajs-2916	28	7	has	have	VERB
iajs-2916	28	8	systemic	systemic	ADJ
iajs-2916	28	9	and	and	CCONJ
iajs-2916	28	10	tissue	tissue	NOUN
iajs-2916	28	11	-	-	PUNCT
iajs-2916	28	12	level	level	NOUN
iajs-2916	28	13	effects	effect	NOUN
iajs-2916	28	14	,	,	PUNCT
iajs-2916	28	15	affecting	affect	VERB
iajs-2916	28	16	the	the	DET
iajs-2916	28	17	subject	subject	NOUN
iajs-2916	28	18	's	's	PART
iajs-2916	28	19	metabolic	metabolic	NOUN
iajs-2916	28	20	status	status	NOUN
iajs-2916	28	21	.	.	PUNCT
iajs-2916	29	1	ir	ir	PROPN
iajs-2916	29	2	is	be	AUX
iajs-2916	29	3	a	a	DET
iajs-2916	29	4	hallmark	hallmark	NOUN
iajs-2916	29	5	of	of	ADP
iajs-2916	29	6	early	early	ADJ
iajs-2916	29	7	-	-	PUNCT
iajs-2916	29	8	onset	onset	NOUN
iajs-2916	29	9	t2	t2	NOUN
iajs-2916	29	10	dm	dm	NUM
iajs-2916	29	11	that	that	PRON
iajs-2916	29	12	can	can	AUX
iajs-2916	29	13	occur	occur	VERB
iajs-2916	29	14	in	in	ADP
iajs-2916	29	15	the	the	DET
iajs-2916	29	16	main	main	ADJ
iajs-2916	29	17	calorie	calorie	NOUN
iajs-2916	29	18	storage	storage	NOUN
iajs-2916	29	19	areas	area	NOUN
iajs-2916	29	20	,	,	PUNCT
iajs-2916	29	21	such	such	ADJ
iajs-2916	29	22	as	as	ADP
iajs-2916	29	23	adipose	adipose	ADJ
iajs-2916	29	24	tissue	tissue	NOUN
iajs-2916	29	25	(	(	PUNCT
iajs-2916	29	26	at	at	ADP
iajs-2916	29	27	)	)	PUNCT
iajs-2916	29	28	,	,	PUNCT
iajs-2916	29	29	skeletal	skeletal	ADJ
iajs-2916	29	30	muscle	muscle	NOUN
iajs-2916	29	31	,	,	PUNCT
iajs-2916	29	32	and	and	CCONJ
iajs-2916	29	33	the	the	DET
iajs-2916	29	34	liver	liver	NOUN
iajs-2916	29	35	[	[	X
iajs-2916	29	36	8	8	NUM
iajs-2916	29	37	]	]	PUNCT
iajs-2916	29	38	.	.	PUNCT
iajs-2916	30	1	peripheral	peripheral	ADJ
iajs-2916	30	2	neuropathies	neuropathy	NOUN
iajs-2916	30	3	are	be	AUX
iajs-2916	30	4	illnesses	illness	NOUN
iajs-2916	30	5	of	of	ADP
iajs-2916	30	6	peripheral	peripheral	ADJ
iajs-2916	30	7	nerve	nerve	NOUN
iajs-2916	30	8	cells	cell	NOUN
iajs-2916	30	9	and	and	CCONJ
iajs-2916	30	10	fibers	fiber	NOUN
iajs-2916	30	11	that	that	PRON
iajs-2916	30	12	may	may	AUX
iajs-2916	30	13	be	be	AUX
iajs-2916	30	14	caused	cause	VERB
iajs-2916	30	15	by	by	ADP
iajs-2916	30	16	different	different	ADJ
iajs-2916	30	17	disorders	disorder	NOUN
iajs-2916	30	18	.	.	PUNCT
iajs-2916	31	1	cranial	cranial	ADJ
iajs-2916	31	2	nerves	nerve	NOUN
iajs-2916	31	3	,	,	PUNCT
iajs-2916	31	4	spinal	spinal	ADJ
iajs-2916	31	5	nerve	nerve	NOUN
iajs-2916	31	6	roots	root	NOUN
iajs-2916	31	7	and	and	CCONJ
iajs-2916	31	8	ganglia	ganglia	NOUN
iajs-2916	31	9	,	,	PUNCT
iajs-2916	31	10	nerve	nerve	NOUN
iajs-2916	31	11	trunks	trunk	NOUN
iajs-2916	31	12	and	and	CCONJ
iajs-2916	31	13	divisions	division	NOUN
iajs-2916	31	14	,	,	PUNCT
iajs-2916	31	15	and	and	CCONJ
iajs-2916	31	16	nerves	nerve	NOUN
iajs-2916	31	17	in	in	ADP
iajs-2916	31	18	the	the	DET
iajs-2916	31	19	autonomic	autonomic	ADJ
iajs-2916	31	20	nervous	nervous	ADJ
iajs-2916	31	21	system	system	NOUN
iajs-2916	31	22	are	be	AUX
iajs-2916	31	23	among	among	ADP
iajs-2916	31	24	these	these	DET
iajs-2916	31	25	nerves	nerve	NOUN
iajs-2916	31	26	[	[	X
iajs-2916	31	27	9	9	NUM
iajs-2916	31	28	]	]	PUNCT
iajs-2916	31	29	.	.	PUNCT
iajs-2916	32	1	the	the	DET
iajs-2916	32	2	prevalence	prevalence	NOUN
iajs-2916	32	3	of	of	ADP
iajs-2916	32	4	diabetes	diabetes	NOUN
iajs-2916	32	5	mellitus	mellitus	NOUN
iajs-2916	32	6	has	have	AUX
iajs-2916	32	7	been	be	AUX
iajs-2916	32	8	widely	widely	ADV
iajs-2916	32	9	related	relate	VERB
iajs-2916	32	10	to	to	PART
iajs-2916	32	11	oxidative	oxidative	ADJ
iajs-2916	32	12	stress	stress	NOUN
iajs-2916	32	13	.	.	PUNCT
iajs-2916	33	1	previous	previous	ADJ
iajs-2916	33	2	studies	study	NOUN
iajs-2916	33	3	have	have	AUX
iajs-2916	33	4	proven	prove	VERB
iajs-2916	33	5	that	that	SCONJ
iajs-2916	33	6	the	the	DET
iajs-2916	33	7	oxidative	oxidative	ADJ
iajs-2916	33	8	stress	stress	NOUN
iajs-2916	33	9	(	(	PUNCT
iajs-2916	33	10	ox	ox	NOUN
iajs-2916	33	11	)	)	PUNCT
iajs-2916	33	12	is	be	AUX
iajs-2916	33	13	a	a	DET
iajs-2916	33	14	major	major	ADJ
iajs-2916	33	15	factor	factor	NOUN
iajs-2916	33	16	in	in	ADP
iajs-2916	33	17	the	the	DET
iajs-2916	33	18	development	development	NOUN
iajs-2916	33	19	and	and	CCONJ
iajs-2916	33	20	progression	progression	NOUN
iajs-2916	33	21	of	of	ADP
iajs-2916	33	22	diabetes	diabetes	NOUN
iajs-2916	33	23	and	and	CCONJ
iajs-2916	33	24	its	its	PRON
iajs-2916	33	25	complications	complication	NOUN
iajs-2916	33	26	[	[	X
iajs-2916	33	27	10	10	NUM
iajs-2916	33	28	]	]	PUNCT
iajs-2916	33	29	.	.	PUNCT
iajs-2916	34	1	antioxidant	antioxidant	ADJ
iajs-2916	34	2	strategies	strategy	NOUN
iajs-2916	34	3	may	may	AUX
iajs-2916	34	4	be	be	AUX
iajs-2916	34	5	useful	useful	ADJ
iajs-2916	34	6	in	in	ADP
iajs-2916	34	7	preventing	prevent	VERB
iajs-2916	34	8	or	or	CCONJ
iajs-2916	34	9	treating	treat	VERB
iajs-2916	34	10	the	the	DET
iajs-2916	34	11	disease	disease	NOUN
iajs-2916	34	12	,	,	PUNCT
iajs-2916	34	13	concerning	concern	VERB
iajs-2916	34	14	the	the	DET
iajs-2916	34	15	role	role	NOUN
iajs-2916	34	16	of	of	ADP
iajs-2916	34	17	oxidative	oxidative	ADJ
iajs-2916	34	18	stress	stress	NOUN
iajs-2916	34	19	in	in	ADP
iajs-2916	34	20	the	the	DET
iajs-2916	34	21	onset	onset	NOUN
iajs-2916	34	22	and	and	CCONJ
iajs-2916	34	23	progression	progression	NOUN
iajs-2916	34	24	of	of	ADP
iajs-2916	34	25	diabetes	diabetes	NOUN
iajs-2916	34	26	.	.	PUNCT
iajs-2916	35	1	in	in	ADP
iajs-2916	35	2	this	this	DET
iajs-2916	35	3	regard	regard	NOUN
iajs-2916	35	4	,	,	PUNCT
iajs-2916	35	5	some	some	DET
iajs-2916	35	6	types	type	NOUN
iajs-2916	35	7	of	of	ADP
iajs-2916	35	8	fruits	fruit	NOUN
iajs-2916	35	9	raise	raise	VERB
iajs-2916	35	10	the	the	DET
iajs-2916	35	11	level	level	NOUN
iajs-2916	35	12	of	of	ADP
iajs-2916	35	13	glucose	glucose	NOUN
iajs-2916	35	14	in	in	ADP
iajs-2916	35	15	the	the	DET
iajs-2916	35	16	blood	blood	NOUN
iajs-2916	35	17	,	,	PUNCT
iajs-2916	35	18	and	and	CCONJ
iajs-2916	35	19	some	some	DET
iajs-2916	35	20	fruits	fruit	NOUN
iajs-2916	35	21	and	and	CCONJ
iajs-2916	35	22	vegetables	vegetable	NOUN
iajs-2916	35	23	are	be	AUX
iajs-2916	35	24	rich	rich	ADJ
iajs-2916	35	25	in	in	ADP
iajs-2916	35	26	antioxidant	antioxidant	ADJ
iajs-2916	35	27	components	component	NOUN
iajs-2916	35	28	.	.	PUNCT
iajs-2916	36	1	several	several	ADJ
iajs-2916	36	2	studies	study	NOUN
iajs-2916	36	3	have	have	AUX
iajs-2916	36	4	reported	report	VERB
iajs-2916	36	5	the	the	DET
iajs-2916	36	6	favorable	favorable	ADJ
iajs-2916	36	7	benefits	benefit	NOUN
iajs-2916	36	8	of	of	ADP
iajs-2916	36	9	various	various	ADJ
iajs-2916	36	10	diets	diet	NOUN
iajs-2916	36	11	or	or	CCONJ
iajs-2916	36	12	meals	meal	NOUN
iajs-2916	36	13	in	in	ADP
iajs-2916	36	14	preventing	prevent	VERB
iajs-2916	36	15	diabetes	diabetes	NOUN
iajs-2916	36	16	[	[	X
iajs-2916	36	17	11	11	NUM
iajs-2916	36	18	]	]	PUNCT
iajs-2916	36	19	.	.	PUNCT
iajs-2916	37	1	these	these	DET
iajs-2916	37	2	contents	content	NOUN
iajs-2916	37	3	may	may	AUX
iajs-2916	37	4	serve	serve	VERB
iajs-2916	37	5	as	as	ADP
iajs-2916	37	6	antioxidants	antioxidant	NOUN
iajs-2916	37	7	,	,	PUNCT
iajs-2916	37	8	promote	promote	VERB
iajs-2916	37	9	insulin	insulin	NOUN
iajs-2916	37	10	secretion	secretion	NOUN
iajs-2916	37	11	and	and	CCONJ
iajs-2916	37	12	sensitivity	sensitivity	NOUN
iajs-2916	37	13	,	,	PUNCT
iajs-2916	37	14	and	and	CCONJ
iajs-2916	37	15	reduce	reduce	VERB
iajs-2916	37	16	the	the	DET
iajs-2916	37	17	lipid	lipid	NOUN
iajs-2916	37	18	levels	level	NOUN
iajs-2916	37	19	in	in	ADP
iajs-2916	37	20	the	the	DET
iajs-2916	37	21	blood	blood	NOUN
iajs-2916	38	1	[	[	X
iajs-2916	38	2	12	12	NUM
iajs-2916	38	3	]	]	PUNCT
iajs-2916	38	4	.	.	PUNCT
iajs-2916	39	1	antioxidants	antioxidant	NOUN
iajs-2916	39	2	can	can	AUX
iajs-2916	39	3	also	also	ADV
iajs-2916	39	4	help	help	VERB
iajs-2916	39	5	overcome	overcome	VERB
iajs-2916	39	6	oxidative	oxidative	ADJ
iajs-2916	39	7	stress	stress	NOUN
iajs-2916	39	8	.	.	PUNCT
iajs-2916	40	1	endogenous	endogenous	ADJ
iajs-2916	40	2	antioxidant	antioxidant	ADJ
iajs-2916	40	3	enzymes	enzyme	NOUN
iajs-2916	40	4	are	be	AUX
iajs-2916	40	5	:	:	PUNCT
iajs-2916	40	6	superoxide	superoxide	NOUN
iajs-2916	40	7	dismutase	dismutase	NOUN
iajs-2916	40	8	(	(	PUNCT
iajs-2916	40	9	sod	sod	NOUN
iajs-2916	40	10	)	)	PUNCT
iajs-2916	40	11	,	,	PUNCT
iajs-2916	40	12	catalase	catalase	NOUN
iajs-2916	40	13	(	(	PUNCT
iajs-2916	40	14	cat	cat	NOUN
iajs-2916	40	15	)	)	PUNCT
iajs-2916	40	16	,	,	PUNCT
iajs-2916	40	17	glutathione	glutathione	NOUN
iajs-2916	40	18	peroxidase	peroxidase	NOUN
iajs-2916	40	19	(	(	PUNCT
iajs-2916	40	20	gpx	gpx	PROPN
iajs-2916	40	21	)	)	PUNCT
iajs-2916	40	22	,	,	PUNCT
iajs-2916	40	23	and	and	CCONJ
iajs-2916	40	24	glutathione	glutathione	NOUN
iajs-2916	40	25	s	s	NOUN
iajs-2916	40	26	-	-	NOUN
iajs-2916	40	27	transferase	transferase	NOUN
iajs-2916	40	28	which	which	PRON
iajs-2916	40	29	have	have	VERB
iajs-2916	40	30	a	a	DET
iajs-2916	40	31	role	role	NOUN
iajs-2916	40	32	in	in	ADP
iajs-2916	40	33	oxidative	oxidative	ADJ
iajs-2916	40	34	stress	stress	NOUN
iajs-2916	40	35	defense	defense	NOUN
iajs-2916	40	36	(	(	PUNCT
iajs-2916	40	37	gst	gst	NOUN
iajs-2916	40	38	)	)	PUNCT
iajs-2916	41	1	[	[	X
iajs-2916	41	2	13	13	NUM
iajs-2916	41	3	]	]	PUNCT
iajs-2916	41	4	.	.	PUNCT
iajs-2916	42	1	gsts	gst	NOUN
iajs-2916	42	2	are	be	AUX
iajs-2916	42	3	xenobiotic	xenobiotic	ADJ
iajs-2916	42	4	metabolizing	metabolize	VERB
iajs-2916	42	5	enzymes	enzyme	NOUN
iajs-2916	42	6	through	through	ADP
iajs-2916	42	7	conjugation	conjugation	NOUN
iajs-2916	42	8	with	with	ADP
iajs-2916	42	9	reduced	reduce	VERB
iajs-2916	42	10	glutathione	glutathione	NOUN
iajs-2916	42	11	.	.	PUNCT
iajs-2916	43	1	gsts	gst	NOUN
iajs-2916	43	2	play	play	VERB
iajs-2916	43	3	a	a	DET
iajs-2916	43	4	vital	vital	ADJ
iajs-2916	43	5	function	function	NOUN
iajs-2916	43	6	in	in	ADP
iajs-2916	43	7	cellular	cellular	ADJ
iajs-2916	43	8	defense	defense	NOUN
iajs-2916	43	9	against	against	ADP
iajs-2916	43	10	reactive	reactive	ADJ
iajs-2916	43	11	electrophiles	electrophile	NOUN
iajs-2916	43	12	and	and	CCONJ
iajs-2916	43	13	fatty	fatty	NOUN
iajs-2916	43	14	acid	acid	NOUN
iajs-2916	43	15	hydroperoxides	hydroperoxide	NOUN
iajs-2916	43	16	which	which	PRON
iajs-2916	43	17	are	be	AUX
iajs-2916	43	18	produced	produce	VERB
iajs-2916	43	19	by	by	ADP
iajs-2916	43	20	the	the	DET
iajs-2916	43	21	oxidative	oxidative	ADJ
iajs-2916	43	22	stress	stress	NOUN
iajs-2916	43	23	.	.	PUNCT
iajs-2916	44	1	as	as	ADP
iajs-2916	44	2	a	a	DET
iajs-2916	44	3	result	result	NOUN
iajs-2916	44	4	,	,	PUNCT
iajs-2916	44	5	gsts	gst	NOUN
iajs-2916	44	6	aid	aid	NOUN
iajs-2916	44	7	cell	cell	NOUN
iajs-2916	44	8	detoxification	detoxification	NOUN
iajs-2916	44	9	by	by	ADP
iajs-2916	44	10	minimizing	minimize	VERB
iajs-2916	44	11	the	the	DET
iajs-2916	44	12	tissue	tissue	NOUN
iajs-2916	44	13	damage	damage	NOUN
iajs-2916	44	14	which	which	PRON
iajs-2916	44	15	caused	cause	VERB
iajs-2916	44	16	by	by	ADP
iajs-2916	44	17	free	free	ADJ
iajs-2916	44	18	radical	radical	ADJ
iajs-2916	44	19	attacks	attack	NOUN
iajs-2916	44	20	[	[	X
iajs-2916	44	21	14	14	NUM
iajs-2916	44	22	,	,	PUNCT
iajs-2916	44	23	15	15	NUM
iajs-2916	44	24	]	]	PUNCT
iajs-2916	44	25	.	.	PUNCT
iajs-2916	45	1	the	the	DET
iajs-2916	45	2	present	present	ADJ
iajs-2916	45	3	study	study	NOUN
iajs-2916	45	4	aimed	aim	VERB
iajs-2916	45	5	to	to	PART
iajs-2916	45	6	evaluate	evaluate	VERB
iajs-2916	45	7	the	the	DET
iajs-2916	45	8	insulin	insulin	NOUN
iajs-2916	45	9	resistance	resistance	NOUN
iajs-2916	45	10	and	and	CCONJ
iajs-2916	45	11	gst	gst	NOUN
iajs-2916	45	12	activity	activity	NOUN
iajs-2916	45	13	and	and	CCONJ
iajs-2916	45	14	highlighted	highlight	VERB
iajs-2916	45	15	if	if	SCONJ
iajs-2916	45	16	there	there	PRON
iajs-2916	45	17	is	be	VERB
iajs-2916	45	18	a	a	DET
iajs-2916	45	19	relationship	relationship	NOUN
iajs-2916	45	20	between	between	ADP
iajs-2916	45	21	these	these	DET
iajs-2916	45	22	parameters	parameter	NOUN
iajs-2916	45	23	in	in	ADP
iajs-2916	45	24	diabetic	diabetic	ADJ
iajs-2916	45	25	and	and	CCONJ
iajs-2916	45	26	neuropathy	neuropathy	ADJ
iajs-2916	45	27	patients	patient	NOUN
iajs-2916	45	28	.	.	PUNCT
iajs-2916	46	1	2	2	X
iajs-2916	46	2	.	.	X
iajs-2916	46	3	materials	material	NOUN
iajs-2916	46	4	and	and	CCONJ
iajs-2916	46	5	methods	method	NOUN
iajs-2916	46	6	the	the	DET
iajs-2916	46	7	present	present	ADJ
iajs-2916	46	8	study	study	NOUN
iajs-2916	46	9	is	be	AUX
iajs-2916	46	10	conducted	conduct	VERB
iajs-2916	46	11	at	at	ADP
iajs-2916	46	12	the	the	DET
iajs-2916	46	13	department	department	NOUN
iajs-2916	46	14	of	of	ADP
iajs-2916	46	15	chemistry	chemistry	NOUN
iajs-2916	46	16	,	,	PUNCT
iajs-2916	46	17	college	college	NOUN
iajs-2916	46	18	of	of	ADP
iajs-2916	46	19	sciences	science	NOUN
iajs-2916	46	20	for	for	ADP
iajs-2916	46	21	women	woman	NOUN
iajs-2916	46	22	/	/	SYM
iajs-2916	46	23	university	university	PROPN
iajs-2916	46	24	of	of	ADP
iajs-2916	46	25	baghdad	baghdad	PROPN
iajs-2916	46	26	,	,	PUNCT
iajs-2916	46	27	and	and	CCONJ
iajs-2916	46	28	at	at	ADP
iajs-2916	46	29	the	the	DET
iajs-2916	46	30	national	national	ADJ
iajs-2916	46	31	diabetes	diabetes	NOUN
iajs-2916	46	32	center	center	NOUN
iajs-2916	46	33	for	for	ADP
iajs-2916	46	34	treatment	treatment	NOUN
iajs-2916	46	35	and	and	CCONJ
iajs-2916	46	36	research	research	NOUN
iajs-2916	46	37	at	at	ADP
iajs-2916	46	38	mustansiriyah	mustansiriyah	PROPN
iajs-2916	46	39	university	university	NOUN
iajs-2916	46	40	.	.	PUNCT
iajs-2916	47	1	the	the	DET
iajs-2916	47	2	study	study	NOUN
iajs-2916	47	3	includes	include	VERB
iajs-2916	47	4	(	(	PUNCT
iajs-2916	47	5	120	120	NUM
iajs-2916	47	6	)	)	PUNCT
iajs-2916	47	7	subjects	subject	NOUN
iajs-2916	47	8	divided	divide	VERB
iajs-2916	47	9	into	into	ADP
iajs-2916	47	10	three	three	NUM
iajs-2916	47	11	groups	group	NOUN
iajs-2916	47	12	:	:	PUNCT
iajs-2916	47	13	group	group	NOUN
iajs-2916	47	14	1	1	NUM
iajs-2916	47	15	contains	contain	VERB
iajs-2916	47	16	40	40	NUM
iajs-2916	47	17	healthy	healthy	ADJ
iajs-2916	47	18	people	people	NOUN
iajs-2916	47	19	as	as	ADP
iajs-2916	47	20	a	a	DET
iajs-2916	47	21	control	control	NOUN
iajs-2916	47	22	(	(	PUNCT
iajs-2916	47	23	20	20	NUM
iajs-2916	47	24	males	male	NOUN
iajs-2916	47	25	,	,	PUNCT
iajs-2916	47	26	and	and	CCONJ
iajs-2916	47	27	20	20	NUM
iajs-2916	47	28	females	female	NOUN
iajs-2916	47	29	)	)	PUNCT
iajs-2916	47	30	with	with	ADP
iajs-2916	47	31	ages	age	NOUN
iajs-2916	47	32	of	of	ADP
iajs-2916	47	33	(	(	PUNCT
iajs-2916	47	34	3466	3466	NUM
iajs-2916	47	35	)	)	PUNCT
iajs-2916	47	36	.	.	PUNCT
iajs-2916	48	1	group	group	NOUN
iajs-2916	48	2	2	2	NUM
iajs-2916	48	3	contains	contain	VERB
iajs-2916	48	4	40	40	NUM
iajs-2916	48	5	subjects	subject	NOUN
iajs-2916	48	6	with	with	ADP
iajs-2916	48	7	type	type	NOUN
iajs-2916	48	8	2	2	NUM
iajs-2916	48	9	diabetes	diabetes	NOUN
iajs-2916	48	10	mellitus	mellitus	NOUN
iajs-2916	48	11	(	(	PUNCT
iajs-2916	48	12	18	18	NUM
iajs-2916	48	13	males	male	NOUN
iajs-2916	48	14	and	and	CCONJ
iajs-2916	48	15	22	22	NUM
iajs-2916	48	16	females	female	NOUN
iajs-2916	48	17	)	)	PUNCT
iajs-2916	48	18	with	with	ADP
iajs-2916	48	19	ages	age	NOUN
iajs-2916	48	20	of	of	ADP
iajs-2916	48	21	(	(	PUNCT
iajs-2916	48	22	34	34	NUM
iajs-2916	48	23	-	-	SYM
iajs-2916	48	24	65	65	NUM
iajs-2916	48	25	)	)	PUNCT
iajs-2916	48	26	.	.	PUNCT
iajs-2916	49	1	group	group	NOUN
iajs-2916	49	2	3	3	NUM
iajs-2916	49	3	has	have	VERB
iajs-2916	49	4	40	40	NUM
iajs-2916	49	5	subjects	subject	NOUN
iajs-2916	49	6	with	with	ADP
iajs-2916	49	7	type	type	NOUN
iajs-2916	49	8	2	2	NUM
iajs-2916	49	9	diabetes	diabetes	NOUN
iajs-2916	49	10	mellitus	mellitus	NOUN
iajs-2916	49	11	with	with	ADP
iajs-2916	49	12	neuropathy	neuropathy	ADJ
iajs-2916	49	13	(	(	PUNCT
iajs-2916	49	14	18	18	NUM
iajs-2916	49	15	males	male	NOUN
iajs-2916	49	16	and	and	CCONJ
iajs-2916	49	17	22	22	NUM
iajs-2916	49	18	females	female	NOUN
iajs-2916	49	19	)	)	PUNCT
iajs-2916	49	20	in	in	ADP
iajs-2916	49	21	ages	age	NOUN
iajs-2916	49	22	ranging	range	VERB
iajs-2916	49	23	(	(	PUNCT
iajs-2916	49	24	37	37	NUM
iajs-2916	49	25	-	-	SYM
iajs-2916	49	26	66	66	NUM
iajs-2916	49	27	)	)	PUNCT
iajs-2916	49	28	.	.	PUNCT
iajs-2916	50	1	peripheral	peripheral	ADJ
iajs-2916	50	2	neuropathy	neuropathy	ADJ
iajs-2916	50	3	patients	patient	NOUN
iajs-2916	50	4	were	be	AUX
iajs-2916	50	5	evaluated	evaluate	VERB
iajs-2916	50	6	by	by	ADP
iajs-2916	50	7	a	a	DET
iajs-2916	50	8	neurologist	neurologist	NOUN
iajs-2916	50	9	at	at	ADP
iajs-2916	50	10	the	the	DET
iajs-2916	50	11	national	national	ADJ
iajs-2916	50	12	diabetes	diabetes	NOUN
iajs-2916	50	13	center	center	NOUN
iajs-2916	50	14	using	use	VERB
iajs-2916	50	15	the	the	DET
iajs-2916	50	16	toronto	toronto	PROPN
iajs-2916	50	17	clinical	clinical	ADJ
iajs-2916	50	18	scale	scale	NOUN
iajs-2916	50	19	.	.	PUNCT
iajs-2916	51	1	from	from	ADP
iajs-2916	51	2	each	each	DET
iajs-2916	51	3	participating	participate	VERB
iajs-2916	51	4	subject	subject	NOUN
iajs-2916	51	5	(	(	PUNCT
iajs-2916	51	6	patient	patient	NOUN
iajs-2916	51	7	and	and	CCONJ
iajs-2916	51	8	control	control	NOUN
iajs-2916	51	9	)	)	PUNCT
iajs-2916	51	10	,	,	PUNCT
iajs-2916	51	11	about	about	ADV
iajs-2916	51	12	10	10	NUM
iajs-2916	51	13	ml	ml	NOUN
iajs-2916	51	14	of	of	ADP
iajs-2916	51	15	venous	venous	ADJ
iajs-2916	51	16	blood	blood	NOUN
iajs-2916	51	17	was	be	AUX
iajs-2916	51	18	collected	collect	VERB
iajs-2916	51	19	using	use	VERB
iajs-2916	51	20	a	a	DET
iajs-2916	51	21	10	10	NUM
iajs-2916	51	22	ml	ml	ADV
iajs-2916	51	23	disposable	disposable	ADJ
iajs-2916	51	24	syringe	syringe	NOUN
iajs-2916	51	25	.	.	PUNCT
iajs-2916	52	1	the	the	DET
iajs-2916	52	2	ihjpas	ihjpas	PROPN
iajs-2916	52	3	.	.	PUNCT
iajs-2916	53	1	53	53	NUM
iajs-2916	53	2	(	(	PUNCT
iajs-2916	53	3	4)2022	4)2022	SYM
iajs-2916	53	4	196	196	NUM
iajs-2916	53	5	blood	blood	NOUN
iajs-2916	53	6	was	be	AUX
iajs-2916	53	7	distributed	distribute	VERB
iajs-2916	53	8	into	into	ADP
iajs-2916	53	9	two	two	NUM
iajs-2916	53	10	parts	part	NOUN
iajs-2916	53	11	;	;	PUNCT
iajs-2916	53	12	the	the	DET
iajs-2916	53	13	first	first	ADJ
iajs-2916	53	14	was	be	AUX
iajs-2916	53	15	dispensed	dispense	VERB
iajs-2916	53	16	in	in	ADP
iajs-2916	53	17	a	a	DET
iajs-2916	53	18	gel	gel	NOUN
iajs-2916	53	19	tube	tube	NOUN
iajs-2916	53	20	to	to	PART
iajs-2916	53	21	collect	collect	VERB
iajs-2916	53	22	the	the	DET
iajs-2916	53	23	serum	serum	NOUN
iajs-2916	53	24	(	(	PUNCT
iajs-2916	53	25	after	after	ADP
iajs-2916	53	26	clotting	clotting	NOUN
iajs-2916	53	27	,	,	PUNCT
iajs-2916	53	28	blood	blood	NOUN
iajs-2916	53	29	was	be	AUX
iajs-2916	53	30	centrifuged	centrifuge	VERB
iajs-2916	53	31	at	at	ADP
iajs-2916	53	32	3000	3000	NUM
iajs-2916	53	33	rpm	rpm	NOUN
iajs-2916	53	34	for	for	ADP
iajs-2916	53	35	10	10	NUM
iajs-2916	53	36	minutes	minute	NOUN
iajs-2916	53	37	at	at	ADP
iajs-2916	53	38	room	room	NOUN
iajs-2916	53	39	temperature	temperature	NOUN
iajs-2916	53	40	,	,	PUNCT
iajs-2916	53	41	and	and	CCONJ
iajs-2916	53	42	then	then	ADV
iajs-2916	53	43	serum	serum	NOUN
iajs-2916	53	44	was	be	AUX
iajs-2916	53	45	separated	separate	VERB
iajs-2916	53	46	,	,	PUNCT
iajs-2916	53	47	distributed	distribute	VERB
iajs-2916	53	48	into	into	ADP
iajs-2916	53	49	aliquots	aliquot	NOUN
iajs-2916	53	50	in	in	ADP
iajs-2916	53	51	an	an	DET
iajs-2916	53	52	eppendorf	eppendorf	ADJ
iajs-2916	53	53	tube	tube	NOUN
iajs-2916	53	54	,	,	PUNCT
iajs-2916	53	55	and	and	CCONJ
iajs-2916	53	56	stored	store	VERB
iajs-2916	53	57	at	at	ADP
iajs-2916	53	58	-20	-20	NUM
iajs-2916	53	59	°	°	NOUN
iajs-2916	53	60	c	c	NOUN
iajs-2916	53	61	until	until	ADP
iajs-2916	53	62	assayed	assayed	ADJ
iajs-2916	53	63	)	)	PUNCT
iajs-2916	53	64	.	.	PUNCT
iajs-2916	54	1	the	the	DET
iajs-2916	54	2	second	second	ADJ
iajs-2916	54	3	part	part	NOUN
iajs-2916	54	4	was	be	AUX
iajs-2916	54	5	drawn	draw	VERB
iajs-2916	54	6	in	in	ADP
iajs-2916	54	7	an	an	DET
iajs-2916	54	8	edta	edta	NOUN
iajs-2916	54	9	tube	tube	NOUN
iajs-2916	54	10	and	and	CCONJ
iajs-2916	54	11	analyzed	analyze	VERB
iajs-2916	54	12	for	for	ADP
iajs-2916	54	13	hba1c	hba1c	PROPN
iajs-2916	54	14	assay	assay	NOUN
iajs-2916	54	15	.	.	PUNCT
iajs-2916	55	1	the	the	DET
iajs-2916	55	2	patients	patient	NOUN
iajs-2916	55	3	were	be	AUX
iajs-2916	55	4	under	under	ADP
iajs-2916	55	5	the	the	DET
iajs-2916	55	6	treatment	treatment	NOUN
iajs-2916	55	7	with	with	ADP
iajs-2916	55	8	metformin	metformin	NOUN
iajs-2916	55	9	and	and	CCONJ
iajs-2916	55	10	sulfonylurea	sulfonylurea	NOUN
iajs-2916	55	11	drugs	drug	NOUN
iajs-2916	55	12	.	.	PUNCT
iajs-2916	56	1	fasting	fast	VERB
iajs-2916	56	2	serum	serum	NOUN
iajs-2916	56	3	insulin	insulin	NOUN
iajs-2916	56	4	concentrations	concentration	NOUN
iajs-2916	56	5	were	be	AUX
iajs-2916	56	6	determined	determine	VERB
iajs-2916	56	7	by	by	ADP
iajs-2916	56	8	enzyme	enzyme	NOUN
iajs-2916	56	9	-	-	PUNCT
iajs-2916	56	10	linked	link	VERB
iajs-2916	56	11	immunoassay	immunoassay	NOUN
iajs-2916	56	12	(	(	PUNCT
iajs-2916	56	13	elisa	elisa	PROPN
iajs-2916	56	14	)	)	PUNCT
iajs-2916	56	15	using	use	VERB
iajs-2916	56	16	a	a	DET
iajs-2916	56	17	kit	kit	NOUN
iajs-2916	56	18	produced	produce	VERB
iajs-2916	56	19	by	by	ADP
iajs-2916	56	20	cusabio	cusabio	NOUN
iajs-2916	56	21	company	company	NOUN
iajs-2916	56	22	in	in	ADP
iajs-2916	56	23	the	the	DET
iajs-2916	56	24	u.s.a	u.s.a	NOUN
iajs-2916	56	25	.	.	PUNCT
iajs-2916	57	1	fasting	fast	VERB
iajs-2916	57	2	blood	blood	NOUN
iajs-2916	57	3	glucose	glucose	NOUN
iajs-2916	57	4	,	,	PUNCT
iajs-2916	57	5	triglyceride	triglyceride	ADJ
iajs-2916	57	6	,	,	PUNCT
iajs-2916	57	7	total	total	ADJ
iajs-2916	57	8	cholesterol	cholesterol	NOUN
iajs-2916	57	9	,	,	PUNCT
iajs-2916	57	10	and	and	CCONJ
iajs-2916	57	11	high	high	ADJ
iajs-2916	57	12	-	-	PUNCT
iajs-2916	57	13	density	density	NOUN
iajs-2916	57	14	lipoprotein	lipoprotein	NOUN
iajs-2916	57	15	were	be	AUX
iajs-2916	57	16	determined	determine	VERB
iajs-2916	57	17	by	by	ADP
iajs-2916	57	18	biolabo	biolabo	NOUN
iajs-2916	57	19	kit	kit	PROPN
iajs-2916	57	20	-	-	PUNCT
iajs-2916	57	21	france	france	PROPN
iajs-2916	57	22	using	use	VERB
iajs-2916	57	23	kenza	kenza	PROPN
iajs-2916	57	24	(	(	PUNCT
iajs-2916	57	25	240tx	240tx	PROPN
iajs-2916	57	26	)	)	PUNCT
iajs-2916	57	27	instrument	instrument	NOUN
iajs-2916	57	28	.	.	PUNCT
iajs-2916	58	1	gsh	gsh	PROPN
iajs-2916	58	2	(	(	PUNCT
iajs-2916	58	3	sigma	sigma	PROPN
iajs-2916	58	4	chemicals	chemical	NOUN
iajs-2916	58	5	,	,	PUNCT
iajs-2916	58	6	u.s.a	u.s.a	PROPN
iajs-2916	58	7	)	)	PUNCT
iajs-2916	58	8	was	be	AUX
iajs-2916	58	9	used	use	VERB
iajs-2916	58	10	to	to	PART
iajs-2916	58	11	manually	manually	ADV
iajs-2916	58	12	measure	measure	VERB
iajs-2916	58	13	gst	gst	NOUN
iajs-2916	58	14	activity	activity	NOUN
iajs-2916	58	15	.	.	PUNCT
iajs-2916	59	1	homeostasis	homeostasis	NOUN
iajs-2916	59	2	model	model	NOUN
iajs-2916	59	3	assessment	assessment	NOUN
iajs-2916	59	4	(	(	PUNCT
iajs-2916	59	5	homa	homa	PROPN
iajs-2916	59	6	ir	ir	PROPN
iajs-2916	59	7	)	)	PUNCT
iajs-2916	59	8	is	be	AUX
iajs-2916	59	9	used	use	VERB
iajs-2916	59	10	to	to	PART
iajs-2916	59	11	determine	determine	VERB
iajs-2916	59	12	the	the	DET
iajs-2916	59	13	insulin	insulin	NOUN
iajs-2916	59	14	resistance	resistance	NOUN
iajs-2916	59	15	by	by	ADP
iajs-2916	59	16	the	the	DET
iajs-2916	59	17	formula	formula	NOUN
iajs-2916	59	18	:	:	PUNCT
iajs-2916	59	19	homa	homa	PROPN
iajs-2916	59	20	ir=	ir=	VERB
iajs-2916	59	21	𝐺𝑙𝑢𝑐𝑜𝑠𝑒	𝐺𝑙𝑢𝑐𝑜𝑠𝑒	PROPN
iajs-2916	59	22	×𝐼𝑛𝑠𝑢𝑙𝑖𝑛	×𝐼𝑛𝑠𝑢𝑙𝑖𝑛	VERB
iajs-2916	59	23	405	405	NUM
iajs-2916	60	1	[	[	X
iajs-2916	60	2	16	16	NUM
iajs-2916	60	3	]	]	PUNCT
iajs-2916	60	4	.	.	PUNCT
iajs-2916	61	1	waist	waist	NOUN
iajs-2916	61	2	to	to	PART
iajs-2916	61	3	hip	hip	VERB
iajs-2916	61	4	ratio	ratio	NOUN
iajs-2916	61	5	:	:	PUNCT
iajs-2916	61	6	𝑊𝐻𝑅	𝑊𝐻𝑅	PROPN
iajs-2916	61	7	=	=	SYM
iajs-2916	61	8	𝑤𝑎𝑖𝑠𝑡	𝑤𝑎𝑖𝑠𝑡	PROPN
iajs-2916	61	9	𝑐𝑚	𝑐𝑚	PROPN
iajs-2916	61	10	÷	÷	PUNCT
iajs-2916	61	11	h𝑖𝑝	h𝑖𝑝	PROPN
iajs-2916	61	12	𝑐𝑚	𝑐𝑚	X
iajs-2916	62	1	[	[	X
iajs-2916	62	2	17	17	NUM
iajs-2916	62	3	]	]	PUNCT
iajs-2916	62	4	.	.	PUNCT
iajs-2916	63	1	body	body	PROPN
iajs-2916	63	2	mass	mass	PROPN
iajs-2916	63	3	index	index	NOUN
iajs-2916	63	4	:	:	PUNCT
iajs-2916	63	5	bmi	bmi	PROPN
iajs-2916	63	6	=	=	SYM
iajs-2916	63	7	weight	weight	NOUN
iajs-2916	63	8	in	in	ADP
iajs-2916	63	9	(	(	PUNCT
iajs-2916	63	10	kilograms)/	kilograms)/	ADJ
iajs-2916	63	11	height	height	NOUN
iajs-2916	63	12	in	in	ADP
iajs-2916	63	13	(	(	PUNCT
iajs-2916	63	14	square	square	ADJ
iajs-2916	63	15	meter	meter	NOUN
iajs-2916	63	16	)	)	PUNCT
iajs-2916	64	1	[	[	X
iajs-2916	64	2	18	18	NUM
iajs-2916	64	3	]	]	PUNCT
iajs-2916	64	4	.	.	PUNCT
iajs-2916	65	1	hba1c	hba1c	PROPN
iajs-2916	65	2	was	be	AUX
iajs-2916	65	3	determined	determine	VERB
iajs-2916	65	4	by	by	ADP
iajs-2916	65	5	high	high	ADJ
iajs-2916	65	6	-	-	PUNCT
iajs-2916	65	7	performance	performance	NOUN
iajs-2916	65	8	liquid	liquid	ADJ
iajs-2916	65	9	chromatography	chromatography	NOUN
iajs-2916	65	10	using	use	VERB
iajs-2916	65	11	hlc-723gx	hlc-723gx	ADJ
iajs-2916	65	12	tosoh	tosoh	NOUN
iajs-2916	65	13	from	from	ADP
iajs-2916	65	14	japan	japan	PROPN
iajs-2916	65	15	.	.	PUNCT
iajs-2916	66	1	ethics	ethic	NOUN
iajs-2916	66	2	approval	approval	NOUN
iajs-2916	66	3	:	:	PUNCT
iajs-2916	66	4	this	this	DET
iajs-2916	66	5	survey	survey	NOUN
iajs-2916	66	6	was	be	AUX
iajs-2916	66	7	approved	approve	VERB
iajs-2916	66	8	by	by	ADP
iajs-2916	66	9	the	the	DET
iajs-2916	66	10	scientific	scientific	ADJ
iajs-2916	66	11	committee	committee	NOUN
iajs-2916	66	12	of	of	ADP
iajs-2916	66	13	the	the	DET
iajs-2916	66	14	college	college	NOUN
iajs-2916	66	15	of	of	ADP
iajs-2916	66	16	science	science	NOUN
iajs-2916	66	17	for	for	ADP
iajs-2916	66	18	women	woman	NOUN
iajs-2916	66	19	,	,	PUNCT
iajs-2916	66	20	and	and	CCONJ
iajs-2916	66	21	a	a	DET
iajs-2916	66	22	verbal	verbal	ADJ
iajs-2916	66	23	consent	consent	NOUN
iajs-2916	66	24	form	form	NOUN
iajs-2916	66	25	was	be	AUX
iajs-2916	66	26	obtained	obtain	VERB
iajs-2916	66	27	from	from	ADP
iajs-2916	66	28	each	each	DET
iajs-2916	66	29	participant	participant	NOUN
iajs-2916	66	30	enrolled	enrol	VERB
iajs-2916	66	31	in	in	ADP
iajs-2916	66	32	the	the	DET
iajs-2916	66	33	study	study	NOUN
iajs-2916	66	34	.	.	PUNCT
iajs-2916	67	1	3	3	X
iajs-2916	67	2	.	.	X
iajs-2916	67	3	data	datum	NOUN
iajs-2916	67	4	analysis	analysis	NOUN
iajs-2916	67	5	the	the	DET
iajs-2916	67	6	spss	spss	NOUN
iajs-2916	67	7	(	(	PUNCT
iajs-2916	67	8	version	version	NOUN
iajs-2916	67	9	26	26	NUM
iajs-2916	67	10	)	)	PUNCT
iajs-2916	67	11	application	application	NOUN
iajs-2916	67	12	was	be	AUX
iajs-2916	67	13	used	use	VERB
iajs-2916	67	14	to	to	PART
iajs-2916	67	15	conduct	conduct	VERB
iajs-2916	67	16	the	the	DET
iajs-2916	67	17	statistical	statistical	ADJ
iajs-2916	67	18	analysis	analysis	NOUN
iajs-2916	67	19	.	.	PUNCT
iajs-2916	68	1	the	the	DET
iajs-2916	68	2	data	datum	NOUN
iajs-2916	68	3	was	be	AUX
iajs-2916	68	4	presented	present	VERB
iajs-2916	68	5	as	as	ADP
iajs-2916	68	6	(	(	PUNCT
iajs-2916	68	7	mean	mean	NOUN
iajs-2916	68	8	±	±	NUM
iajs-2916	68	9	se	se	NOUN
iajs-2916	68	10	)	)	PUNCT
iajs-2916	68	11	median	median	NOUN
iajs-2916	68	12	.	.	PUNCT
iajs-2916	69	1	the	the	DET
iajs-2916	69	2	anova	anova	PROPN
iajs-2916	69	3	test	test	NOUN
iajs-2916	69	4	was	be	AUX
iajs-2916	69	5	applied	apply	VERB
iajs-2916	69	6	to	to	PART
iajs-2916	69	7	find	find	VERB
iajs-2916	69	8	the	the	DET
iajs-2916	69	9	difference	difference	NOUN
iajs-2916	69	10	between	between	ADP
iajs-2916	69	11	parameters	parameter	NOUN
iajs-2916	69	12	in	in	ADP
iajs-2916	69	13	terms	term	NOUN
iajs-2916	69	14	of	of	ADP
iajs-2916	69	15	t	t	NOUN
iajs-2916	69	16	-	-	PUNCT
iajs-2916	69	17	test	test	NOUN
iajs-2916	69	18	,	,	PUNCT
iajs-2916	69	19	(	(	PUNCT
iajs-2916	69	20	p	p	NOUN
iajs-2916	69	21	-	-	PUNCT
iajs-2916	69	22	value	value	NOUN
iajs-2916	69	23	)	)	PUNCT
iajs-2916	69	24	,	,	PUNCT
iajs-2916	69	25	lsd	lsd	NOUN
iajs-2916	69	26	,	,	PUNCT
iajs-2916	69	27	and	and	CCONJ
iajs-2916	69	28	correlation	correlation	NOUN
iajs-2916	69	29	coefficient	coefficient	NOUN
iajs-2916	69	30	(	(	PUNCT
iajs-2916	69	31	r	r	NOUN
iajs-2916	69	32	)	)	PUNCT
iajs-2916	69	33	.	.	PUNCT
iajs-2916	70	1	estimation	estimation	NOUN
iajs-2916	70	2	by	by	ADP
iajs-2916	70	3	analyzing	analyze	VERB
iajs-2916	70	4	for	for	ADP
iajs-2916	70	5	linear	linear	ADJ
iajs-2916	70	6	regression	regression	NOUN
iajs-2916	70	7	was	be	AUX
iajs-2916	70	8	employed	employ	VERB
iajs-2916	70	9	in	in	ADP
iajs-2916	70	10	the	the	DET
iajs-2916	70	11	statistical	statistical	ADJ
iajs-2916	70	12	test	test	NOUN
iajs-2916	70	13	.	.	PUNCT
iajs-2916	71	1	the	the	DET
iajs-2916	71	2	statistical	statistical	ADJ
iajs-2916	71	3	significance	significance	NOUN
iajs-2916	71	4	was	be	AUX
iajs-2916	71	5	determined	determine	VERB
iajs-2916	71	6	by	by	ADP
iajs-2916	71	7	the	the	DET
iajs-2916	71	8	probability	probability	NOUN
iajs-2916	71	9	value	value	NOUN
iajs-2916	71	10	,	,	PUNCT
iajs-2916	71	11	which	which	PRON
iajs-2916	71	12	was	be	AUX
iajs-2916	71	13	acknowledged	acknowledge	VERB
iajs-2916	71	14	as	as	ADP
iajs-2916	71	15	significant	significant	ADJ
iajs-2916	71	16	at	at	ADP
iajs-2916	71	17	(	(	PUNCT
iajs-2916	71	18	p≤	p≤	NOUN
iajs-2916	71	19	0.05	0.05	NUM
iajs-2916	71	20	)	)	PUNCT
iajs-2916	71	21	,	,	PUNCT
iajs-2916	71	22	and	and	CCONJ
iajs-2916	71	23	nonsignificant	nonsignificant	ADJ
iajs-2916	71	24	at	at	ADP
iajs-2916	71	25	(	(	PUNCT
iajs-2916	71	26	p	p	X
iajs-2916	71	27	>	>	X
iajs-2916	71	28	0.05	0.05	NUM
iajs-2916	71	29	)	)	PUNCT
iajs-2916	71	30	.	.	PUNCT
iajs-2916	72	1	4	4	X
iajs-2916	72	2	.	.	NOUN
iajs-2916	72	3	results	result	NOUN
iajs-2916	72	4	and	and	CCONJ
iajs-2916	72	5	discussion	discussion	NOUN
iajs-2916	72	6	the	the	DET
iajs-2916	72	7	mean	mean	ADJ
iajs-2916	72	8	values	value	NOUN
iajs-2916	72	9	of	of	ADP
iajs-2916	72	10	bmi	bmi	NOUN
iajs-2916	72	11	,	,	PUNCT
iajs-2916	72	12	w	w	PROPN
iajs-2916	72	13	/	/	SYM
iajs-2916	72	14	h	h	NOUN
iajs-2916	72	15	ratio	ratio	NOUN
iajs-2916	72	16	,	,	PUNCT
iajs-2916	72	17	fbs	fbs	PROPN
iajs-2916	72	18	,	,	PUNCT
iajs-2916	72	19	hba1c	hba1c	PROPN
iajs-2916	72	20	,	,	PUNCT
iajs-2916	72	21	cholesterol	cholesterol	NOUN
iajs-2916	72	22	,	,	PUNCT
iajs-2916	72	23	t.g	t.g	PROPN
iajs-2916	72	24	,	,	PUNCT
iajs-2916	72	25	hdl	hdl	PROPN
iajs-2916	72	26	,	,	PUNCT
iajs-2916	72	27	ldl	ldl	NOUN
iajs-2916	72	28	-	-	PUNCT
iajs-2916	72	29	c	c	PROPN
iajs-2916	72	30	,	,	PUNCT
iajs-2916	72	31	vldl	vldl	NOUN
iajs-2916	72	32	of	of	ADP
iajs-2916	72	33	the	the	DET
iajs-2916	72	34	g1	g1	PROPN
iajs-2916	72	35	control	control	PROPN
iajs-2916	72	36	group	group	PROPN
iajs-2916	72	37	and	and	CCONJ
iajs-2916	72	38	g2	g2	PROPN
iajs-2916	72	39	diabetic	diabetic	ADJ
iajs-2916	72	40	group	group	NOUN
iajs-2916	72	41	,	,	PUNCT
iajs-2916	72	42	and	and	CCONJ
iajs-2916	72	43	g3	g3	PROPN
iajs-2916	72	44	neuropathy	neuropathy	ADJ
iajs-2916	72	45	group	group	NOUN
iajs-2916	72	46	listed	list	VERB
iajs-2916	72	47	in	in	ADP
iajs-2916	72	48	table	table	NOUN
iajs-2916	72	49	1	1	NUM
iajs-2916	72	50	have	have	AUX
iajs-2916	72	51	shown	show	VERB
iajs-2916	72	52	a	a	DET
iajs-2916	72	53	significant	significant	ADJ
iajs-2916	72	54	difference	difference	NOUN
iajs-2916	72	55	among	among	ADP
iajs-2916	72	56	g1	g1	PROPN
iajs-2916	72	57	and	and	CCONJ
iajs-2916	72	58	g2	g2	PROPN
iajs-2916	72	59	,	,	PUNCT
iajs-2916	72	60	and	and	CCONJ
iajs-2916	72	61	g3	g3	NOUN
iajs-2916	72	62	with	with	ADP
iajs-2916	72	63	(	(	PUNCT
iajs-2916	72	64	p≤0.05	p≤0.05	NOUN
iajs-2916	72	65	)	)	PUNCT
iajs-2916	72	66	.	.	PUNCT
iajs-2916	73	1	the	the	DET
iajs-2916	73	2	results	result	NOUN
iajs-2916	73	3	agree	agree	VERB
iajs-2916	73	4	with	with	ADP
iajs-2916	73	5	nermina	nermina	NOUN
iajs-2916	73	6	babic	babic	NOUN
iajs-2916	73	7	et	et	PROPN
iajs-2916	73	8	al	al	PROPN
iajs-2916	73	9	.	.	PUNCT
iajs-2916	74	1	[	[	X
iajs-2916	74	2	19	19	NUM
iajs-2916	74	3	]	]	PUNCT
iajs-2916	74	4	,	,	PUNCT
iajs-2916	74	5	neeraj	neeraj	PROPN
iajs-2916	74	6	chhari	chhari	PROPN
iajs-2916	74	7	et	et	PROPN
iajs-2916	74	8	al	al	PROPN
iajs-2916	74	9	.	.	PUNCT
iajs-2916	75	1	[	[	X
iajs-2916	75	2	20	20	NUM
iajs-2916	75	3	]	]	PUNCT
iajs-2916	75	4	,	,	PUNCT
iajs-2916	75	5	and	and	CCONJ
iajs-2916	75	6	subarna	subarna	PROPN
iajs-2916	75	7	dhoj	dhoj	PROPN
iajs-2916	75	8	thapa	thapa	PROPN
iajs-2916	75	9	et	et	PROPN
iajs-2916	75	10	al	al	PROPN
iajs-2916	75	11	.	.	PUNCT
iajs-2916	76	1	[	[	X
iajs-2916	76	2	21	21	NUM
iajs-2916	76	3	]	]	PUNCT
iajs-2916	76	4	.	.	PUNCT
iajs-2916	76	5	dyslipidemias	dyslipidemias	PROPN
iajs-2916	76	6	,	,	PUNCT
iajs-2916	76	7	particularly	particularly	ADV
iajs-2916	76	8	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2916	76	9	and	and	CCONJ
iajs-2916	76	10	low	low	ADJ
iajs-2916	76	11	levels	level	NOUN
iajs-2916	76	12	of	of	ADP
iajs-2916	76	13	high	high	ADJ
iajs-2916	76	14	-	-	PUNCT
iajs-2916	76	15	density	density	NOUN
iajs-2916	76	16	lipoprotein	lipoprotein	ADJ
iajs-2916	76	17	cholesterol	cholesterol	NOUN
iajs-2916	76	18	are	be	AUX
iajs-2916	76	19	common	common	ADJ
iajs-2916	76	20	phenotypes	phenotype	NOUN
iajs-2916	76	21	associated	associate	VERB
iajs-2916	76	22	with	with	ADP
iajs-2916	76	23	diabetes	diabetes	NOUN
iajs-2916	76	24	mellitus	mellitus	NOUN
iajs-2916	76	25	.	.	PUNCT
iajs-2916	77	1	many	many	ADJ
iajs-2916	77	2	studies	study	NOUN
iajs-2916	77	3	have	have	AUX
iajs-2916	77	4	found	find	VERB
iajs-2916	77	5	an	an	DET
iajs-2916	77	6	inverse	inverse	NOUN
iajs-2916	77	7	relationship	relationship	NOUN
iajs-2916	77	8	between	between	ADP
iajs-2916	77	9	hdl	hdl	PROPN
iajs-2916	77	10	and	and	CCONJ
iajs-2916	77	11	total	total	ADJ
iajs-2916	77	12	cholesterol	cholesterol	NOUN
iajs-2916	77	13	content	content	NOUN
iajs-2916	77	14	and	and	CCONJ
iajs-2916	77	15	also	also	ADV
iajs-2916	77	16	the	the	DET
iajs-2916	77	17	risk	risk	NOUN
iajs-2916	77	18	of	of	ADP
iajs-2916	77	19	atherosclerotic	atherosclerotic	ADJ
iajs-2916	77	20	vascular	vascular	ADJ
iajs-2916	77	21	disease	disease	NOUN
iajs-2916	77	22	.	.	PUNCT
iajs-2916	78	1	hydrophobic	hydrophobic	NOUN
iajs-2916	78	2	cholesteryl	cholesteryl	PROPN
iajs-2916	78	3	esters	ester	NOUN
iajs-2916	78	4	are	be	AUX
iajs-2916	78	5	entropically	entropically	ADV
iajs-2916	78	6	transferred	transfer	VERB
iajs-2916	78	7	to	to	ADP
iajs-2916	78	8	triglyceride	triglyceride	ADJ
iajs-2916	78	9	-	-	PUNCT
iajs-2916	78	10	rich	rich	ADJ
iajs-2916	78	11	lipoproteins	lipoprotein	NOUN
iajs-2916	78	12	in	in	ADP
iajs-2916	78	13	the	the	DET
iajs-2916	78	14	presence	presence	NOUN
iajs-2916	78	15	of	of	ADP
iajs-2916	78	16	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2916	78	17	,	,	PUNCT
iajs-2916	78	18	lowering	lower	VERB
iajs-2916	78	19	cholesterol	cholesterol	NOUN
iajs-2916	78	20	content	content	NOUN
iajs-2916	78	21	in	in	ADP
iajs-2916	78	22	hdl	hdl	PROPN
iajs-2916	78	23	and	and	CCONJ
iajs-2916	78	24	changing	change	VERB
iajs-2916	78	25	hdl	hdl	PROPN
iajs-2916	78	26	molecular	molecular	ADJ
iajs-2916	78	27	speciation	speciation	NOUN
iajs-2916	78	28	[	[	X
iajs-2916	78	29	22	22	NUM
iajs-2916	78	30	]	]	PUNCT
iajs-2916	78	31	.	.	PUNCT
iajs-2916	79	1	hyperglycemia	hyperglycemia	NOUN
iajs-2916	79	2	-	-	PUNCT
iajs-2916	79	3	induced	induce	VERB
iajs-2916	79	4	advanced	advanced	ADJ
iajs-2916	79	5	glycation	glycation	NOUN
iajs-2916	79	6	end	end	NOUN
iajs-2916	79	7	products	product	NOUN
iajs-2916	79	8	,	,	PUNCT
iajs-2916	79	9	oxidative	oxidative	ADJ
iajs-2916	79	10	stress	stress	NOUN
iajs-2916	79	11	,	,	PUNCT
iajs-2916	79	12	and	and	CCONJ
iajs-2916	79	13	inflammation	inflammation	NOUN
iajs-2916	79	14	all	all	PRON
iajs-2916	79	15	contribute	contribute	VERB
iajs-2916	79	16	to	to	ADP
iajs-2916	79	17	hdl	hdl	PROPN
iajs-2916	79	18	dysfunction	dysfunction	NOUN
iajs-2916	79	19	in	in	ADP
iajs-2916	79	20	ihjpas	ihjpas	PROPN
iajs-2916	79	21	.	.	PUNCT
iajs-2916	80	1	53	53	NUM
iajs-2916	80	2	(	(	PUNCT
iajs-2916	80	3	4)2022	4)2022	NOUN
iajs-2916	80	4	197	197	NUM
iajs-2916	80	5	diabetes	diabetes	NOUN
iajs-2916	80	6	mellitus	mellitus	NOUN
iajs-2916	80	7	,	,	PUNCT
iajs-2916	80	8	which	which	PRON
iajs-2916	80	9	raises	raise	VERB
iajs-2916	80	10	the	the	DET
iajs-2916	80	11	chances	chance	NOUN
iajs-2916	80	12	of	of	ADP
iajs-2916	80	13	getting	get	VERB
iajs-2916	80	14	cardiac	cardiac	ADJ
iajs-2916	80	15	disease	disease	NOUN
iajs-2916	80	16	[	[	X
iajs-2916	80	17	23	23	NUM
iajs-2916	80	18	]	]	PUNCT
iajs-2916	80	19	.	.	PUNCT
iajs-2916	81	1	table	table	NOUN
iajs-2916	81	2	1	1	NUM
iajs-2916	81	3	.	.	PUNCT
iajs-2916	82	1	a	a	DET
iajs-2916	82	2	comparison	comparison	NOUN
iajs-2916	82	3	between	between	ADP
iajs-2916	82	4	the	the	DET
iajs-2916	82	5	control	control	NOUN
iajs-2916	82	6	and	and	CCONJ
iajs-2916	82	7	patients	patient	NOUN
iajs-2916	82	8	group	group	NOUN
iajs-2916	82	9	regarding	regard	VERB
iajs-2916	82	10	biochemical	biochemical	ADJ
iajs-2916	82	11	parameters	parameter	NOUN
iajs-2916	82	12	data	datum	NOUN
iajs-2916	82	13	were	be	AUX
iajs-2916	82	14	presented	present	VERB
iajs-2916	82	15	as	as	ADP
iajs-2916	82	16	(	(	PUNCT
iajs-2916	82	17	mean	mean	NOUN
iajs-2916	82	18	±	±	NUM
iajs-2916	82	19	se	se	NOUN
iajs-2916	82	20	)	)	PUNCT
iajs-2916	82	21	median	median	ADJ
iajs-2916	82	22	lsd	lsd	NOUN
iajs-2916	82	23	:	:	PUNCT
iajs-2916	82	24	least	least	ADJ
iajs-2916	82	25	significant	significant	ADJ
iajs-2916	82	26	difference	difference	NOUN
iajs-2916	82	27	*	*	PUNCT
iajs-2916	82	28	significant	significant	ADJ
iajs-2916	82	29	difference	difference	NOUN
iajs-2916	82	30	between	between	ADP
iajs-2916	82	31	means	mean	NOUN
iajs-2916	82	32	using	use	VERB
iajs-2916	82	33	anova	anova	PROPN
iajs-2916	82	34	-test	-test	PROPN
iajs-2916	82	35	at	at	ADP
iajs-2916	82	36	0.05	0.05	NUM
iajs-2916	82	37	level	level	NOUN
iajs-2916	82	38	.	.	PUNCT
iajs-2916	83	1	*	*	PUNCT
iajs-2916	83	2	*	*	PUNCT
iajs-2916	83	3	highly	highly	ADV
iajs-2916	83	4	significant	significant	ADJ
iajs-2916	83	5	difference	difference	NOUN
iajs-2916	83	6	between	between	ADP
iajs-2916	83	7	means	mean	NOUN
iajs-2916	83	8	using	use	VERB
iajs-2916	83	9	anova	anova	PROPN
iajs-2916	83	10	-test	-test	PROPN
iajs-2916	83	11	at	at	ADP
iajs-2916	83	12	0.05	0.05	NUM
iajs-2916	83	13	level	level	NOUN
iajs-2916	83	14	.	.	PUNCT
iajs-2916	84	1	the	the	DET
iajs-2916	84	2	mean	mean	ADJ
iajs-2916	84	3	values	value	NOUN
iajs-2916	84	4	of	of	ADP
iajs-2916	84	5	insulin	insulin	NOUN
iajs-2916	84	6	and	and	CCONJ
iajs-2916	84	7	homa	homa	PROPN
iajs-2916	84	8	ir	ir	PROPN
iajs-2916	84	9	for	for	ADP
iajs-2916	84	10	all	all	DET
iajs-2916	84	11	the	the	DET
iajs-2916	84	12	studied	study	VERB
iajs-2916	84	13	groups	group	NOUN
iajs-2916	84	14	in	in	ADP
iajs-2916	84	15	the	the	DET
iajs-2916	84	16	current	current	ADJ
iajs-2916	84	17	study	study	NOUN
iajs-2916	84	18	are	be	AUX
iajs-2916	84	19	shown	show	VERB
iajs-2916	84	20	in	in	ADP
iajs-2916	84	21	table	table	NOUN
iajs-2916	84	22	2	2	NUM
iajs-2916	84	23	.	.	PUNCT
iajs-2916	85	1	the	the	DET
iajs-2916	85	2	mean	mean	ADJ
iajs-2916	85	3	values	value	NOUN
iajs-2916	85	4	in	in	ADP
iajs-2916	85	5	this	this	DET
iajs-2916	85	6	table	table	NOUN
iajs-2916	85	7	revealed	reveal	VERB
iajs-2916	85	8	that	that	SCONJ
iajs-2916	85	9	there	there	PRON
iajs-2916	85	10	were	be	VERB
iajs-2916	85	11	significant	significant	ADJ
iajs-2916	85	12	differences	difference	NOUN
iajs-2916	85	13	in	in	ADP
iajs-2916	85	14	insulin	insulin	NOUN
iajs-2916	85	15	levels	level	NOUN
iajs-2916	85	16	(	(	PUNCT
iajs-2916	85	17	μiu	μiu	PROPN
iajs-2916	85	18	/	/	SYM
iajs-2916	85	19	ml	ml	NOUN
iajs-2916	85	20	)	)	PUNCT
iajs-2916	85	21	between	between	ADP
iajs-2916	85	22	the	the	DET
iajs-2916	85	23	patient	patient	ADJ
iajs-2916	85	24	groups	group	NOUN
iajs-2916	85	25	with	with	ADP
iajs-2916	85	26	diabetes	diabetes	NOUN
iajs-2916	85	27	and	and	CCONJ
iajs-2916	85	28	neuropathy	neuropathy	ADJ
iajs-2916	85	29	and	and	CCONJ
iajs-2916	85	30	the	the	DET
iajs-2916	85	31	control	control	NOUN
iajs-2916	85	32	group	group	NOUN
iajs-2916	85	33	(	(	PUNCT
iajs-2916	85	34	p≤0.05	p≤0.05	NOUN
iajs-2916	85	35	)	)	PUNCT
iajs-2916	85	36	.	.	PUNCT
iajs-2916	86	1	the	the	DET
iajs-2916	86	2	current	current	ADJ
iajs-2916	86	3	study	study	NOUN
iajs-2916	86	4	is	be	AUX
iajs-2916	86	5	in	in	ADP
iajs-2916	86	6	agreement	agreement	NOUN
iajs-2916	86	7	with	with	ADP
iajs-2916	86	8	the	the	DET
iajs-2916	86	9	study	study	NOUN
iajs-2916	86	10	of	of	ADP
iajs-2916	86	11	rosemary	rosemary	PROPN
iajs-2916	86	12	c.	c.	PROPN
iajs-2916	86	13	temple	temple	PROPN
iajs-2916	86	14	et	et	PROPN
iajs-2916	86	15	al	al	PROPN
iajs-2916	86	16	.	.	PUNCT
iajs-2916	87	1	[	[	X
iajs-2916	87	2	24	24	NUM
iajs-2916	87	3	]	]	PUNCT
iajs-2916	87	4	.	.	PUNCT
iajs-2916	88	1	moreover	moreover	ADV
iajs-2916	88	2	,	,	PUNCT
iajs-2916	88	3	christian	christian	PROPN
iajs-2916	88	4	weyer	weyer	PROPN
iajs-2916	88	5	et	et	PROPN
iajs-2916	88	6	al	al	PROPN
iajs-2916	88	7	.	.	PUNCT
iajs-2916	89	1	[	[	X
iajs-2916	89	2	25	25	NUM
iajs-2916	89	3	]	]	PUNCT
iajs-2916	89	4	have	have	AUX
iajs-2916	89	5	shown	show	VERB
iajs-2916	89	6	that	that	SCONJ
iajs-2916	89	7	during	during	ADP
iajs-2916	89	8	the	the	DET
iajs-2916	89	9	shift	shift	NOUN
iajs-2916	89	10	from	from	ADP
iajs-2916	89	11	normal	normal	ADJ
iajs-2916	89	12	glucose	glucose	NOUN
iajs-2916	89	13	tolerance	tolerance	NOUN
iajs-2916	89	14	(	(	PUNCT
iajs-2916	89	15	ngt	ngt	X
iajs-2916	89	16	)	)	PUNCT
iajs-2916	89	17	to	to	ADP
iajs-2916	89	18	impaired	impair	VERB
iajs-2916	89	19	glucose	glucose	NOUN
iajs-2916	89	20	tolerance	tolerance	NOUN
iajs-2916	89	21	(	(	PUNCT
iajs-2916	89	22	igt	igt	PROPN
iajs-2916	89	23	)	)	PUNCT
iajs-2916	89	24	,	,	PUNCT
iajs-2916	89	25	the	the	DET
iajs-2916	89	26	acute	acute	ADJ
iajs-2916	89	27	insulin	insulin	NOUN
iajs-2916	89	28	response	response	NOUN
iajs-2916	89	29	(	(	PUNCT
iajs-2916	89	30	air	air	NOUN
iajs-2916	89	31	)	)	PUNCT
iajs-2916	89	32	to	to	ADP
iajs-2916	89	33	glucose	glucose	NOUN
iajs-2916	89	34	decreased	decrease	VERB
iajs-2916	89	35	by	by	ADP
iajs-2916	89	36	27	27	NUM
iajs-2916	89	37	%	%	NOUN
iajs-2916	89	38	,	,	PUNCT
iajs-2916	89	39	demonstrating	demonstrate	VERB
iajs-2916	89	40	conclusively	conclusively	ADV
iajs-2916	89	41	that	that	SCONJ
iajs-2916	89	42	insulin	insulin	NOUN
iajs-2916	89	43	secretion	secretion	NOUN
iajs-2916	89	44	abnormalities	abnormality	NOUN
iajs-2916	89	45	(	(	PUNCT
iajs-2916	89	46	significantly	significantly	ADV
iajs-2916	89	47	decrease	decrease	NOUN
iajs-2916	89	48	)	)	PUNCT
iajs-2916	89	49	occur	occur	VERB
iajs-2916	89	50	early	early	ADV
iajs-2916	89	51	in	in	ADP
iajs-2916	89	52	the	the	DET
iajs-2916	89	53	progression	progression	NOUN
iajs-2916	89	54	of	of	ADP
iajs-2916	89	55	diabetes	diabetes	NOUN
iajs-2916	89	56	type	type	NOUN
iajs-2916	89	57	2	2	NUM
iajs-2916	89	58	.	.	NOUN
iajs-2916	89	59	free	free	ADJ
iajs-2916	89	60	fatty	fatty	NOUN
iajs-2916	89	61	acids	acid	NOUN
iajs-2916	89	62	(	(	PUNCT
iajs-2916	89	63	ffas	ffas	NOUN
iajs-2916	89	64	)	)	PUNCT
iajs-2916	89	65	are	be	AUX
iajs-2916	89	66	essential	essential	ADJ
iajs-2916	89	67	for	for	ADP
iajs-2916	89	68	the	the	DET
iajs-2916	89	69	regular	regular	ADJ
iajs-2916	89	70	operation	operation	NOUN
iajs-2916	89	71	of	of	ADP
iajs-2916	89	72	the	the	DET
iajs-2916	89	73	pancreatic	pancreatic	ADJ
iajs-2916	89	74	beta	beta	NOUN
iajs-2916	89	75	-	-	PUNCT
iajs-2916	89	76	cell	cell	NOUN
iajs-2916	89	77	,	,	PUNCT
iajs-2916	89	78	as	as	ADV
iajs-2916	89	79	well	well	ADV
iajs-2916	89	80	as	as	ADP
iajs-2916	89	81	its	its	PRON
iajs-2916	89	82	ability	ability	NOUN
iajs-2916	89	83	to	to	PART
iajs-2916	89	84	adjust	adjust	VERB
iajs-2916	89	85	for	for	ADP
iajs-2916	89	86	insulin	insulin	NOUN
iajs-2916	89	87	resistance	resistance	NOUN
iajs-2916	89	88	and	and	CCONJ
iajs-2916	89	89	failure	failure	NOUN
iajs-2916	89	90	in	in	ADP
iajs-2916	89	91	type	type	NOUN
iajs-2916	89	92	2	2	NUM
iajs-2916	89	93	diabetes	diabetes	NOUN
iajs-2916	89	94	.	.	PUNCT
iajs-2916	90	1	islet	islet	NOUN
iajs-2916	90	2	tissue	tissue	NOUN
iajs-2916	90	3	deficient	deficient	ADJ
iajs-2916	90	4	in	in	ADP
iajs-2916	90	5	fatty	fatty	ADJ
iajs-2916	90	6	acids	acid	NOUN
iajs-2916	90	7	(	(	PUNCT
iajs-2916	90	8	fas	fas	NOUN
iajs-2916	90	9	)	)	PUNCT
iajs-2916	90	10	loses	lose	VERB
iajs-2916	90	11	glucosestimulated	glucosestimulate	VERB
iajs-2916	90	12	insulin	insulin	NOUN
iajs-2916	90	13	secretion	secretion	NOUN
iajs-2916	90	14	(	(	PUNCT
iajs-2916	90	15	gsis	gsis	PROPN
iajs-2916	90	16	)	)	PUNCT
iajs-2916	90	17	,	,	PUNCT
iajs-2916	90	18	a	a	DET
iajs-2916	90	19	process	process	NOUN
iajs-2916	90	20	that	that	PRON
iajs-2916	90	21	may	may	AUX
iajs-2916	90	22	be	be	AUX
iajs-2916	90	23	reversed	reverse	VERB
iajs-2916	90	24	quickly	quickly	ADV
iajs-2916	90	25	with	with	ADP
iajs-2916	90	26	exogenous	exogenous	ADJ
iajs-2916	90	27	ffas	ffas	NOUN
iajs-2916	90	28	nevertheless	nevertheless	ADV
iajs-2916	90	29	;	;	PUNCT
iajs-2916	90	30	saturated	saturated	ADJ
iajs-2916	90	31	ffas	ffas	NOUN
iajs-2916	90	32	might	might	AUX
iajs-2916	90	33	impair	impair	VERB
iajs-2916	90	34	insulin	insulin	NOUN
iajs-2916	90	35	biosynthesis	biosynthesis	NOUN
iajs-2916	90	36	[	[	X
iajs-2916	90	37	26	26	NUM
iajs-2916	90	38	]	]	PUNCT
iajs-2916	90	39	.	.	PUNCT
iajs-2916	91	1	insulin	insulin	NOUN
iajs-2916	91	2	secretion	secretion	NOUN
iajs-2916	91	3	is	be	AUX
iajs-2916	91	4	also	also	ADV
iajs-2916	91	5	consumed	consume	VERB
iajs-2916	91	6	in	in	ADP
iajs-2916	91	7	excess	excess	ADJ
iajs-2916	91	8	over	over	ADP
iajs-2916	91	9	time	time	NOUN
iajs-2916	91	10	,	,	PUNCT
iajs-2916	91	11	especially	especially	ADV
iajs-2916	91	12	when	when	SCONJ
iajs-2916	91	13	combined	combine	VERB
iajs-2916	91	14	with	with	ADP
iajs-2916	91	15	high	high	ADJ
iajs-2916	91	16	blood	blood	NOUN
iajs-2916	91	17	sugar	sugar	NOUN
iajs-2916	91	18	.	.	PUNCT
iajs-2916	92	1	this	this	PRON
iajs-2916	92	2	is	be	AUX
iajs-2916	92	3	because	because	SCONJ
iajs-2916	92	4	,	,	PUNCT
iajs-2916	92	5	in	in	ADP
iajs-2916	92	6	the	the	DET
iajs-2916	92	7	natural	natural	ADJ
iajs-2916	92	8	history	history	NOUN
iajs-2916	92	9	of	of	ADP
iajs-2916	92	10	this	this	DET
iajs-2916	92	11	condition	condition	NOUN
iajs-2916	92	12	,	,	PUNCT
iajs-2916	92	13	postprandial	postprandial	ADJ
iajs-2916	92	14	hyperglycemia	hyperglycemia	NOUN
iajs-2916	92	15	and	and	CCONJ
iajs-2916	92	16	dyslipidemia	dyslipidemia	NOUN
iajs-2916	92	17	are	be	AUX
iajs-2916	92	18	typical	typical	ADJ
iajs-2916	92	19	parameters	parameter	NOUN
iajs-2916	92	20	control	control	PROPN
iajs-2916	92	21	group	group	NOUN
iajs-2916	92	22	(	(	PUNCT
iajs-2916	92	23	1	1	NUM
iajs-2916	92	24	)	)	PUNCT
iajs-2916	92	25	no	no	INTJ
iajs-2916	92	26	.	.	PUNCT
iajs-2916	93	1	(	(	PUNCT
iajs-2916	93	2	40	40	NUM
iajs-2916	93	3	)	)	PUNCT
iajs-2916	93	4	diabetes	diabetes	NOUN
iajs-2916	93	5	mellitus	mellitus	NOUN
iajs-2916	93	6	(	(	PUNCT
iajs-2916	93	7	dm	dm	PROPN
iajs-2916	93	8	)	)	PUNCT
iajs-2916	93	9	group	group	NOUN
iajs-2916	93	10	(	(	PUNCT
iajs-2916	93	11	2	2	NUM
iajs-2916	93	12	)	)	PUNCT
iajs-2916	93	13	no	no	NOUN
iajs-2916	93	14	.	.	PUNCT
iajs-2916	94	1	(	(	PUNCT
iajs-2916	94	2	40	40	NUM
iajs-2916	94	3	)	)	PUNCT
iajs-2916	94	4	neuropathy	neuropathy	ADJ
iajs-2916	94	5	group	group	NOUN
iajs-2916	94	6	(	(	PUNCT
iajs-2916	94	7	3	3	NUM
iajs-2916	94	8	)	)	PUNCT
iajs-2916	94	9	no	no	NOUN
iajs-2916	94	10	.	.	PUNCT
iajs-2916	95	1	(	(	PUNCT
iajs-2916	95	2	40	40	NUM
iajs-2916	95	3	)	)	PUNCT
iajs-2916	95	4	p	p	ADJ
iajs-2916	95	5	-	-	PUNCT
iajs-2916	95	6	value	value	NOUN
iajs-2916	95	7	lsd	lsd	NOUN
iajs-2916	95	8	between	between	ADP
iajs-2916	95	9	groups	group	NOUN
iajs-2916	95	10	(	(	PUNCT
iajs-2916	95	11	1,2	1,2	NUM
iajs-2916	95	12	)	)	PUNCT
iajs-2916	95	13	lsd	lsd	NOUN
iajs-2916	95	14	between	between	ADP
iajs-2916	95	15	groups	group	NOUN
iajs-2916	95	16	(	(	PUNCT
iajs-2916	95	17	1,3	1,3	NUM
iajs-2916	95	18	)	)	PUNCT
iajs-2916	95	19	lsd	lsd	NOUN
iajs-2916	95	20	between	between	ADP
iajs-2916	95	21	groups	group	NOUN
iajs-2916	95	22	(	(	PUNCT
iajs-2916	95	23	2,3	2,3	NUM
iajs-2916	95	24	)	)	PUNCT
iajs-2916	95	25	age	age	NOUN
iajs-2916	95	26	(	(	PUNCT
iajs-2916	95	27	year	year	NOUN
iajs-2916	95	28	)	)	PUNCT
iajs-2916	95	29	51.07	51.07	NUM
iajs-2916	95	30	±	±	NUM
iajs-2916	95	31	1.15	1.15	NUM
iajs-2916	95	32	(	(	PUNCT
iajs-2916	95	33	51	51	NUM
iajs-2916	95	34	)	)	PUNCT
iajs-2916	95	35	52.08	52.08	NUM
iajs-2916	95	36	±	±	NUM
iajs-2916	95	37	1.18	1.18	NUM
iajs-2916	95	38	(	(	PUNCT
iajs-2916	95	39	53.5	53.5	NUM
iajs-2916	95	40	)	)	PUNCT
iajs-2916	95	41	53	53	NUM
iajs-2916	95	42	±	±	NUM
iajs-2916	95	43	1.18	1.18	NUM
iajs-2916	95	44	(	(	PUNCT
iajs-2916	95	45	54.5	54.5	NUM
iajs-2916	95	46	)	)	PUNCT
iajs-2916	95	47	0.513	0.513	NUM
iajs-2916	95	48	0.549	0.549	NUM
iajs-2916	95	49	0.249	0.249	NUM
iajs-2916	95	50	0.579	0.579	NUM
iajs-2916	95	51	bmi	bmi	X
iajs-2916	95	52	(	(	PUNCT
iajs-2916	95	53	kg	kg	NOUN
iajs-2916	95	54	/	/	SYM
iajs-2916	95	55	m2	m2	PROPN
iajs-2916	95	56	)	)	PUNCT
iajs-2916	95	57	23.92	23.92	NUM
iajs-2916	95	58	±	±	NUM
iajs-2916	95	59	0.16	0.16	NUM
iajs-2916	95	60	(	(	PUNCT
iajs-2916	95	61	24.03	24.03	NUM
iajs-2916	95	62	)	)	PUNCT
iajs-2916	95	63	31.05	31.05	NUM
iajs-2916	95	64	±	±	NUM
iajs-2916	95	65	0.73	0.73	NUM
iajs-2916	95	66	(	(	PUNCT
iajs-2916	95	67	30.4	30.4	NUM
iajs-2916	95	68	)	)	PUNCT
iajs-2916	95	69	31.05	31.05	NUM
iajs-2916	95	70	±	±	NUM
iajs-2916	95	71	1.01	1.01	NUM
iajs-2916	95	72	(	(	PUNCT
iajs-2916	95	73	28.92	28.92	NUM
iajs-2916	95	74	)	)	PUNCT
iajs-2916	95	75	0.001	0.001	NUM
iajs-2916	95	76	*	*	PUNCT
iajs-2916	95	77	*	*	NOUN
iajs-2916	95	78	0.001	0.001	NUM
iajs-2916	95	79	*	*	NOUN
iajs-2916	95	80	*	*	NOUN
iajs-2916	95	81	0.001	0.001	NUM
iajs-2916	95	82	*	*	NOUN
iajs-2916	95	83	*	*	PROPN
iajs-2916	95	84	1.00	1.00	NUM
iajs-2916	95	85	w	w	PROPN
iajs-2916	95	86	/	/	SYM
iajs-2916	95	87	h	h	NOUN
iajs-2916	95	88	ratio	ratio	NOUN
iajs-2916	95	89	0.88	0.88	NUM
iajs-2916	95	90	±	±	NUM
iajs-2916	95	91	0.01	0.01	NUM
iajs-2916	95	92	(	(	PUNCT
iajs-2916	95	93	0.895	0.895	NUM
iajs-2916	95	94	)	)	PUNCT
iajs-2916	95	95	0.95	0.95	NUM
iajs-2916	95	96	±	±	NUM
iajs-2916	95	97	0.01	0.01	NUM
iajs-2916	95	98	(	(	PUNCT
iajs-2916	95	99	0.94	0.94	NUM
iajs-2916	95	100	)	)	PUNCT
iajs-2916	95	101	0.967	0.967	NUM
iajs-2916	95	102	±	±	NUM
iajs-2916	95	103	0.014	0.014	NUM
iajs-2916	95	104	(	(	PUNCT
iajs-2916	95	105	0.94	0.94	NUM
iajs-2916	95	106	)	)	PUNCT
iajs-2916	95	107	0.001	0.001	NUM
iajs-2916	95	108	*	*	PUNCT
iajs-2916	95	109	*	*	NOUN
iajs-2916	95	110	0.001	0.001	NUM
iajs-2916	95	111	*	*	NOUN
iajs-2916	95	112	*	*	NOUN
iajs-2916	95	113	0.001	0.001	NUM
iajs-2916	95	114	*	*	SYM
iajs-2916	95	115	*	*	PROPN
iajs-2916	95	116	0.243	0.243	NUM
iajs-2916	95	117	fbs	fbs	X
iajs-2916	95	118	(	(	PUNCT
iajs-2916	95	119	mg	mg	PROPN
iajs-2916	95	120	/	/	SYM
iajs-2916	95	121	dl	dl	NOUN
iajs-2916	95	122	)	)	PUNCT
iajs-2916	95	123	92.07	92.07	NUM
iajs-2916	95	124	±1.61	±1.61	NOUN
iajs-2916	95	125	(	(	PUNCT
iajs-2916	95	126	92.5	92.5	NUM
iajs-2916	95	127	)	)	PUNCT
iajs-2916	95	128	176.05	176.05	NUM
iajs-2916	95	129	±	±	NUM
iajs-2916	95	130	9.77	9.77	NUM
iajs-2916	95	131	(	(	PUNCT
iajs-2916	95	132	157	157	NUM
iajs-2916	95	133	)	)	PUNCT
iajs-2916	95	134	209.37±	209.37±	NUM
iajs-2916	95	135	12.22	12.22	NUM
iajs-2916	95	136	(	(	PUNCT
iajs-2916	95	137	198.5	198.5	NUM
iajs-2916	95	138	)	)	PUNCT
iajs-2916	95	139	0.001	0.001	NUM
iajs-2916	95	140	*	*	PUNCT
iajs-2916	95	141	*	*	NOUN
iajs-2916	95	142	0.001	0.001	NUM
iajs-2916	95	143	*	*	NOUN
iajs-2916	95	144	*	*	NOUN
iajs-2916	95	145	0.001	0.001	NUM
iajs-2916	95	146	*	*	NOUN
iajs-2916	95	147	*	*	NOUN
iajs-2916	95	148	0.011	0.011	NUM
iajs-2916	95	149	*	*	PUNCT
iajs-2916	95	150	hba1c	hba1c	NOUN
iajs-2916	95	151	%	%	NOUN
iajs-2916	95	152	5.005	5.005	NUM
iajs-2916	95	153	±	±	NUM
iajs-2916	95	154	0.05	0.05	NUM
iajs-2916	95	155	(	(	PUNCT
iajs-2916	95	156	5	5	NUM
iajs-2916	95	157	)	)	PUNCT
iajs-2916	95	158	8.56	8.56	NUM
iajs-2916	95	159	±	±	NUM
iajs-2916	95	160	0.27	0.27	NUM
iajs-2916	95	161	(	(	PUNCT
iajs-2916	95	162	8)	8)	NUM
iajs-2916	95	163	9.20	9.20	NUM
iajs-2916	95	164	±	±	NUM
iajs-2916	95	165	0.30	0.30	NUM
iajs-2916	95	166	(	(	PUNCT
iajs-2916	95	167	9	9	NUM
iajs-2916	95	168	)	)	PUNCT
iajs-2916	95	169	0.001	0.001	NUM
iajs-2916	95	170	*	*	NOUN
iajs-2916	95	171	*	*	NOUN
iajs-2916	95	172	0.001	0.001	NUM
iajs-2916	95	173	*	*	NOUN
iajs-2916	95	174	*	*	NOUN
iajs-2916	95	175	0.001	0.001	NUM
iajs-2916	95	176	*	*	NOUN
iajs-2916	95	177	*	*	SYM
iajs-2916	95	178	0.55	0.55	NUM
iajs-2916	95	179	cholesterol	cholesterol	NOUN
iajs-2916	95	180	(	(	PUNCT
iajs-2916	95	181	mg	mg	PROPN
iajs-2916	95	182	/	/	SYM
iajs-2916	95	183	dl	dl	NOUN
iajs-2916	95	184	)	)	PUNCT
iajs-2916	95	185	153.92	153.92	NUM
iajs-2916	95	186	±	±	NUM
iajs-2916	95	187	1.66	1.66	NUM
iajs-2916	95	188	(	(	PUNCT
iajs-2916	95	189	154.5	154.5	NUM
iajs-2916	95	190	)	)	PUNCT
iajs-2916	95	191	169.01	169.01	NUM
iajs-2916	95	192	±	±	NUM
iajs-2916	95	193	5.85	5.85	NUM
iajs-2916	95	194	(	(	PUNCT
iajs-2916	95	195	172.5	172.5	NUM
iajs-2916	95	196	)	)	PUNCT
iajs-2916	95	197	181.97	181.97	NUM
iajs-2916	95	198	±	±	NUM
iajs-2916	95	199	5.45	5.45	NUM
iajs-2916	95	200	(	(	PUNCT
iajs-2916	95	201	176.5	176.5	NUM
iajs-2916	95	202	)	)	PUNCT
iajs-2916	95	203	0.001	0.001	NUM
iajs-2916	95	204	*	*	NOUN
iajs-2916	95	205	*	*	X
iajs-2916	95	206	0.026	0.026	NUM
iajs-2916	95	207	*	*	PUNCT
iajs-2916	95	208	0.001	0.001	NUM
iajs-2916	95	209	*	*	PUNCT
iajs-2916	95	210	*	*	PUNCT
iajs-2916	96	1	0.055	0.055	NUM
iajs-2916	96	2	tg	tg	PROPN
iajs-2916	96	3	(	(	PUNCT
iajs-2916	96	4	mg	mg	PROPN
iajs-2916	96	5	/	/	SYM
iajs-2916	96	6	dl	dl	PROPN
iajs-2916	96	7	)	)	PUNCT
iajs-2916	96	8	104.28	104.28	NUM
iajs-2916	96	9	±	±	NUM
iajs-2916	96	10	3.26	3.26	NUM
iajs-2916	96	11	(	(	PUNCT
iajs-2916	96	12	109.95	109.95	NUM
iajs-2916	96	13	)	)	PUNCT
iajs-2916	96	14	140.62	140.62	NUM
iajs-2916	96	15	±	±	NUM
iajs-2916	96	16	5.51	5.51	NUM
iajs-2916	96	17	(	(	PUNCT
iajs-2916	96	18	34.85	34.85	NUM
iajs-2916	96	19	)	)	PUNCT
iajs-2916	96	20	159	159	NUM
iajs-2916	96	21	±	±	NUM
iajs-2916	96	22	11.72	11.72	NUM
iajs-2916	96	23	(	(	PUNCT
iajs-2916	96	24	146.5	146.5	NUM
iajs-2916	96	25	)	)	PUNCT
iajs-2916	96	26	0.001	0.001	NUM
iajs-2916	96	27	*	*	PUNCT
iajs-2916	96	28	*	*	NOUN
iajs-2916	96	29	0.001	0.001	NUM
iajs-2916	96	30	*	*	NOUN
iajs-2916	96	31	*	*	NOUN
iajs-2916	96	32	0.001	0.001	NUM
iajs-2916	96	33	*	*	PUNCT
iajs-2916	96	34	*	*	PROPN
iajs-2916	96	35	0.091	0.091	NUM
iajs-2916	96	36	hdl	hdl	PROPN
iajs-2916	96	37	-	-	PUNCT
iajs-2916	96	38	c	c	PROPN
iajs-2916	96	39	(	(	PUNCT
iajs-2916	96	40	mg	mg	PROPN
iajs-2916	96	41	/	/	SYM
iajs-2916	96	42	dl	dl	PROPN
iajs-2916	96	43	)	)	PUNCT
iajs-2916	96	44	48.24	48.24	NUM
iajs-2916	96	45	±	±	NOUN
iajs-2916	96	46	0.70	0.70	NUM
iajs-2916	96	47	(	(	PUNCT
iajs-2916	96	48	47	47	NUM
iajs-2916	96	49	)	)	PUNCT
iajs-2916	96	50	26.07	26.07	NUM
iajs-2916	96	51	±	±	NUM
iajs-2916	96	52	1.21	1.21	NUM
iajs-2916	96	53	(	(	PUNCT
iajs-2916	96	54	24.5	24.5	NUM
iajs-2916	96	55	)	)	PUNCT
iajs-2916	96	56	26.02	26.02	NUM
iajs-2916	96	57	±	±	NUM
iajs-2916	96	58	0.98	0.98	NUM
iajs-2916	96	59	(	(	PUNCT
iajs-2916	96	60	25.5	25.5	NUM
iajs-2916	96	61	)	)	PUNCT
iajs-2916	96	62	0.001	0.001	NUM
iajs-2916	96	63	*	*	PUNCT
iajs-2916	96	64	*	*	NOUN
iajs-2916	96	65	0.001	0.001	NUM
iajs-2916	96	66	*	*	NOUN
iajs-2916	96	67	*	*	NOUN
iajs-2916	96	68	0.001	0.001	NUM
iajs-2916	96	69	*	*	SYM
iajs-2916	96	70	*	*	X
iajs-2916	96	71	0.972	0.972	NUM
iajs-2916	96	72	ldl	ldl	PROPN
iajs-2916	96	73	-	-	PUNCT
iajs-2916	96	74	c	c	NOUN
iajs-2916	96	75	(	(	PUNCT
iajs-2916	96	76	mg	mg	PROPN
iajs-2916	96	77	/	/	SYM
iajs-2916	96	78	dl	dl	PROPN
iajs-2916	96	79	)	)	PUNCT
iajs-2916	96	80	84.82	84.82	NUM
iajs-2916	96	81	±	±	NUM
iajs-2916	96	82	1.68	1.68	NUM
iajs-2916	96	83	(	(	PUNCT
iajs-2916	96	84	85.7	85.7	NUM
iajs-2916	96	85	)	)	PUNCT
iajs-2916	96	86	114.81	114.81	NUM
iajs-2916	96	87	±	±	NUM
iajs-2916	96	88	5.63	5.63	NUM
iajs-2916	96	89	(	(	PUNCT
iajs-2916	96	90	122	122	NUM
iajs-2916	96	91	)	)	PUNCT
iajs-2916	96	92	124.11	124.11	NUM
iajs-2916	96	93	±	±	NUM
iajs-2916	96	94	5.98	5.98	NUM
iajs-2916	96	95	(	(	PUNCT
iajs-2916	96	96	122.3	122.3	NUM
iajs-2916	96	97	)	)	PUNCT
iajs-2916	96	98	0.001	0.001	NUM
iajs-2916	96	99	*	*	PUNCT
iajs-2916	96	100	*	*	NOUN
iajs-2916	96	101	0.001	0.001	NUM
iajs-2916	96	102	*	*	NOUN
iajs-2916	96	103	*	*	NOUN
iajs-2916	96	104	0.001	0.001	NUM
iajs-2916	96	105	*	*	NOUN
iajs-2916	96	106	*	*	PROPN
iajs-2916	96	107	0.177	0.177	NUM
iajs-2916	96	108	vldl	vldl	NOUN
iajs-2916	96	109	-	-	PUNCT
iajs-2916	96	110	c	c	NOUN
iajs-2916	96	111	(	(	PUNCT
iajs-2916	96	112	mg	mg	PROPN
iajs-2916	96	113	/	/	SYM
iajs-2916	96	114	dl	dl	PROPN
iajs-2916	96	115	)	)	PUNCT
iajs-2916	96	116	20.85	20.85	NUM
iajs-2916	96	117	±	±	NUM
iajs-2916	96	118	0.65	0.65	NUM
iajs-2916	96	119	(	(	PUNCT
iajs-2916	96	120	21.99	21.99	NUM
iajs-2916	96	121	)	)	PUNCT
iajs-2916	96	122	28.12	28.12	NUM
iajs-2916	96	123	±	±	NUM
iajs-2916	96	124	1.10	1.10	NUM
iajs-2916	96	125	(	(	PUNCT
iajs-2916	96	126	28.4	28.4	NUM
iajs-2916	96	127	)	)	PUNCT
iajs-2916	96	128	31.84	31.84	NUM
iajs-2916	96	129	±	±	NUM
iajs-2916	96	130	2.34	2.34	NUM
iajs-2916	96	131	(	(	PUNCT
iajs-2916	96	132	29.3	29.3	NUM
iajs-2916	96	133	)	)	PUNCT
iajs-2916	96	134	0.001	0.001	NUM
iajs-2916	96	135	*	*	NOUN
iajs-2916	96	136	*	*	NOUN
iajs-2916	96	137	0.001	0.001	NUM
iajs-2916	96	138	*	*	NOUN
iajs-2916	96	139	*	*	NOUN
iajs-2916	96	140	0.001	0.001	NUM
iajs-2916	96	141	*	*	PUNCT
iajs-2916	96	142	*	*	PROPN
iajs-2916	96	143	0.091	0.091	NUM
iajs-2916	96	144	ihjpas	ihjpas	PROPN
iajs-2916	96	145	.	.	PUNCT
iajs-2916	97	1	53	53	NUM
iajs-2916	97	2	(	(	PUNCT
iajs-2916	97	3	4)2022	4)2022	SYM
iajs-2916	97	4	198	198	NUM
iajs-2916	97	5	symptoms	symptom	NOUN
iajs-2916	97	6	that	that	PRON
iajs-2916	97	7	affect	affect	VERB
iajs-2916	97	8	the	the	DET
iajs-2916	97	9	development	development	NOUN
iajs-2916	97	10	of	of	ADP
iajs-2916	97	11	an	an	DET
iajs-2916	97	12	insulin	insulin	NOUN
iajs-2916	97	13	secretory	secretory	ADJ
iajs-2916	97	14	deficiency	deficiency	NOUN
iajs-2916	97	15	[	[	X
iajs-2916	97	16	27	27	NUM
iajs-2916	97	17	]	]	PUNCT
iajs-2916	97	18	.	.	PUNCT
iajs-2916	98	1	homa	homa	PROPN
iajs-2916	98	2	ir	ir	PROPN
iajs-2916	98	3	in	in	ADP
iajs-2916	98	4	table	table	NOUN
iajs-2916	98	5	2	2	NUM
iajs-2916	98	6	showed	show	VERB
iajs-2916	98	7	that	that	SCONJ
iajs-2916	98	8	there	there	PRON
iajs-2916	98	9	is	be	VERB
iajs-2916	98	10	no	no	DET
iajs-2916	98	11	significant	significant	ADJ
iajs-2916	98	12	difference	difference	NOUN
iajs-2916	98	13	between	between	ADP
iajs-2916	98	14	the	the	DET
iajs-2916	98	15	patient	patient	ADJ
iajs-2916	98	16	and	and	CCONJ
iajs-2916	98	17	control	control	NOUN
iajs-2916	98	18	groups	group	NOUN
iajs-2916	98	19	(	(	PUNCT
iajs-2916	98	20	p>0.05	p>0.05	PROPN
iajs-2916	98	21	)	)	PUNCT
iajs-2916	98	22	.	.	PUNCT
iajs-2916	99	1	this	this	PRON
iajs-2916	99	2	might	might	AUX
iajs-2916	99	3	be	be	AUX
iajs-2916	99	4	due	due	ADJ
iajs-2916	99	5	to	to	ADP
iajs-2916	99	6	the	the	DET
iajs-2916	99	7	fact	fact	NOUN
iajs-2916	99	8	that	that	SCONJ
iajs-2916	99	9	all	all	DET
iajs-2916	99	10	patients	patient	NOUN
iajs-2916	99	11	(	(	PUNCT
iajs-2916	99	12	dm	dm	NOUN
iajs-2916	99	13	and	and	CCONJ
iajs-2916	99	14	nu	nu	PROPN
iajs-2916	99	15	.	.	PROPN
iajs-2916	99	16	)	)	PUNCT
iajs-2916	99	17	were	be	AUX
iajs-2916	99	18	under	under	ADP
iajs-2916	99	19	oral	oral	ADJ
iajs-2916	99	20	treatment	treatment	NOUN
iajs-2916	99	21	.	.	PUNCT
iajs-2916	100	1	the	the	DET
iajs-2916	100	2	results	result	NOUN
iajs-2916	100	3	of	of	ADP
iajs-2916	100	4	this	this	DET
iajs-2916	100	5	study	study	NOUN
iajs-2916	100	6	are	be	AUX
iajs-2916	100	7	similar	similar	ADJ
iajs-2916	100	8	with	with	ADP
iajs-2916	100	9	a	a	DET
iajs-2916	100	10	recent	recent	ADJ
iajs-2916	100	11	study	study	NOUN
iajs-2916	100	12	that	that	PRON
iajs-2916	100	13	found	find	VERB
iajs-2916	100	14	that	that	SCONJ
iajs-2916	100	15	metformin	metformin	NOUN
iajs-2916	100	16	,	,	PUNCT
iajs-2916	100	17	when	when	SCONJ
iajs-2916	100	18	administered	administer	VERB
iajs-2916	100	19	as	as	ADP
iajs-2916	100	20	part	part	NOUN
iajs-2916	100	21	of	of	ADP
iajs-2916	100	22	an	an	DET
iajs-2916	100	23	anti	anti	ADJ
iajs-2916	100	24	-	-	ADJ
iajs-2916	100	25	diabetic	diabetic	ADJ
iajs-2916	100	26	therapy	therapy	NOUN
iajs-2916	100	27	in	in	ADP
iajs-2916	100	28	t2	t2	PROPN
iajs-2916	100	29	dm	dm	PROPN
iajs-2916	100	30	patients	patient	NOUN
iajs-2916	100	31	,	,	PUNCT
iajs-2916	100	32	improved	improve	VERB
iajs-2916	100	33	glucose	glucose	NOUN
iajs-2916	100	34	and	and	CCONJ
iajs-2916	100	35	lipid	lipid	NOUN
iajs-2916	100	36	metabolism	metabolism	NOUN
iajs-2916	100	37	,	,	PUNCT
iajs-2916	100	38	decreased	decrease	VERB
iajs-2916	100	39	beta	beta	NOUN
iajs-2916	100	40	-	-	PUNCT
iajs-2916	100	41	cell	cell	NOUN
iajs-2916	100	42	activity	activity	NOUN
iajs-2916	100	43	,	,	PUNCT
iajs-2916	100	44	and	and	CCONJ
iajs-2916	100	45	enhanced	enhance	VERB
iajs-2916	100	46	insulin	insulin	NOUN
iajs-2916	100	47	sensitivity	sensitivity	NOUN
iajs-2916	100	48	[	[	X
iajs-2916	100	49	28	28	NUM
iajs-2916	100	50	]	]	PUNCT
iajs-2916	100	51	.	.	PUNCT
iajs-2916	101	1	with	with	ADP
iajs-2916	101	2	the	the	DET
iajs-2916	101	3	addition	addition	NOUN
iajs-2916	101	4	of	of	ADP
iajs-2916	101	5	low	low	ADJ
iajs-2916	101	6	-	-	PUNCT
iajs-2916	101	7	dose	dose	NOUN
iajs-2916	101	8	sulfonylurea	sulfonylurea	NOUN
iajs-2916	101	9	to	to	ADP
iajs-2916	101	10	the	the	DET
iajs-2916	101	11	treatment	treatment	NOUN
iajs-2916	101	12	plan	plan	NOUN
iajs-2916	101	13	,	,	PUNCT
iajs-2916	101	14	the	the	DET
iajs-2916	101	15	reduction	reduction	NOUN
iajs-2916	101	16	in	in	ADP
iajs-2916	101	17	(	(	PUNCT
iajs-2916	101	18	ir	ir	NOUN
iajs-2916	101	19	)	)	PUNCT
iajs-2916	101	20	insulin	insulin	NOUN
iajs-2916	101	21	resistance	resistance	NOUN
iajs-2916	101	22	was	be	AUX
iajs-2916	101	23	considerably	considerably	ADV
iajs-2916	101	24	greater	great	ADJ
iajs-2916	101	25	than	than	ADP
iajs-2916	101	26	without	without	ADP
iajs-2916	101	27	it	it	PRON
iajs-2916	101	28	.	.	PUNCT
iajs-2916	102	1	homa	homa	PROPN
iajs-2916	102	2	ir	ir	PROPN
iajs-2916	102	3	is	be	AUX
iajs-2916	102	4	a	a	DET
iajs-2916	102	5	reliable	reliable	ADJ
iajs-2916	102	6	test	test	NOUN
iajs-2916	102	7	for	for	ADP
iajs-2916	102	8	detecting	detect	VERB
iajs-2916	102	9	(	(	PUNCT
iajs-2916	102	10	ir	ir	NOUN
iajs-2916	102	11	)	)	PUNCT
iajs-2916	103	1	[	[	X
iajs-2916	103	2	29	29	NUM
iajs-2916	103	3	]	]	PUNCT
iajs-2916	103	4	.	.	PUNCT
iajs-2916	104	1	akira	akira	PROPN
iajs-2916	104	2	katsuki	katsuki	PROPN
iajs-2916	104	3	et	et	PROPN
iajs-2916	104	4	al	al	PROPN
iajs-2916	104	5	.	.	PUNCT
iajs-2916	105	1	[	[	X
iajs-2916	105	2	30	30	NUM
iajs-2916	105	3	]	]	PUNCT
iajs-2916	105	4	study	study	NOUN
iajs-2916	105	5	concluded	conclude	VERB
iajs-2916	105	6	that	that	SCONJ
iajs-2916	105	7	homa	homa	PROPN
iajs-2916	105	8	ir	ir	PROPN
iajs-2916	105	9	is	be	AUX
iajs-2916	105	10	a	a	DET
iajs-2916	105	11	reliable	reliable	ADJ
iajs-2916	105	12	method	method	NOUN
iajs-2916	105	13	for	for	ADP
iajs-2916	105	14	determining	determine	VERB
iajs-2916	105	15	insulin	insulin	NOUN
iajs-2916	105	16	resistance	resistance	NOUN
iajs-2916	105	17	in	in	ADP
iajs-2916	105	18	patients	patient	NOUN
iajs-2916	105	19	under	under	ADP
iajs-2916	105	20	treatment	treatment	NOUN
iajs-2916	105	21	with	with	ADP
iajs-2916	105	22	sulfonylurea	sulfonylurea	NOUN
iajs-2916	105	23	,	,	PUNCT
iajs-2916	105	24	diet	diet	NOUN
iajs-2916	105	25	and	and	CCONJ
iajs-2916	105	26	exercises	exercise	NOUN
iajs-2916	105	27	.	.	PUNCT
iajs-2916	106	1	according	accord	VERB
iajs-2916	106	2	to	to	ADP
iajs-2916	106	3	a	a	DET
iajs-2916	106	4	recent	recent	ADJ
iajs-2916	106	5	study	study	NOUN
iajs-2916	106	6	,	,	PUNCT
iajs-2916	106	7	metformin	metformin	NOUN
iajs-2916	106	8	improved	improve	VERB
iajs-2916	106	9	insulin	insulin	NOUN
iajs-2916	106	10	resistance	resistance	NOUN
iajs-2916	106	11	by	by	ADP
iajs-2916	106	12	lowering	lower	VERB
iajs-2916	106	13	the	the	DET
iajs-2916	106	14	expression	expression	NOUN
iajs-2916	106	15	of	of	ADP
iajs-2916	106	16	mir223	mir223	PROPN
iajs-2916	106	17	in	in	ADP
iajs-2916	106	18	adipocytes	adipocyte	NOUN
iajs-2916	106	19	.	.	PUNCT
iajs-2916	107	1	in	in	ADP
iajs-2916	107	2	insulin	insulin	NOUN
iajs-2916	107	3	-	-	PUNCT
iajs-2916	107	4	resistant	resistant	ADJ
iajs-2916	107	5	adipocytes	adipocyte	NOUN
iajs-2916	107	6	against	against	ADP
iajs-2916	107	7	non	non	ADJ
iajs-2916	107	8	-	-	ADJ
iajs-2916	107	9	resistant	resistant	ADJ
iajs-2916	107	10	adipocytes	adipocyte	NOUN
iajs-2916	107	11	,	,	PUNCT
iajs-2916	107	12	and	and	CCONJ
iajs-2916	107	13	diabetic	diabetic	ADJ
iajs-2916	107	14	adipose	adipose	PRON
iajs-2916	107	15	tissue	tissue	NOUN
iajs-2916	107	16	versus	versus	ADP
iajs-2916	107	17	non	non	ADJ
iajs-2916	107	18	-	-	NOUN
iajs-2916	107	19	diabetics	diabetic	NOUN
iajs-2916	107	20	,	,	PUNCT
iajs-2916	107	21	mir223	mir223	NOUN
iajs-2916	107	22	expression	expression	NOUN
iajs-2916	107	23	was	be	AUX
iajs-2916	107	24	significantly	significantly	ADV
iajs-2916	107	25	higher	high	ADJ
iajs-2916	107	26	[	[	X
iajs-2916	107	27	31	31	NUM
iajs-2916	107	28	]	]	PUNCT
iajs-2916	107	29	.	.	PUNCT
iajs-2916	108	1	the	the	DET
iajs-2916	108	2	impact	impact	NOUN
iajs-2916	108	3	of	of	ADP
iajs-2916	108	4	prolonged	prolonged	ADJ
iajs-2916	108	5	metformin	metformin	NOUN
iajs-2916	108	6	treatment	treatment	NOUN
iajs-2916	108	7	(	(	PUNCT
iajs-2916	108	8	a	a	DET
iajs-2916	108	9	medicine	medicine	NOUN
iajs-2916	108	10	that	that	PRON
iajs-2916	108	11	improves	improve	VERB
iajs-2916	108	12	insulin	insulin	NOUN
iajs-2916	108	13	sensitivity	sensitivity	NOUN
iajs-2916	108	14	)	)	PUNCT
iajs-2916	108	15	on	on	ADP
iajs-2916	108	16	diabetic	diabetic	ADJ
iajs-2916	108	17	complications	complication	NOUN
iajs-2916	108	18	was	be	AUX
iajs-2916	108	19	helpful	helpful	ADJ
iajs-2916	108	20	.	.	PUNCT
iajs-2916	109	1	compared	compare	VERB
iajs-2916	109	2	to	to	ADP
iajs-2916	109	3	the	the	DET
iajs-2916	109	4	traditional	traditional	ADJ
iajs-2916	109	5	group	group	NOUN
iajs-2916	109	6	treated	treat	VERB
iajs-2916	109	7	just	just	ADV
iajs-2916	109	8	with	with	ADP
iajs-2916	109	9	diet	diet	NOUN
iajs-2916	109	10	,	,	PUNCT
iajs-2916	109	11	metformin	metformin	NOUN
iajs-2916	109	12	-	-	PUNCT
iajs-2916	109	13	treated	treat	VERB
iajs-2916	109	14	individuals	individual	NOUN
iajs-2916	109	15	had	have	VERB
iajs-2916	109	16	a	a	DET
iajs-2916	109	17	32	32	NUM
iajs-2916	109	18	%	%	NOUN
iajs-2916	109	19	lower	low	ADJ
iajs-2916	109	20	risk	risk	NOUN
iajs-2916	109	21	of	of	ADP
iajs-2916	109	22	any	any	DET
iajs-2916	109	23	diabetes	diabetes	NOUN
iajs-2916	109	24	-	-	PUNCT
iajs-2916	109	25	related	relate	VERB
iajs-2916	109	26	outcome	outcome	NOUN
iajs-2916	109	27	,	,	PUNCT
iajs-2916	109	28	including	include	VERB
iajs-2916	109	29	macrovascular	macrovascular	ADJ
iajs-2916	109	30	problems	problem	NOUN
iajs-2916	109	31	.	.	PUNCT
iajs-2916	110	1	compared	compare	VERB
iajs-2916	110	2	with	with	ADP
iajs-2916	110	3	the	the	DET
iajs-2916	110	4	control	control	NOUN
iajs-2916	110	5	group	group	NOUN
iajs-2916	110	6	,	,	PUNCT
iajs-2916	110	7	metformin	metformin	NOUN
iajs-2916	110	8	patients	patient	NOUN
iajs-2916	110	9	had	have	VERB
iajs-2916	110	10	a	a	DET
iajs-2916	110	11	42	42	NUM
iajs-2916	110	12	%	%	NOUN
iajs-2916	110	13	lower	low	ADJ
iajs-2916	110	14	risk	risk	NOUN
iajs-2916	110	15	of	of	ADP
iajs-2916	110	16	diabetes	diabetes	NOUN
iajs-2916	110	17	-	-	PUNCT
iajs-2916	110	18	related	relate	VERB
iajs-2916	110	19	death	death	NOUN
iajs-2916	110	20	and	and	CCONJ
iajs-2916	110	21	a	a	DET
iajs-2916	110	22	36	36	NUM
iajs-2916	110	23	%	%	NOUN
iajs-2916	110	24	decreased	decrease	VERB
iajs-2916	110	25	chance	chance	NOUN
iajs-2916	110	26	of	of	ADP
iajs-2916	110	27	dying	die	VERB
iajs-2916	110	28	from	from	ADP
iajs-2916	110	29	any	any	DET
iajs-2916	110	30	causes	cause	NOUN
iajs-2916	110	31	[	[	X
iajs-2916	110	32	32	32	NUM
iajs-2916	110	33	]	]	PUNCT
iajs-2916	110	34	.	.	PUNCT
iajs-2916	111	1	regarding	regard	VERB
iajs-2916	111	2	gst	gst	PROPN
iajs-2916	111	3	,	,	PUNCT
iajs-2916	111	4	the	the	DET
iajs-2916	111	5	mean	mean	ADJ
iajs-2916	111	6	values	value	NOUN
iajs-2916	111	7	in	in	ADP
iajs-2916	111	8	(	(	PUNCT
iajs-2916	111	9	iu	iu	PROPN
iajs-2916	111	10	/	/	SYM
iajs-2916	111	11	l	l	NOUN
iajs-2916	111	12	)	)	PUNCT
iajs-2916	111	13	for	for	ADP
iajs-2916	111	14	all	all	DET
iajs-2916	111	15	the	the	DET
iajs-2916	111	16	studied	study	VERB
iajs-2916	111	17	groups	group	NOUN
iajs-2916	111	18	in	in	ADP
iajs-2916	111	19	the	the	DET
iajs-2916	111	20	present	present	ADJ
iajs-2916	111	21	study	study	NOUN
iajs-2916	111	22	are	be	AUX
iajs-2916	111	23	shown	show	VERB
iajs-2916	111	24	in	in	ADP
iajs-2916	111	25	table	table	NOUN
iajs-2916	111	26	2	2	NUM
iajs-2916	111	27	and	and	CCONJ
iajs-2916	111	28	figure	figure	VERB
iajs-2916	111	29	1	1	NUM
iajs-2916	111	30	table	table	NOUN
iajs-2916	111	31	2	2	NUM
iajs-2916	111	32	.	.	PUNCT
iajs-2916	111	33	comparison	comparison	NOUN
iajs-2916	111	34	of	of	ADP
iajs-2916	111	35	insulin	insulin	NOUN
iajs-2916	111	36	,	,	PUNCT
iajs-2916	111	37	homa	homa	PROPN
iajs-2916	111	38	ir	ir	PROPN
iajs-2916	111	39	and	and	CCONJ
iajs-2916	111	40	gst	gst	PROPN
iajs-2916	111	41	between	between	ADP
iajs-2916	111	42	control	control	NOUN
iajs-2916	111	43	and	and	CCONJ
iajs-2916	111	44	patient	patient	ADJ
iajs-2916	111	45	groups	group	NOUN
iajs-2916	111	46	data	datum	NOUN
iajs-2916	111	47	were	be	AUX
iajs-2916	111	48	presented	present	VERB
iajs-2916	111	49	as	as	ADP
iajs-2916	111	50	(	(	PUNCT
iajs-2916	111	51	mean	mean	NOUN
iajs-2916	111	52	±	±	NUM
iajs-2916	111	53	se	se	NOUN
iajs-2916	111	54	)	)	PUNCT
iajs-2916	111	55	median	median	ADJ
iajs-2916	111	56	lsd	lsd	NOUN
iajs-2916	111	57	:	:	PUNCT
iajs-2916	111	58	least	least	ADJ
iajs-2916	111	59	significant	significant	ADJ
iajs-2916	111	60	difference	difference	NOUN
iajs-2916	111	61	*	*	PUNCT
iajs-2916	111	62	significant	significant	ADJ
iajs-2916	111	63	difference	difference	NOUN
iajs-2916	111	64	between	between	ADP
iajs-2916	111	65	means	mean	NOUN
iajs-2916	111	66	using	use	VERB
iajs-2916	111	67	anova	anova	PROPN
iajs-2916	111	68	-test	-test	PROPN
iajs-2916	111	69	at	at	ADP
iajs-2916	111	70	0.05	0.05	NUM
iajs-2916	111	71	level	level	NOUN
iajs-2916	111	72	*	*	PUNCT
iajs-2916	111	73	*	*	ADJ
iajs-2916	111	74	highly	highly	ADV
iajs-2916	111	75	significant	significant	ADJ
iajs-2916	111	76	difference	difference	NOUN
iajs-2916	111	77	between	between	ADP
iajs-2916	111	78	means	mean	NOUN
iajs-2916	111	79	using	use	VERB
iajs-2916	111	80	anova	anova	PROPN
iajs-2916	111	81	-test	-test	PROPN
iajs-2916	111	82	at	at	ADP
iajs-2916	111	83	0.05	0.05	NUM
iajs-2916	111	84	level	level	NOUN
iajs-2916	111	85	.	.	PUNCT
iajs-2916	112	1	parameters	parameter	NOUN
iajs-2916	112	2	control	control	PROPN
iajs-2916	112	3	group	group	PROPN
iajs-2916	112	4	(	(	PUNCT
iajs-2916	112	5	1	1	NUM
iajs-2916	112	6	)	)	PUNCT
iajs-2916	112	7	no	no	INTJ
iajs-2916	112	8	.	.	PUNCT
iajs-2916	113	1	(	(	PUNCT
iajs-2916	113	2	40	40	NUM
iajs-2916	113	3	)	)	PUNCT
iajs-2916	113	4	diabetes	diabetes	NOUN
iajs-2916	113	5	mellitus	mellitus	NOUN
iajs-2916	113	6	(	(	PUNCT
iajs-2916	113	7	dm	dm	PROPN
iajs-2916	113	8	)	)	PUNCT
iajs-2916	113	9	group	group	NOUN
iajs-2916	113	10	(	(	PUNCT
iajs-2916	113	11	2	2	NUM
iajs-2916	113	12	)	)	PUNCT
iajs-2916	113	13	no	no	NOUN
iajs-2916	113	14	.	.	PUNCT
iajs-2916	114	1	(	(	PUNCT
iajs-2916	114	2	40	40	NUM
iajs-2916	114	3	)	)	PUNCT
iajs-2916	114	4	neuropathy	neuropathy	ADJ
iajs-2916	114	5	group	group	NOUN
iajs-2916	114	6	(	(	PUNCT
iajs-2916	114	7	3	3	NUM
iajs-2916	114	8	)	)	PUNCT
iajs-2916	114	9	no	no	NOUN
iajs-2916	114	10	.	.	PUNCT
iajs-2916	115	1	(	(	PUNCT
iajs-2916	115	2	40	40	NUM
iajs-2916	115	3	)	)	PUNCT
iajs-2916	115	4	p	p	ADJ
iajs-2916	115	5	-	-	PUNCT
iajs-2916	115	6	value	value	NOUN
iajs-2916	115	7	lsd	lsd	NOUN
iajs-2916	115	8	between	between	ADP
iajs-2916	115	9	groups	group	NOUN
iajs-2916	115	10	(	(	PUNCT
iajs-2916	115	11	1,2	1,2	NUM
iajs-2916	115	12	)	)	PUNCT
iajs-2916	115	13	lsd	lsd	NOUN
iajs-2916	115	14	between	between	ADP
iajs-2916	115	15	groups	group	NOUN
iajs-2916	115	16	(	(	PUNCT
iajs-2916	115	17	1,3	1,3	NUM
iajs-2916	115	18	)	)	PUNCT
iajs-2916	115	19	lsd	lsd	NOUN
iajs-2916	115	20	between	between	ADP
iajs-2916	115	21	groups	group	NOUN
iajs-2916	115	22	(	(	PUNCT
iajs-2916	115	23	2,3	2,3	NUM
iajs-2916	115	24	)	)	PUNCT
iajs-2916	115	25	insulin	insulin	NOUN
iajs-2916	115	26	(	(	PUNCT
iajs-2916	115	27	μiu	μiu	PROPN
iajs-2916	115	28	/	/	SYM
iajs-2916	115	29	ml	ml	NOUN
iajs-2916	115	30	)	)	PUNCT
iajs-2916	115	31	3.14	3.14	NUM
iajs-2916	115	32	±	±	NUM
iajs-2916	115	33	0.26	0.26	NUM
iajs-2916	115	34	(	(	PUNCT
iajs-2916	115	35	2.75	2.75	NUM
iajs-2916	115	36	)	)	PUNCT
iajs-2916	115	37	1.95	1.95	NUM
iajs-2916	115	38	±	±	NUM
iajs-2916	115	39	0.19	0.19	NUM
iajs-2916	115	40	(	(	PUNCT
iajs-2916	115	41	1.8	1.8	NUM
iajs-2916	115	42	)	)	PUNCT
iajs-2916	115	43	1.69	1.69	NUM
iajs-2916	115	44	±	±	NUM
iajs-2916	115	45	0.13	0.13	NUM
iajs-2916	115	46	(	(	PUNCT
iajs-2916	115	47	1.4	1.4	NUM
iajs-2916	115	48	)	)	PUNCT
iajs-2916	115	49	0.001	0.001	NUM
iajs-2916	115	50	*	*	PUNCT
iajs-2916	115	51	*	*	NOUN
iajs-2916	115	52	0.001	0.001	NUM
iajs-2916	115	53	*	*	NOUN
iajs-2916	115	54	*	*	NOUN
iajs-2916	115	55	0.001	0.001	NUM
iajs-2916	115	56	*	*	NOUN
iajs-2916	115	57	*	*	PUNCT
iajs-2916	115	58	0.375	0.375	NUM
iajs-2916	115	59	homa	homa	PROPN
iajs-2916	115	60	ir	ir	PROPN
iajs-2916	115	61	0.71	0.71	NUM
iajs-2916	115	62	±	±	NUM
iajs-2916	115	63	0.06	0.06	NUM
iajs-2916	115	64	(	(	PUNCT
iajs-2916	115	65	0.57	0.57	NUM
iajs-2916	115	66	)	)	PUNCT
iajs-2916	115	67	0.82	0.82	NUM
iajs-2916	115	68	±	±	NUM
iajs-2916	115	69	0.08	0.08	NUM
iajs-2916	115	70	(	(	PUNCT
iajs-2916	115	71	0.7	0.7	NUM
iajs-2916	115	72	)	)	PUNCT
iajs-2916	115	73	0.82	0.82	NUM
iajs-2916	115	74	±	±	NUM
iajs-2916	115	75	0.065	0.065	NUM
iajs-2916	115	76	(	(	PUNCT
iajs-2916	115	77	0.71	0.71	NUM
iajs-2916	115	78	)	)	PUNCT
iajs-2916	115	79	0.46	0.46	NUM
iajs-2916	115	80	0.291	0.291	NUM
iajs-2916	115	81	0.271	0.271	NUM
iajs-2916	115	82	0.966	0.966	NUM
iajs-2916	115	83	gst	gst	NOUN
iajs-2916	115	84	activity	activity	NOUN
iajs-2916	115	85	(	(	PUNCT
iajs-2916	115	86	iu	iu	NOUN
iajs-2916	115	87	/	/	SYM
iajs-2916	115	88	l	l	NOUN
iajs-2916	115	89	)	)	PUNCT
iajs-2916	115	90	0.74	0.74	NUM
iajs-2916	115	91	±	±	NUM
iajs-2916	115	92	0.68	0.68	NUM
iajs-2916	115	93	(	(	PUNCT
iajs-2916	115	94	2	2	NUM
iajs-2916	115	95	)	)	PUNCT
iajs-2916	115	96	2.89	2.89	NUM
iajs-2916	115	97	±	±	NUM
iajs-2916	115	98	0.74	0.74	NUM
iajs-2916	115	99	(	(	PUNCT
iajs-2916	115	100	2.54	2.54	NUM
iajs-2916	115	101	)	)	PUNCT
iajs-2916	115	102	3.53	3.53	NUM
iajs-2916	115	103	±	±	NUM
iajs-2916	115	104	0.85	0.85	NUM
iajs-2916	115	105	(	(	PUNCT
iajs-2916	115	106	2.58	2.58	NUM
iajs-2916	115	107	)	)	PUNCT
iajs-2916	115	108	0.029	0.029	NUM
iajs-2916	115	109	*	*	PUNCT
iajs-2916	115	110	0.120	0.120	NUM
iajs-2916	115	111	0.030	0.030	NUM
iajs-2916	115	112	*	*	NOUN
iajs-2916	115	113	0.825	0.825	NUM
iajs-2916	115	114	ihjpas	ihjpa	VERB
iajs-2916	115	115	.	.	PUNCT
iajs-2916	116	1	53	53	NUM
iajs-2916	116	2	(	(	PUNCT
iajs-2916	116	3	4)2022	4)2022	NOUN
iajs-2916	116	4	199	199	NUM
iajs-2916	116	5	figure	figure	NOUN
iajs-2916	116	6	1	1	NUM
iajs-2916	116	7	.	.	PUNCT
iajs-2916	116	8	gst	gst	NOUN
iajs-2916	116	9	activity	activity	NOUN
iajs-2916	116	10	(	(	PUNCT
iajs-2916	116	11	iu	iu	PROPN
iajs-2916	116	12	/	/	SYM
iajs-2916	116	13	l	l	NOUN
iajs-2916	116	14	)	)	PUNCT
iajs-2916	116	15	between	between	ADP
iajs-2916	116	16	groups	group	NOUN
iajs-2916	116	17	there	there	PRON
iajs-2916	116	18	is	be	VERB
iajs-2916	116	19	a	a	DET
iajs-2916	116	20	difference	difference	NOUN
iajs-2916	116	21	in	in	ADP
iajs-2916	116	22	the	the	DET
iajs-2916	116	23	mean	mean	NOUN
iajs-2916	116	24	between	between	ADP
iajs-2916	116	25	the	the	DET
iajs-2916	116	26	control	control	NOUN
iajs-2916	116	27	(	(	PUNCT
iajs-2916	116	28	0.74±0.68	0.74±0.68	NOUN
iajs-2916	116	29	)	)	PUNCT
iajs-2916	116	30	and	and	CCONJ
iajs-2916	116	31	dm	dm	PROPN
iajs-2916	116	32	(	(	PUNCT
iajs-2916	116	33	2.89±0.74	2.89±0.74	NUM
iajs-2916	116	34	)	)	PUNCT
iajs-2916	116	35	and	and	CCONJ
iajs-2916	116	36	nu	nu	PROPN
iajs-2916	116	37	.	.	PROPN
iajs-2916	116	38	groups	group	NOUN
iajs-2916	116	39	(	(	PUNCT
iajs-2916	116	40	3.53±0.85	3.53±0.85	NUM
iajs-2916	116	41	)	)	PUNCT
iajs-2916	116	42	;	;	PUNCT
iajs-2916	116	43	the	the	DET
iajs-2916	116	44	result	result	NOUN
iajs-2916	116	45	suggested	suggest	VERB
iajs-2916	116	46	a	a	DET
iajs-2916	116	47	significant	significant	ADJ
iajs-2916	116	48	difference	difference	NOUN
iajs-2916	116	49	in	in	ADP
iajs-2916	116	50	gst	gst	NOUN
iajs-2916	116	51	activities	activity	NOUN
iajs-2916	116	52	between	between	ADP
iajs-2916	116	53	patients	patient	NOUN
iajs-2916	116	54	and	and	CCONJ
iajs-2916	116	55	the	the	DET
iajs-2916	116	56	control	control	NOUN
iajs-2916	116	57	groups	group	NOUN
iajs-2916	116	58	with	with	ADP
iajs-2916	116	59	(	(	PUNCT
iajs-2916	116	60	p≤0.05	p≤0.05	NOUN
iajs-2916	116	61	)	)	PUNCT
iajs-2916	116	62	lsd	lsd	NOUN
iajs-2916	116	63	showed	show	VERB
iajs-2916	116	64	a	a	DET
iajs-2916	116	65	significant	significant	ADJ
iajs-2916	116	66	difference	difference	NOUN
iajs-2916	116	67	between	between	ADP
iajs-2916	116	68	the	the	DET
iajs-2916	116	69	control	control	NOUN
iajs-2916	116	70	and	and	CCONJ
iajs-2916	116	71	neuropathy	neuropathy	ADJ
iajs-2916	116	72	groups	group	NOUN
iajs-2916	116	73	(	(	PUNCT
iajs-2916	116	74	p≤0.05	p≤0.05	NOUN
iajs-2916	116	75	)	)	PUNCT
iajs-2916	116	76	as	as	SCONJ
iajs-2916	116	77	shown	show	VERB
iajs-2916	116	78	in	in	ADP
iajs-2916	116	79	figure	figure	NOUN
iajs-2916	116	80	1	1	NUM
iajs-2916	117	1	antioxidant	antioxidant	NOUN
iajs-2916	117	2	glutathione	glutathione	NOUN
iajs-2916	117	3	s	s	NOUN
iajs-2916	117	4	-	-	NOUN
iajs-2916	117	5	transferase	transferase	NOUN
iajs-2916	117	6	is	be	AUX
iajs-2916	117	7	a	a	DET
iajs-2916	117	8	multigene	multigene	ADJ
iajs-2916	117	9	protein	protein	NOUN
iajs-2916	117	10	family	family	NOUN
iajs-2916	117	11	that	that	PRON
iajs-2916	117	12	has	have	VERB
iajs-2916	117	13	a	a	DET
iajs-2916	117	14	role	role	NOUN
iajs-2916	117	15	in	in	ADP
iajs-2916	117	16	the	the	DET
iajs-2916	117	17	metabolism	metabolism	NOUN
iajs-2916	117	18	of	of	ADP
iajs-2916	117	19	diseases	disease	NOUN
iajs-2916	117	20	causing	cause	VERB
iajs-2916	117	21	electrophilic	electrophilic	ADJ
iajs-2916	117	22	substrates	substrate	NOUN
iajs-2916	117	23	,	,	PUNCT
iajs-2916	117	24	protecting	protect	VERB
iajs-2916	117	25	cells	cell	NOUN
iajs-2916	117	26	from	from	ADP
iajs-2916	117	27	oxidative	oxidative	ADJ
iajs-2916	117	28	stress	stress	NOUN
iajs-2916	117	29	and	and	CCONJ
iajs-2916	117	30	monitoring	monitor	VERB
iajs-2916	117	31	cellular	cellular	ADJ
iajs-2916	117	32	activation	activation	NOUN
iajs-2916	117	33	.	.	PUNCT
iajs-2916	118	1	the	the	DET
iajs-2916	118	2	results	result	NOUN
iajs-2916	118	3	of	of	ADP
iajs-2916	118	4	this	this	DET
iajs-2916	118	5	study	study	NOUN
iajs-2916	118	6	are	be	AUX
iajs-2916	118	7	in	in	ADP
iajs-2916	118	8	agreement	agreement	NOUN
iajs-2916	118	9	with	with	ADP
iajs-2916	118	10	a	a	DET
iajs-2916	118	11	previous	previous	ADJ
iajs-2916	118	12	study	study	NOUN
iajs-2916	118	13	which	which	PRON
iajs-2916	118	14	showed	show	VERB
iajs-2916	118	15	a	a	DET
iajs-2916	118	16	significant	significant	ADJ
iajs-2916	118	17	difference	difference	NOUN
iajs-2916	118	18	in	in	ADP
iajs-2916	118	19	gst	gst	NOUN
iajs-2916	118	20	activity	activity	NOUN
iajs-2916	118	21	between	between	ADP
iajs-2916	118	22	dm	dm	PROPN
iajs-2916	118	23	patients	patient	NOUN
iajs-2916	118	24	and	and	CCONJ
iajs-2916	118	25	control	control	NOUN
iajs-2916	118	26	.	.	PUNCT
iajs-2916	119	1	there	there	PRON
iajs-2916	119	2	is	be	VERB
iajs-2916	119	3	strong	strong	ADJ
iajs-2916	119	4	evidence	evidence	NOUN
iajs-2916	119	5	that	that	SCONJ
iajs-2916	119	6	oxidative	oxidative	ADJ
iajs-2916	119	7	stress	stress	NOUN
iajs-2916	119	8	(	(	PUNCT
iajs-2916	119	9	os	os	NOUN
iajs-2916	119	10	)	)	PUNCT
iajs-2916	119	11	plays	play	VERB
iajs-2916	119	12	a	a	DET
iajs-2916	119	13	key	key	ADJ
iajs-2916	119	14	role	role	NOUN
iajs-2916	119	15	in	in	ADP
iajs-2916	119	16	diabetes	diabetes	NOUN
iajs-2916	119	17	development	development	NOUN
iajs-2916	119	18	and	and	CCONJ
iajs-2916	119	19	complications	complication	NOUN
iajs-2916	119	20	[	[	X
iajs-2916	119	21	33	33	NUM
iajs-2916	119	22	]	]	PUNCT
iajs-2916	119	23	.	.	PUNCT
iajs-2916	120	1	also	also	ADV
iajs-2916	120	2	,	,	PUNCT
iajs-2916	120	3	mohini	mohini	PROPN
iajs-2916	120	4	sharma	sharma	PROPN
iajs-2916	120	5	et	et	PROPN
iajs-2916	120	6	al	al	PROPN
iajs-2916	120	7	.	.	PUNCT
iajs-2916	121	1	[	[	X
iajs-2916	121	2	34	34	NUM
iajs-2916	121	3	]	]	PUNCT
iajs-2916	121	4	revealed	reveal	VERB
iajs-2916	121	5	that	that	SCONJ
iajs-2916	121	6	the	the	DET
iajs-2916	121	7	highest	high	ADJ
iajs-2916	121	8	gst	gst	NOUN
iajs-2916	121	9	activity	activity	NOUN
iajs-2916	121	10	in	in	ADP
iajs-2916	121	11	t2	t2	NOUN
iajs-2916	121	12	dm	dm	PRON
iajs-2916	121	13	may	may	AUX
iajs-2916	121	14	represent	represent	VERB
iajs-2916	121	15	a	a	DET
iajs-2916	121	16	compensatory	compensatory	ADJ
iajs-2916	121	17	strategy	strategy	NOUN
iajs-2916	121	18	in	in	ADP
iajs-2916	121	19	response	response	NOUN
iajs-2916	121	20	to	to	ADP
iajs-2916	121	21	oxidative	oxidative	ADJ
iajs-2916	121	22	stress	stress	NOUN
iajs-2916	121	23	.	.	PUNCT
iajs-2916	122	1	on	on	ADP
iajs-2916	122	2	the	the	DET
iajs-2916	122	3	contrary	contrary	NOUN
iajs-2916	122	4	,	,	PUNCT
iajs-2916	122	5	sarkar	sarkar	PROPN
iajs-2916	122	6	a.	a.	PROPN
iajs-2916	122	7	et	et	PROPN
iajs-2916	122	8	al	al	PROPN
iajs-2916	122	9	.	.	PUNCT
iajs-2916	123	1	[	[	X
iajs-2916	123	2	35	35	NUM
iajs-2916	123	3	]	]	PUNCT
iajs-2916	123	4	reported	report	VERB
iajs-2916	123	5	that	that	SCONJ
iajs-2916	123	6	there	there	PRON
iajs-2916	123	7	is	be	VERB
iajs-2916	123	8	no	no	DET
iajs-2916	123	9	significant	significant	ADJ
iajs-2916	123	10	difference	difference	NOUN
iajs-2916	123	11	was	be	AUX
iajs-2916	123	12	found	find	VERB
iajs-2916	123	13	in	in	ADP
iajs-2916	123	14	gst	gst	NOUN
iajs-2916	123	15	between	between	ADP
iajs-2916	123	16	type	type	NOUN
iajs-2916	123	17	2	2	NUM
iajs-2916	123	18	dm	dm	NOUN
iajs-2916	123	19	patients	patient	NOUN
iajs-2916	123	20	and	and	CCONJ
iajs-2916	123	21	healthy	healthy	ADJ
iajs-2916	123	22	.	.	PUNCT
iajs-2916	124	1	in	in	ADP
iajs-2916	124	2	plasma	plasma	NOUN
iajs-2916	124	3	and	and	CCONJ
iajs-2916	124	4	membrane	membrane	NOUN
iajs-2916	124	5	proteins	protein	NOUN
iajs-2916	124	6	,	,	PUNCT
iajs-2916	124	7	there	there	PRON
iajs-2916	124	8	was	be	VERB
iajs-2916	124	9	autoxidation	autoxidation	NOUN
iajs-2916	124	10	of	of	ADP
iajs-2916	124	11	unsaturated	unsaturated	ADJ
iajs-2916	124	12	lipids	lipids	ADJ
iajs-2916	124	13	and	and	CCONJ
iajs-2916	124	14	sugar	sugar	NOUN
iajs-2916	124	15	-	-	PUNCT
iajs-2916	124	16	protein	protein	NOUN
iajs-2916	124	17	adducts	adduct	NOUN
iajs-2916	124	18	,	,	PUNCT
iajs-2916	124	19	as	as	ADV
iajs-2916	124	20	well	well	ADV
iajs-2916	124	21	as	as	ADP
iajs-2916	124	22	sugars	sugar	NOUN
iajs-2916	124	23	themselves	themselves	PRON
iajs-2916	124	24	;	;	PUNCT
iajs-2916	124	25	all	all	PRON
iajs-2916	124	26	created	create	VERB
iajs-2916	124	27	free	free	ADJ
iajs-2916	124	28	radicals	radical	NOUN
iajs-2916	124	29	which	which	PRON
iajs-2916	124	30	were	be	AUX
iajs-2916	124	31	probable	probable	ADJ
iajs-2916	124	32	causes	cause	NOUN
iajs-2916	124	33	of	of	ADP
iajs-2916	124	34	oxidative	oxidative	ADJ
iajs-2916	124	35	stress	stress	NOUN
iajs-2916	124	36	and	and	CCONJ
iajs-2916	124	37	protein	protein	NOUN
iajs-2916	124	38	degradation	degradation	NOUN
iajs-2916	124	39	in	in	ADP
iajs-2916	124	40	diabetes	diabetes	NOUN
iajs-2916	124	41	.	.	PUNCT
iajs-2916	125	1	as	as	SCONJ
iajs-2916	125	2	the	the	DET
iajs-2916	125	3	oxidative	oxidative	ADJ
iajs-2916	125	4	stress	stress	NOUN
iajs-2916	125	5	increased	increase	VERB
iajs-2916	125	6	the	the	DET
iajs-2916	125	7	formation	formation	NOUN
iajs-2916	125	8	of	of	ADP
iajs-2916	125	9	free	free	ADJ
iajs-2916	125	10	radicals	radical	NOUN
iajs-2916	125	11	and	and	CCONJ
iajs-2916	125	12	the	the	DET
iajs-2916	125	13	weakening	weakening	NOUN
iajs-2916	125	14	of	of	ADP
iajs-2916	125	15	the	the	DET
iajs-2916	125	16	free	free	ADJ
iajs-2916	125	17	radical	radical	ADJ
iajs-2916	125	18	inhibitors	inhibitor	NOUN
iajs-2916	125	19	and	and	CCONJ
iajs-2916	125	20	scavengers	scavenger	NOUN
iajs-2916	125	21	would	would	AUX
iajs-2916	125	22	in	in	ADP
iajs-2916	125	23	turn	turn	NOUN
iajs-2916	125	24	,	,	PUNCT
iajs-2916	125	25	increase	increase	VERB
iajs-2916	125	26	the	the	DET
iajs-2916	125	27	oxidative	oxidative	ADJ
iajs-2916	125	28	stress	stress	NOUN
iajs-2916	125	29	leading	lead	VERB
iajs-2916	125	30	to	to	ADP
iajs-2916	125	31	cell	cell	NOUN
iajs-2916	125	32	damage	damage	NOUN
iajs-2916	125	33	and	and	CCONJ
iajs-2916	125	34	death	death	NOUN
iajs-2916	126	1	[	[	X
iajs-2916	126	2	36	36	NUM
iajs-2916	126	3	]	]	PUNCT
iajs-2916	126	4	.	.	PUNCT
iajs-2916	127	1	regarding	regard	VERB
iajs-2916	127	2	to	to	ADP
iajs-2916	127	3	the	the	DET
iajs-2916	127	4	study	study	NOUN
iajs-2916	127	5	by	by	ADP
iajs-2916	127	6	mohammad	mohammad	PROPN
iajs-2916	127	7	bagher	bagher	PROPN
iajs-2916	127	8	hashemi	hashemi	PROPN
iajs-2916	127	9	-	-	PUNCT
iajs-2916	127	10	soteh	soteh	NOUN
iajs-2916	127	11	et	et	PROPN
iajs-2916	127	12	al	al	PROPN
iajs-2916	127	13	.	.	PUNCT
iajs-2916	128	1	[	[	X
iajs-2916	128	2	37	37	NUM
iajs-2916	128	3	]	]	PUNCT
iajs-2916	128	4	the	the	DET
iajs-2916	128	5	gstt1null	gstt1null	NOUN
iajs-2916	128	6	genotype	genotype	NOUN
iajs-2916	128	7	was	be	AUX
iajs-2916	128	8	considerably	considerably	ADV
iajs-2916	128	9	more	more	ADV
iajs-2916	128	10	common	common	ADJ
iajs-2916	128	11	in	in	ADP
iajs-2916	128	12	diabetic	diabetic	ADJ
iajs-2916	128	13	neuropathy	neuropathy	ADJ
iajs-2916	128	14	patients	patient	NOUN
iajs-2916	128	15	than	than	ADP
iajs-2916	128	16	in	in	ADP
iajs-2916	128	17	nonneuropathic	nonneuropathic	ADJ
iajs-2916	128	18	individuals	individual	NOUN
iajs-2916	128	19	.	.	PUNCT
iajs-2916	129	1	the	the	DET
iajs-2916	129	2	involvement	involvement	NOUN
iajs-2916	129	3	of	of	ADP
iajs-2916	129	4	the	the	DET
iajs-2916	129	5	gstt1	gstt1	NOUN
iajs-2916	129	6	-	-	PUNCT
iajs-2916	129	7	null	null	NOUN
iajs-2916	129	8	genotype	genotype	NOUN
iajs-2916	129	9	in	in	ADP
iajs-2916	129	10	predisposing	predispose	VERB
iajs-2916	129	11	patients	patient	NOUN
iajs-2916	129	12	with	with	ADP
iajs-2916	129	13	t2	t2	NOUN
iajs-2916	129	14	dm	dm	PROPN
iajs-2916	129	15	was	be	AUX
iajs-2916	129	16	a	a	DET
iajs-2916	129	17	higher	high	ADJ
iajs-2916	129	18	risk	risk	NOUN
iajs-2916	129	19	factor	factor	NOUN
iajs-2916	129	20	for	for	ADP
iajs-2916	129	21	diabetic	diabetic	ADJ
iajs-2916	129	22	neuropathy	neuropathy	ADJ
iajs-2916	129	23	.	.	PUNCT
iajs-2916	129	24	table	table	NOUN
iajs-2916	129	25	3	3	NUM
iajs-2916	129	26	shows	show	VERB
iajs-2916	129	27	that	that	SCONJ
iajs-2916	129	28	(	(	PUNCT
iajs-2916	129	29	37.5	37.5	NUM
iajs-2916	129	30	%	%	NOUN
iajs-2916	129	31	)	)	PUNCT
iajs-2916	129	32	of	of	ADP
iajs-2916	129	33	neuropathy	neuropathy	ADJ
iajs-2916	129	34	patients	patient	NOUN
iajs-2916	129	35	and	and	CCONJ
iajs-2916	129	36	(	(	PUNCT
iajs-2916	129	37	65	65	NUM
iajs-2916	129	38	%	%	NOUN
iajs-2916	129	39	)	)	PUNCT
iajs-2916	129	40	of	of	ADP
iajs-2916	129	41	diabetic	diabetic	ADJ
iajs-2916	129	42	patients	patient	NOUN
iajs-2916	129	43	are	be	AUX
iajs-2916	129	44	under	under	ADP
iajs-2916	129	45	metformin	metformin	NOUN
iajs-2916	129	46	treatment	treatment	NOUN
iajs-2916	129	47	,	,	PUNCT
iajs-2916	129	48	also	also	ADV
iajs-2916	129	49	(	(	PUNCT
iajs-2916	129	50	32.5	32.5	NUM
iajs-2916	129	51	%	%	NOUN
iajs-2916	129	52	)	)	PUNCT
iajs-2916	129	53	of	of	ADP
iajs-2916	129	54	neuropathy	neuropathy	ADJ
iajs-2916	129	55	patients	patient	NOUN
iajs-2916	129	56	and	and	CCONJ
iajs-2916	129	57	(	(	PUNCT
iajs-2916	129	58	5	5	NUM
iajs-2916	129	59	%	%	NOUN
iajs-2916	129	60	)	)	PUNCT
iajs-2916	129	61	of	of	ADP
iajs-2916	129	62	diabetic	diabetic	ADJ
iajs-2916	129	63	patients	patient	NOUN
iajs-2916	129	64	are	be	AUX
iajs-2916	129	65	under	under	ADP
iajs-2916	129	66	(	(	PUNCT
iajs-2916	129	67	metformin	metformin	NOUN
iajs-2916	129	68	+	+	CCONJ
iajs-2916	129	69	daonil	daonil	ADJ
iajs-2916	129	70	)	)	PUNCT
iajs-2916	129	71	treatment	treatment	NOUN
iajs-2916	129	72	,	,	PUNCT
iajs-2916	129	73	and	and	CCONJ
iajs-2916	129	74	(	(	PUNCT
iajs-2916	129	75	12.5	12.5	NUM
iajs-2916	129	76	%	%	NOUN
iajs-2916	129	77	)	)	PUNCT
iajs-2916	129	78	neuropathy	neuropathy	ADJ
iajs-2916	129	79	patients	patient	NOUN
iajs-2916	129	80	are	be	AUX
iajs-2916	129	81	treated	treat	VERB
iajs-2916	129	82	with	with	ADP
iajs-2916	129	83	glimepiride	glimepiride	NOUN
iajs-2916	129	84	.	.	PUNCT
iajs-2916	130	1	0.74	0.74	NUM
iajs-2916	130	2	2.89	2.89	NUM
iajs-2916	130	3	3.53	3.53	NUM
iajs-2916	130	4	0	0	NUM
iajs-2916	130	5	0.5	0.5	NUM
iajs-2916	130	6	1	1	NUM
iajs-2916	130	7	1.5	1.5	NUM
iajs-2916	130	8	2	2	NUM
iajs-2916	130	9	2.5	2.5	NUM
iajs-2916	130	10	3	3	NUM
iajs-2916	130	11	3.5	3.5	NUM
iajs-2916	130	12	4	4	NUM
iajs-2916	130	13	control	control	NOUN
iajs-2916	130	14	group	group	NOUN
iajs-2916	130	15	diabetes	diabetes	NOUN
iajs-2916	130	16	mellitus	mellitus	NOUN
iajs-2916	130	17	(	(	PUNCT
iajs-2916	130	18	dm	dm	PROPN
iajs-2916	130	19	)	)	PUNCT
iajs-2916	130	20	group	group	NOUN
iajs-2916	130	21	neuropathy	neuropathy	ADJ
iajs-2916	130	22	group	group	NOUN
iajs-2916	130	23	gst	gst	NOUN
iajs-2916	130	24	activity	activity	NOUN
iajs-2916	130	25	(	(	PUNCT
iajs-2916	130	26	iu	iu	PROPN
iajs-2916	130	27	/	/	SYM
iajs-2916	130	28	l	l	NOUN
iajs-2916	130	29	)	)	PUNCT
iajs-2916	130	30	control	control	NOUN
iajs-2916	130	31	group	group	NOUN
iajs-2916	130	32	diabetes	diabetes	NOUN
iajs-2916	130	33	mellitus	mellitus	NOUN
iajs-2916	130	34	(	(	PUNCT
iajs-2916	130	35	dm	dm	PROPN
iajs-2916	130	36	)	)	PUNCT
iajs-2916	130	37	group	group	NOUN
iajs-2916	130	38	neuropathy	neuropathy	ADJ
iajs-2916	130	39	group	group	NOUN
iajs-2916	130	40	ihjpas	ihjpa	VERB
iajs-2916	130	41	.	.	PUNCT
iajs-2916	131	1	53	53	NUM
iajs-2916	131	2	(	(	PUNCT
iajs-2916	131	3	4)2022	4)2022	NOUN
iajs-2916	131	4	200	200	NUM
iajs-2916	131	5	table	table	NOUN
iajs-2916	131	6	3	3	NUM
iajs-2916	131	7	.	.	PUNCT
iajs-2916	132	1	the	the	DET
iajs-2916	132	2	medication	medication	NOUN
iajs-2916	132	3	used	use	VERB
iajs-2916	132	4	for	for	ADP
iajs-2916	132	5	the	the	DET
iajs-2916	132	6	treatment	treatment	NOUN
iajs-2916	132	7	of	of	ADP
iajs-2916	132	8	the	the	DET
iajs-2916	132	9	patients	patient	NOUN
iajs-2916	132	10	'	'	PART
iajs-2916	132	11	group	group	NOUN
iajs-2916	132	12	.	.	PUNCT
iajs-2916	133	1	table	table	NOUN
iajs-2916	133	2	4	4	NUM
iajs-2916	133	3	.	.	PUNCT
iajs-2916	134	1	correlation	correlation	NOUN
iajs-2916	134	2	between	between	ADP
iajs-2916	134	3	homa	homa	PROPN
iajs-2916	134	4	ir	ir	PROPN
iajs-2916	134	5	and	and	CCONJ
iajs-2916	134	6	other	other	ADJ
iajs-2916	134	7	biochemical	biochemical	ADJ
iajs-2916	134	8	parameters	parameter	NOUN
iajs-2916	134	9	*	*	PUNCT
iajs-2916	134	10	correlation	correlation	NOUN
iajs-2916	134	11	is	be	AUX
iajs-2916	134	12	significant	significant	ADJ
iajs-2916	134	13	at	at	ADP
iajs-2916	134	14	the	the	DET
iajs-2916	134	15	0.05	0.05	NUM
iajs-2916	134	16	level	level	NOUN
iajs-2916	134	17	.	.	PUNCT
iajs-2916	135	1	*	*	PUNCT
iajs-2916	135	2	*	*	PUNCT
iajs-2916	135	3	correlation	correlation	NOUN
iajs-2916	135	4	is	be	AUX
iajs-2916	135	5	highly	highly	ADV
iajs-2916	135	6	significant	significant	ADJ
iajs-2916	135	7	at	at	ADP
iajs-2916	135	8	the	the	DET
iajs-2916	135	9	0.05	0.05	NUM
iajs-2916	135	10	level	level	NOUN
iajs-2916	135	11	.	.	PUNCT
iajs-2916	136	1	parameters	parameter	NOUN
iajs-2916	136	2	diabetes	diabete	VERB
iajs-2916	136	3	mellitus	mellitus	NOUN
iajs-2916	136	4	(	(	PUNCT
iajs-2916	136	5	dm	dm	PROPN
iajs-2916	136	6	)	)	PUNCT
iajs-2916	136	7	group	group	NOUN
iajs-2916	136	8	no	no	INTJ
iajs-2916	136	9	.	.	PUNCT
iajs-2916	137	1	(	(	PUNCT
iajs-2916	137	2	40	40	NUM
iajs-2916	137	3	)	)	PUNCT
iajs-2916	137	4	neuropathy	neuropathy	ADJ
iajs-2916	137	5	group	group	NOUN
iajs-2916	137	6	no	no	INTJ
iajs-2916	137	7	.	.	PUNCT
iajs-2916	138	1	(	(	PUNCT
iajs-2916	138	2	40	40	NUM
iajs-2916	138	3	)	)	PUNCT
iajs-2916	138	4	no	no	INTJ
iajs-2916	138	5	.	.	PUNCT
iajs-2916	139	1	%	%	INTJ
iajs-2916	139	2	no	no	INTJ
iajs-2916	139	3	.	.	PUNCT
iajs-2916	140	1	%	%	NOUN
iajs-2916	140	2	medicines	medicine	NOUN
iajs-2916	140	3	used	use	VERB
iajs-2916	140	4	daonil	daonil	NOUN
iajs-2916	140	5	6	6	NUM
iajs-2916	140	6	15	15	NUM
iajs-2916	140	7	2	2	NUM
iajs-2916	140	8	5	5	NUM
iajs-2916	140	9	daonil	daonil	NOUN
iajs-2916	140	10	-metformin	-metformin	NOUN
iajs-2916	140	11	2	2	NUM
iajs-2916	140	12	5	5	NUM
iajs-2916	140	13	13	13	NUM
iajs-2916	140	14	32.5	32.5	NUM
iajs-2916	140	15	amaryl	amaryl	NOUN
iajs-2916	140	16	3	3	NUM
iajs-2916	140	17	7.5	7.5	NUM
iajs-2916	140	18	3	3	NUM
iajs-2916	140	19	7.5	7.5	NUM
iajs-2916	140	20	amaryl	amaryl	ADJ
iajs-2916	140	21	-metformin	-metformin	PROPN
iajs-2916	140	22	------1	------1	PROPN
iajs-2916	140	23	2.5	2.5	NUM
iajs-2916	140	24	glibenglamied	glibenglamie	VERB
iajs-2916	140	25	1	1	NUM
iajs-2916	140	26	2.5	2.5	NUM
iajs-2916	140	27	1	1	NUM
iajs-2916	140	28	2.5	2.5	NUM
iajs-2916	140	29	glimepiride	glimepiride	NOUN
iajs-2916	140	30	------5	------5	PROPN
iajs-2916	140	31	12.5	12.5	NUM
iajs-2916	140	32	metformin	metformin	NOUN
iajs-2916	140	33	26	26	NUM
iajs-2916	140	34	65	65	NUM
iajs-2916	140	35	15	15	NUM
iajs-2916	140	36	37.5	37.5	NUM
iajs-2916	140	37	metformin	metformin	NOUN
iajs-2916	140	38	-	-	PUNCT
iajs-2916	140	39	vildagliptin	vildagliptin	PROPN
iajs-2916	140	40	1	1	NUM
iajs-2916	140	41	2.5	2.5	NUM
iajs-2916	140	42	------	------	PUNCT
iajs-2916	140	43	metformin	metformin	NOUN
iajs-2916	140	44	-	-	PUNCT
iajs-2916	140	45	gliptinen	gliptinen	PROPN
iajs-2916	140	46	1	1	NUM
iajs-2916	140	47	2.5	2.5	NUM
iajs-2916	140	48	------	------	PUNCT
iajs-2916	141	1	homa	homa	PROPN
iajs-2916	141	2	ir	ir	PROPN
iajs-2916	141	3	control	control	PROPN
iajs-2916	141	4	group	group	PROPN
iajs-2916	141	5	no	no	INTJ
iajs-2916	141	6	.	.	PUNCT
iajs-2916	142	1	(	(	PUNCT
iajs-2916	142	2	40	40	NUM
iajs-2916	142	3	)	)	PUNCT
iajs-2916	142	4	diabetes	diabetes	NOUN
iajs-2916	142	5	mellitus	mellitus	NOUN
iajs-2916	142	6	(	(	PUNCT
iajs-2916	142	7	dm	dm	PROPN
iajs-2916	142	8	)	)	PUNCT
iajs-2916	142	9	group	group	NOUN
iajs-2916	142	10	no	no	INTJ
iajs-2916	142	11	.	.	PUNCT
iajs-2916	143	1	(	(	PUNCT
iajs-2916	143	2	40	40	NUM
iajs-2916	143	3	)	)	PUNCT
iajs-2916	143	4	neuropathy	neuropathy	ADJ
iajs-2916	143	5	group	group	NOUN
iajs-2916	143	6	no	no	INTJ
iajs-2916	143	7	.	.	PUNCT
iajs-2916	144	1	(	(	PUNCT
iajs-2916	144	2	40	40	NUM
iajs-2916	144	3	)	)	PUNCT
iajs-2916	144	4	age	age	NOUN
iajs-2916	144	5	(	(	PUNCT
iajs-2916	144	6	years	year	NOUN
iajs-2916	144	7	)	)	PUNCT
iajs-2916	144	8	r	r	NOUN
iajs-2916	144	9	-0.033	-0.033	PUNCT
iajs-2916	144	10	0.032	0.032	NUM
iajs-2916	144	11	0.056	0.056	NUM
iajs-2916	144	12	p	p	ADJ
iajs-2916	144	13	0.839	0.839	NUM
iajs-2916	144	14	0.847	0.847	NUM
iajs-2916	144	15	0.733	0.733	NUM
iajs-2916	144	16	weight	weight	NOUN
iajs-2916	144	17	(	(	PUNCT
iajs-2916	144	18	kg	kg	NOUN
iajs-2916	144	19	)	)	PUNCT
iajs-2916	144	20	r	r	NOUN
iajs-2916	144	21	0.170	0.170	NUM
iajs-2916	144	22	-0.063	-0.063	PUNCT
iajs-2916	144	23	0.009	0.009	NUM
iajs-2916	144	24	p	p	NOUN
iajs-2916	144	25	0.293	0.293	NUM
iajs-2916	144	26	0.698	0.698	NUM
iajs-2916	144	27	0.956	0.956	NUM
iajs-2916	144	28	length	length	NOUN
iajs-2916	144	29	(	(	PUNCT
iajs-2916	144	30	cm	cm	NOUN
iajs-2916	144	31	)	)	PUNCT
iajs-2916	144	32	r	r	NOUN
iajs-2916	144	33	0.231	0.231	NUM
iajs-2916	144	34	-0.052	-0.052	NUM
iajs-2916	144	35	0.072	0.072	NUM
iajs-2916	144	36	p	p	NOUN
iajs-2916	144	37	0.152	0.152	NUM
iajs-2916	144	38	0.750	0.750	NUM
iajs-2916	144	39	0.660	0.660	NUM
iajs-2916	144	40	bmi	bmi	NOUN
iajs-2916	144	41	(	(	PUNCT
iajs-2916	144	42	kg	kg	NOUN
iajs-2916	144	43	/	/	SYM
iajs-2916	144	44	m2	m2	PROPN
iajs-2916	144	45	)	)	PUNCT
iajs-2916	144	46	r	r	NOUN
iajs-2916	144	47	-0.044	-0.044	NUM
iajs-2916	144	48	-0.051	-0.051	PROPN
iajs-2916	144	49	-0.032	-0.032	ADP
iajs-2916	144	50	p	p	PRON
iajs-2916	144	51	0.786	0.786	NUM
iajs-2916	144	52	0.755	0.755	NUM
iajs-2916	144	53	0.844	0.844	NUM
iajs-2916	144	54	w	w	NOUN
iajs-2916	144	55	/	/	SYM
iajs-2916	144	56	h	h	NOUN
iajs-2916	144	57	ratio	ratio	NOUN
iajs-2916	144	58	r	r	NOUN
iajs-2916	144	59	0.296	0.296	NUM
iajs-2916	144	60	-0.163	-0.163	NOUN
iajs-2916	144	61	-0.120	-0.120	PUNCT
iajs-2916	144	62	p	p	PROPN
iajs-2916	144	63	0.063	0.063	NUM
iajs-2916	144	64	0.316	0.316	NUM
iajs-2916	144	65	0.459	0.459	NUM
iajs-2916	144	66	fbs	fbs	ADJ
iajs-2916	144	67	(	(	PUNCT
iajs-2916	144	68	mg	mg	PROPN
iajs-2916	144	69	/	/	SYM
iajs-2916	144	70	dl	dl	NOUN
iajs-2916	144	71	)	)	PUNCT
iajs-2916	144	72	r	r	NOUN
iajs-2916	144	73	0.075	0.075	NUM
iajs-2916	144	74	0.264	0.264	NUM
iajs-2916	144	75	0.358	0.358	NUM
iajs-2916	144	76	*	*	PUNCT
iajs-2916	145	1	p	p	X
iajs-2916	145	2	0.647	0.647	NUM
iajs-2916	145	3	0.099	0.099	NUM
iajs-2916	145	4	0.023	0.023	NUM
iajs-2916	145	5	hba1c	hba1c	PRON
iajs-2916	145	6	%	%	NOUN
iajs-2916	145	7	r	r	NOUN
iajs-2916	145	8	-0.170	-0.170	PUNCT
iajs-2916	145	9	0.115	0.115	NUM
iajs-2916	145	10	0.201	0.201	NUM
iajs-2916	145	11	p	p	NOUN
iajs-2916	145	12	0.296	0.296	NUM
iajs-2916	145	13	0.481	0.481	NUM
iajs-2916	145	14	0.214	0.214	NUM
iajs-2916	145	15	cholesterol	cholesterol	NOUN
iajs-2916	145	16	(	(	PUNCT
iajs-2916	145	17	mg	mg	PROPN
iajs-2916	145	18	/	/	SYM
iajs-2916	145	19	dl	dl	NOUN
iajs-2916	145	20	)	)	PUNCT
iajs-2916	145	21	r	r	NOUN
iajs-2916	145	22	-0.110	-0.110	NOUN
iajs-2916	145	23	-0.111	-0.111	NOUN
iajs-2916	145	24	0.076	0.076	NUM
iajs-2916	145	25	p	p	PROPN
iajs-2916	145	26	0.498	0.498	NUM
iajs-2916	145	27	0.495	0.495	NUM
iajs-2916	145	28	0.640	0.640	NUM
iajs-2916	145	29	tg	tg	PROPN
iajs-2916	145	30	(	(	PUNCT
iajs-2916	145	31	mg	mg	PROPN
iajs-2916	145	32	/	/	SYM
iajs-2916	145	33	dl	dl	NOUN
iajs-2916	145	34	)	)	PUNCT
iajs-2916	145	35	r	r	NOUN
iajs-2916	145	36	0.324	0.324	NUM
iajs-2916	145	37	*	*	SYM
iajs-2916	145	38	0.173	0.173	NUM
iajs-2916	145	39	-0.079	-0.079	PUNCT
iajs-2916	145	40	p	p	PROPN
iajs-2916	145	41	0.042	0.042	NUM
iajs-2916	145	42	0.285	0.285	NUM
iajs-2916	145	43	0.541	0.541	NUM
iajs-2916	145	44	hdl	hdl	PROPN
iajs-2916	145	45	-	-	PUNCT
iajs-2916	145	46	c	c	PROPN
iajs-2916	145	47	(	(	PUNCT
iajs-2916	145	48	mg	mg	PROPN
iajs-2916	145	49	/	/	SYM
iajs-2916	145	50	dl	dl	NOUN
iajs-2916	145	51	)	)	PUNCT
iajs-2916	145	52	r	r	NOUN
iajs-2916	145	53	-0.330	-0.330	PROPN
iajs-2916	145	54	*	*	NOUN
iajs-2916	145	55	0.104	0.104	NUM
iajs-2916	145	56	-0.315	-0.315	PUNCT
iajs-2916	145	57	*	*	PUNCT
iajs-2916	146	1	p	p	X
iajs-2916	146	2	0.038	0.038	NUM
iajs-2916	146	3	0.524	0.524	NUM
iajs-2916	146	4	0.047	0.047	NUM
iajs-2916	146	5	ldl	ldl	PROPN
iajs-2916	146	6	-	-	PUNCT
iajs-2916	146	7	c	c	NOUN
iajs-2916	146	8	(	(	PUNCT
iajs-2916	146	9	mg	mg	PROPN
iajs-2916	146	10	/	/	SYM
iajs-2916	146	11	dl	dl	NOUN
iajs-2916	146	12	)	)	PUNCT
iajs-2916	146	13	r	r	NOUN
iajs-2916	147	1	-0.095	-0.095	NOUN
iajs-2916	147	2	-0.172	-0.172	NOUN
iajs-2916	147	3	0.160	0.160	NUM
iajs-2916	147	4	p	p	NOUN
iajs-2916	147	5	0.558	0.558	NUM
iajs-2916	147	6	0.290	0.290	NUM
iajs-2916	147	7	0.323	0.323	NUM
iajs-2916	147	8	vldl	vldl	NOUN
iajs-2916	147	9	-	-	PUNCT
iajs-2916	147	10	c	c	NOUN
iajs-2916	147	11	(	(	PUNCT
iajs-2916	147	12	mg	mg	PROPN
iajs-2916	147	13	/	/	SYM
iajs-2916	147	14	dl	dl	NOUN
iajs-2916	147	15	)	)	PUNCT
iajs-2916	147	16	r	r	NOUN
iajs-2916	147	17	0.324	0.324	NUM
iajs-2916	147	18	*	*	SYM
iajs-2916	147	19	0.173	0.173	NUM
iajs-2916	147	20	-0.099	-0.099	PUNCT
iajs-2916	148	1	p	p	X
iajs-2916	148	2	0.042	0.042	NUM
iajs-2916	148	3	0.285	0.285	NUM
iajs-2916	148	4	0.543	0.543	NUM
iajs-2916	148	5	insulin	insulin	NOUN
iajs-2916	148	6	(	(	PUNCT
iajs-2916	148	7	μiu	μiu	PROPN
iajs-2916	148	8	/	/	SYM
iajs-2916	148	9	ml	ml	NOUN
iajs-2916	148	10	)	)	PUNCT
iajs-2916	148	11	r	r	NOUN
iajs-2916	148	12	0.982	0.982	NUM
iajs-2916	148	13	*	*	PUNCT
iajs-2916	148	14	*	*	PUNCT
iajs-2916	148	15	0.865	0.865	NUM
iajs-2916	148	16	*	*	X
iajs-2916	148	17	*	*	PUNCT
iajs-2916	148	18	0.704	0.704	NUM
iajs-2916	148	19	*	*	PUNCT
iajs-2916	148	20	*	*	PUNCT
iajs-2916	148	21	p	p	X
iajs-2916	148	22	0.0001	0.0001	NUM
iajs-2916	148	23	0.0001	0.0001	NUM
iajs-2916	148	24	0.0001	0.0001	NUM
iajs-2916	148	25	gst	gst	NOUN
iajs-2916	148	26	activity	activity	NOUN
iajs-2916	148	27	(	(	PUNCT
iajs-2916	148	28	iu	iu	NOUN
iajs-2916	148	29	/	/	SYM
iajs-2916	148	30	l	l	NOUN
iajs-2916	148	31	)	)	PUNCT
iajs-2916	148	32	r	r	NOUN
iajs-2916	148	33	0.347	0.347	NUM
iajs-2916	148	34	*	*	NOUN
iajs-2916	148	35	0.148	0.148	NUM
iajs-2916	148	36	-0.155	-0.155	PUNCT
iajs-2916	148	37	p	p	NOUN
iajs-2916	148	38	0.027	0.027	NUM
iajs-2916	148	39	0.358	0.358	NUM
iajs-2916	148	40	0.337	0.337	NUM
iajs-2916	148	41	ihjpas	ihjpa	NOUN
iajs-2916	148	42	.	.	PUNCT
iajs-2916	149	1	53	53	NUM
iajs-2916	149	2	(	(	PUNCT
iajs-2916	149	3	4)2022	4)2022	NOUN
iajs-2916	149	4	201	201	NUM
iajs-2916	149	5	table	table	NOUN
iajs-2916	149	6	4	4	NUM
iajs-2916	149	7	shows	show	VERB
iajs-2916	149	8	a	a	DET
iajs-2916	149	9	positive	positive	ADJ
iajs-2916	149	10	correlation	correlation	NOUN
iajs-2916	149	11	between	between	ADP
iajs-2916	149	12	homa	homa	PROPN
iajs-2916	149	13	ir	ir	PROPN
iajs-2916	149	14	and	and	CCONJ
iajs-2916	149	15	insulin	insulin	NOUN
iajs-2916	149	16	in	in	ADP
iajs-2916	149	17	dm(r=0.865**p≤0.05	dm(r=0.865**p≤0.05	NOUN
iajs-2916	149	18	)	)	PUNCT
iajs-2916	149	19	and	and	CCONJ
iajs-2916	149	20	nu	nu	PROPN
iajs-2916	149	21	.	.	PROPN
iajs-2916	149	22	groups	group	NOUN
iajs-2916	149	23	(	(	PUNCT
iajs-2916	149	24	r=0.704**p≤0.05	r=0.704**p≤0.05	NOUN
iajs-2916	149	25	)	)	PUNCT
iajs-2916	149	26	insulin	insulin	NOUN
iajs-2916	149	27	has	have	VERB
iajs-2916	149	28	a	a	DET
iajs-2916	149	29	major	major	ADJ
iajs-2916	149	30	role	role	NOUN
iajs-2916	149	31	in	in	ADP
iajs-2916	149	32	glucose	glucose	NOUN
iajs-2916	149	33	homeostasis	homeostasis	NOUN
iajs-2916	149	34	control	control	NOUN
iajs-2916	149	35	due	due	ADP
iajs-2916	149	36	to	to	ADP
iajs-2916	149	37	its	its	PRON
iajs-2916	149	38	integrated	integrate	VERB
iajs-2916	149	39	activities	activity	NOUN
iajs-2916	149	40	on	on	ADP
iajs-2916	149	41	carbohydrates	carbohydrate	NOUN
iajs-2916	149	42	,	,	PUNCT
iajs-2916	149	43	protein	protein	NOUN
iajs-2916	149	44	,	,	PUNCT
iajs-2916	149	45	and	and	CCONJ
iajs-2916	149	46	lipid	lipid	ADJ
iajs-2916	149	47	metabolism	metabolism	NOUN
iajs-2916	149	48	.	.	PUNCT
iajs-2916	150	1	the	the	DET
iajs-2916	150	2	liver	liver	NOUN
iajs-2916	150	3	,	,	PUNCT
iajs-2916	150	4	muscle	muscle	NOUN
iajs-2916	150	5	,	,	PUNCT
iajs-2916	150	6	and	and	CCONJ
iajs-2916	150	7	fat	fat	NOUN
iajs-2916	150	8	are	be	AUX
iajs-2916	150	9	the	the	DET
iajs-2916	150	10	tissues	tissue	NOUN
iajs-2916	150	11	where	where	SCONJ
iajs-2916	150	12	these	these	DET
iajs-2916	150	13	glucoregulatory	glucoregulatory	NOUN
iajs-2916	150	14	effects	effect	NOUN
iajs-2916	150	15	are	be	AUX
iajs-2916	150	16	most	most	ADV
iajs-2916	150	17	prominent	prominent	ADJ
iajs-2916	150	18	.	.	PUNCT
iajs-2916	151	1	although	although	SCONJ
iajs-2916	151	2	insulin	insulin	NOUN
iajs-2916	151	3	has	have	VERB
iajs-2916	151	4	a	a	DET
iajs-2916	151	5	wide	wide	ADJ
iajs-2916	151	6	range	range	NOUN
iajs-2916	151	7	of	of	ADP
iajs-2916	151	8	effects	effect	NOUN
iajs-2916	151	9	,	,	PUNCT
iajs-2916	151	10	the	the	DET
iajs-2916	151	11	phrase	phrase	NOUN
iajs-2916	151	12	"	"	PUNCT
iajs-2916	151	13	insulin	insulin	NOUN
iajs-2916	151	14	resistance	resistance	NOUN
iajs-2916	151	15	"	"	PUNCT
iajs-2916	151	16	usually	usually	ADV
iajs-2916	151	17	relates	relate	VERB
iajs-2916	151	18	to	to	ADP
iajs-2916	151	19	insulin	insulin	NOUN
iajs-2916	151	20	's	's	PART
iajs-2916	151	21	impact	impact	NOUN
iajs-2916	151	22	on	on	ADP
iajs-2916	151	23	glucose	glucose	NOUN
iajs-2916	151	24	homeostasis	homeostasis	NOUN
iajs-2916	151	25	[	[	X
iajs-2916	151	26	38	38	NUM
iajs-2916	151	27	]	]	PUNCT
iajs-2916	151	28	.	.	PUNCT
iajs-2916	152	1	homa	homa	PROPN
iajs-2916	152	2	ir	ir	PROPN
iajs-2916	152	3	also	also	ADV
iajs-2916	152	4	also	also	ADV
iajs-2916	152	5	a	a	DET
iajs-2916	152	6	negative	negative	ADJ
iajs-2916	152	7	relationship	relationship	NOUN
iajs-2916	152	8	with	with	ADP
iajs-2916	152	9	hdl	hdl	PROPN
iajs-2916	152	10	(	(	PUNCT
iajs-2916	152	11	r=-0.315	r=-0.315	PROPN
iajs-2916	152	12	*	*	PROPN
iajs-2916	152	13	,	,	PUNCT
iajs-2916	152	14	p≤0.05	p≤0.05	NOUN
iajs-2916	152	15	)	)	PUNCT
iajs-2916	152	16	.	.	PUNCT
iajs-2916	153	1	the	the	DET
iajs-2916	153	2	results	result	NOUN
iajs-2916	153	3	of	of	ADP
iajs-2916	153	4	this	this	DET
iajs-2916	153	5	study	study	NOUN
iajs-2916	153	6	was	be	AUX
iajs-2916	153	7	in	in	ADP
iajs-2916	153	8	agreement	agreement	NOUN
iajs-2916	153	9	with	with	ADP
iajs-2916	153	10	the	the	DET
iajs-2916	153	11	study	study	NOUN
iajs-2916	153	12	by	by	ADP
iajs-2916	153	13	boris	boris	PROPN
iajs-2916	153	14	waldman	waldman	PROPN
iajs-2916	153	15	et	et	PROPN
iajs-2916	153	16	al	al	PROPN
iajs-2916	153	17	.	.	PUNCT
iajs-2916	154	1	[	[	X
iajs-2916	154	2	39	39	NUM
iajs-2916	154	3	]	]	PUNCT
iajs-2916	154	4	who	who	PRON
iajs-2916	154	5	also	also	ADV
iajs-2916	154	6	found	find	VERB
iajs-2916	154	7	that	that	SCONJ
iajs-2916	154	8	homa	homa	NOUN
iajs-2916	154	9	-	-	PUNCT
iajs-2916	154	10	ir	ir	PROPN
iajs-2916	154	11	levels	level	NOUN
iajs-2916	154	12	were	be	AUX
iajs-2916	154	13	negatively	negatively	ADV
iajs-2916	154	14	related	relate	VERB
iajs-2916	154	15	to	to	ADP
iajs-2916	154	16	hdl	hdl	PROPN
iajs-2916	154	17	-	-	PUNCT
iajs-2916	154	18	c	c	PROPN
iajs-2916	154	19	levels	level	NOUN
iajs-2916	154	20	in	in	ADP
iajs-2916	154	21	dm	dm	PROPN
iajs-2916	154	22	patients	patient	NOUN
iajs-2916	154	23	.	.	PUNCT
iajs-2916	155	1	regarding	regard	VERB
iajs-2916	155	2	the	the	DET
iajs-2916	155	3	t2	t2	NOUN
iajs-2916	155	4	dm	dm	NOUN
iajs-2916	155	5	patients	patient	NOUN
iajs-2916	155	6	,	,	PUNCT
iajs-2916	155	7	abnormal	abnormal	ADJ
iajs-2916	155	8	fat	fat	ADJ
iajs-2916	155	9	metabolism	metabolism	NOUN
iajs-2916	155	10	is	be	AUX
iajs-2916	155	11	the	the	DET
iajs-2916	155	12	primary	primary	ADJ
iajs-2916	155	13	factor	factor	NOUN
iajs-2916	155	14	of	of	ADP
iajs-2916	155	15	vascular	vascular	ADJ
iajs-2916	155	16	complications	complication	NOUN
iajs-2916	155	17	.	.	PUNCT
iajs-2916	156	1	studies	study	NOUN
iajs-2916	156	2	on	on	ADP
iajs-2916	156	3	human	human	ADJ
iajs-2916	156	4	islet	islet	NOUN
iajs-2916	156	5	cells	cell	NOUN
iajs-2916	156	6	and	and	CCONJ
iajs-2916	156	7	animals	animal	NOUN
iajs-2916	156	8	showed	show	VERB
iajs-2916	156	9	that	that	SCONJ
iajs-2916	156	10	exogenous	exogenous	ADJ
iajs-2916	156	11	hdl	hdl	PROPN
iajs-2916	156	12	enhanced	enhance	VERB
iajs-2916	156	13	insulin	insulin	NOUN
iajs-2916	156	14	production	production	NOUN
iajs-2916	156	15	by	by	ADP
iajs-2916	156	16	enhanced	enhanced	ADJ
iajs-2916	156	17	reverse	reverse	ADJ
iajs-2916	156	18	cholesterol	cholesterol	NOUN
iajs-2916	156	19	transfer	transfer	NOUN
iajs-2916	156	20	,	,	PUNCT
iajs-2916	156	21	reduction	reduction	NOUN
iajs-2916	156	22	of	of	ADP
iajs-2916	156	23	ldl	ldl	NOUN
iajs-2916	156	24	,	,	PUNCT
iajs-2916	156	25	and	and	CCONJ
iajs-2916	156	26	inflammation	inflammation	NOUN
iajs-2916	156	27	-	-	PUNCT
iajs-2916	156	28	induced	induce	VERB
iajs-2916	156	29	death	death	NOUN
iajs-2916	156	30	of	of	ADP
iajs-2916	156	31	pancreatic	pancreatic	ADJ
iajs-2916	156	32	β	β	NOUN
iajs-2916	156	33	-	-	NOUN
iajs-2916	156	34	cells	cell	NOUN
iajs-2916	156	35	[	[	X
iajs-2916	156	36	40	40	NUM
iajs-2916	156	37	-	-	SYM
iajs-2916	156	38	41	41	NUM
iajs-2916	156	39	]	]	PUNCT
iajs-2916	156	40	.	.	PUNCT
iajs-2916	157	1	moreover	moreover	ADV
iajs-2916	157	2	,	,	PUNCT
iajs-2916	157	3	hdl	hdl	PROPN
iajs-2916	157	4	may	may	AUX
iajs-2916	157	5	have	have	VERB
iajs-2916	157	6	an	an	DET
iajs-2916	157	7	impact	impact	NOUN
iajs-2916	157	8	on	on	ADP
iajs-2916	157	9	glucose	glucose	NOUN
iajs-2916	157	10	homeostasis	homeostasis	NOUN
iajs-2916	157	11	through	through	ADP
iajs-2916	157	12	processes	process	NOUN
iajs-2916	157	13	such	such	ADJ
iajs-2916	157	14	as	as	ADP
iajs-2916	157	15	insulin	insulin	NOUN
iajs-2916	157	16	secretion	secretion	NOUN
iajs-2916	157	17	,	,	PUNCT
iajs-2916	157	18	increased	increase	VERB
iajs-2916	157	19	insulin	insulin	NOUN
iajs-2916	157	20	sensitivity	sensitivity	NOUN
iajs-2916	157	21	,	,	PUNCT
iajs-2916	157	22	and	and	CCONJ
iajs-2916	157	23	direct	direct	ADJ
iajs-2916	157	24	glucose	glucose	NOUN
iajs-2916	157	25	intake	intake	NOUN
iajs-2916	157	26	by	by	ADP
iajs-2916	157	27	the	the	DET
iajs-2916	157	28	muscle	muscle	NOUN
iajs-2916	157	29	[	[	X
iajs-2916	157	30	42	42	NUM
iajs-2916	157	31	]	]	PUNCT
iajs-2916	157	32	.	.	PUNCT
iajs-2916	158	1	homa	homa	PROPN
iajs-2916	158	2	ir	ir	PROPN
iajs-2916	158	3	showed	show	VERB
iajs-2916	158	4	a	a	DET
iajs-2916	158	5	positive	positive	ADJ
iajs-2916	158	6	relationship	relationship	NOUN
iajs-2916	158	7	with	with	ADP
iajs-2916	158	8	fbs	fbs	PROPN
iajs-2916	158	9	in	in	ADP
iajs-2916	158	10	neuropathy	neuropathy	ADJ
iajs-2916	158	11	group	group	NOUN
iajs-2916	158	12	(	(	PUNCT
iajs-2916	158	13	r=0.358	r=0.358	NOUN
iajs-2916	158	14	*	*	NUM
iajs-2916	158	15	,	,	PUNCT
iajs-2916	158	16	p≤0.05	p≤0.05	NOUN
iajs-2916	158	17	)	)	PUNCT
iajs-2916	158	18	a	a	DET
iajs-2916	158	19	little	little	ADJ
iajs-2916	158	20	increase	increase	NOUN
iajs-2916	158	21	in	in	ADP
iajs-2916	158	22	insulin	insulin	NOUN
iajs-2916	158	23	resistance	resistance	NOUN
iajs-2916	158	24	have	have	AUX
iajs-2916	158	25	been	be	AUX
iajs-2916	158	26	noticed	notice	VERB
iajs-2916	158	27	by	by	ADP
iajs-2916	158	28	the	the	DET
iajs-2916	158	29	effect	effect	NOUN
iajs-2916	158	30	of	of	ADP
iajs-2916	158	31	elevated	elevated	ADJ
iajs-2916	158	32	fbs	fbs	PROPN
iajs-2916	158	33	due	due	ADP
iajs-2916	158	34	to	to	ADP
iajs-2916	158	35	insufficient	insufficient	ADJ
iajs-2916	158	36	insulin	insulin	NOUN
iajs-2916	158	37	to	to	PART
iajs-2916	158	38	handle	handle	VERB
iajs-2916	158	39	glucose	glucose	NOUN
iajs-2916	158	40	.	.	PUNCT
iajs-2916	159	1	a	a	DET
iajs-2916	159	2	previous	previous	ADJ
iajs-2916	159	3	study	study	NOUN
iajs-2916	159	4	found	find	VERB
iajs-2916	159	5	that	that	SCONJ
iajs-2916	159	6	increased	increase	VERB
iajs-2916	159	7	glucose	glucose	NOUN
iajs-2916	159	8	levels	level	NOUN
iajs-2916	159	9	and/or	and/or	CCONJ
iajs-2916	159	10	fast	fast	ADJ
iajs-2916	159	11	glucose	glucose	NOUN
iajs-2916	159	12	fluxes	flux	NOUN
iajs-2916	159	13	led	lead	VERB
iajs-2916	159	14	to	to	PART
iajs-2916	159	15	reduce	reduce	VERB
iajs-2916	159	16	the	the	DET
iajs-2916	159	17	pain	pain	NOUN
iajs-2916	159	18	of	of	ADP
iajs-2916	159	19	tolerance	tolerance	NOUN
iajs-2916	159	20	.	.	PUNCT
iajs-2916	160	1	these	these	DET
iajs-2916	160	2	results	result	NOUN
iajs-2916	160	3	might	might	AUX
iajs-2916	160	4	have	have	VERB
iajs-2916	160	5	consequences	consequence	NOUN
iajs-2916	160	6	for	for	ADP
iajs-2916	160	7	the	the	DET
iajs-2916	160	8	pathogenesis	pathogenesis	NOUN
iajs-2916	160	9	and	and	CCONJ
iajs-2916	160	10	treatment	treatment	NOUN
iajs-2916	160	11	of	of	ADP
iajs-2916	160	12	painful	painful	ADJ
iajs-2916	160	13	diabetic	diabetic	NOUN
iajs-2916	160	14	neuropathy	neuropathy	ADJ
iajs-2916	160	15	in	in	ADP
iajs-2916	160	16	the	the	DET
iajs-2916	160	17	future	future	NOUN
iajs-2916	160	18	[	[	X
iajs-2916	160	19	43	43	NUM
iajs-2916	160	20	]	]	PUNCT
iajs-2916	160	21	.	.	PUNCT
iajs-2916	161	1	insulin	insulin	NOUN
iajs-2916	161	2	enhances	enhance	VERB
iajs-2916	161	3	the	the	DET
iajs-2916	161	4	expression	expression	NOUN
iajs-2916	161	5	of	of	ADP
iajs-2916	161	6	the	the	DET
iajs-2916	161	7	hexokinase	hexokinase	NOUN
iajs-2916	161	8	gene	gene	NOUN
iajs-2916	161	9	in	in	ADP
iajs-2916	161	10	glut4	glut4	PROPN
iajs-2916	161	11	and	and	CCONJ
iajs-2916	161	12	therefore	therefore	ADV
iajs-2916	161	13	it	it	PRON
iajs-2916	161	14	helps	help	VERB
iajs-2916	161	15	glucose	glucose	NOUN
iajs-2916	161	16	retention	retention	NOUN
iajs-2916	161	17	in	in	ADP
iajs-2916	161	18	cells	cell	NOUN
iajs-2916	161	19	[	[	X
iajs-2916	161	20	44	44	NUM
iajs-2916	161	21	,	,	PUNCT
iajs-2916	161	22	45	45	NUM
iajs-2916	161	23	]	]	PUNCT
iajs-2916	161	24	.	.	PUNCT
iajs-2916	162	1	this	this	DET
iajs-2916	162	2	procedure	procedure	NOUN
iajs-2916	162	3	is	be	AUX
iajs-2916	162	4	essential	essential	ADJ
iajs-2916	162	5	because	because	SCONJ
iajs-2916	162	6	it	it	PRON
iajs-2916	162	7	improves	improve	VERB
iajs-2916	162	8	the	the	DET
iajs-2916	162	9	reduction	reduction	NOUN
iajs-2916	162	10	of	of	ADP
iajs-2916	162	11	blood	blood	NOUN
iajs-2916	162	12	glucose	glucose	NOUN
iajs-2916	162	13	levels	level	NOUN
iajs-2916	162	14	after	after	ADP
iajs-2916	162	15	a	a	DET
iajs-2916	162	16	meal	meal	NOUN
iajs-2916	162	17	[	[	X
iajs-2916	162	18	46	46	NUM
iajs-2916	162	19	]	]	PUNCT
iajs-2916	162	20	.	.	PUNCT
iajs-2916	163	1	any	any	DET
iajs-2916	163	2	reduction	reduction	NOUN
iajs-2916	163	3	in	in	ADP
iajs-2916	163	4	these	these	DET
iajs-2916	163	5	receptors	receptor	NOUN
iajs-2916	163	6	reduces	reduce	VERB
iajs-2916	163	7	the	the	DET
iajs-2916	163	8	insulin	insulin	NOUN
iajs-2916	163	9	sensitivity	sensitivity	NOUN
iajs-2916	163	10	significantly	significantly	ADV
iajs-2916	163	11	[	[	X
iajs-2916	163	12	47	47	NUM
iajs-2916	163	13	]	]	PUNCT
iajs-2916	163	14	.	.	PUNCT
iajs-2916	164	1	the	the	DET
iajs-2916	164	2	present	present	ADJ
iajs-2916	164	3	study	study	NOUN
iajs-2916	164	4	has	have	AUX
iajs-2916	164	5	shown	show	VERB
iajs-2916	164	6	there	there	PRON
iajs-2916	164	7	is	be	VERB
iajs-2916	164	8	no	no	DET
iajs-2916	164	9	relationship	relationship	NOUN
iajs-2916	164	10	between	between	ADP
iajs-2916	164	11	the	the	DET
iajs-2916	164	12	insulin	insulin	NOUN
iajs-2916	164	13	resistance	resistance	NOUN
iajs-2916	164	14	and	and	CCONJ
iajs-2916	164	15	gst	gst	NOUN
iajs-2916	164	16	activity	activity	NOUN
iajs-2916	164	17	in	in	ADP
iajs-2916	164	18	patient	patient	ADJ
iajs-2916	164	19	groups	group	NOUN
iajs-2916	164	20	.	.	PUNCT
iajs-2916	165	1	the	the	DET
iajs-2916	165	2	limitation	limitation	NOUN
iajs-2916	165	3	of	of	ADP
iajs-2916	165	4	this	this	DET
iajs-2916	165	5	study	study	NOUN
iajs-2916	165	6	is	be	AUX
iajs-2916	165	7	the	the	DET
iajs-2916	165	8	delay	delay	NOUN
iajs-2916	165	9	in	in	ADP
iajs-2916	165	10	obtaining	obtain	VERB
iajs-2916	165	11	samples	sample	NOUN
iajs-2916	165	12	for	for	ADP
iajs-2916	165	13	peripheral	peripheral	ADJ
iajs-2916	165	14	neuropathy	neuropathy	ADJ
iajs-2916	165	15	patients	patient	NOUN
iajs-2916	165	16	because	because	SCONJ
iajs-2916	165	17	the	the	DET
iajs-2916	165	18	patient	patient	NOUN
iajs-2916	165	19	was	be	AUX
iajs-2916	165	20	subjected	subject	VERB
iajs-2916	165	21	to	to	ADP
iajs-2916	165	22	a	a	DET
iajs-2916	165	23	precise	precise	ADJ
iajs-2916	165	24	medical	medical	ADJ
iajs-2916	165	25	examination	examination	NOUN
iajs-2916	165	26	by	by	ADP
iajs-2916	165	27	the	the	DET
iajs-2916	165	28	neurologist	neurologist	NOUN
iajs-2916	165	29	,	,	PUNCT
iajs-2916	165	30	according	accord	VERB
iajs-2916	165	31	to	to	ADP
iajs-2916	165	32	the	the	DET
iajs-2916	165	33	toronto	toronto	PROPN
iajs-2916	165	34	system	system	NOUN
iajs-2916	165	35	,	,	PUNCT
iajs-2916	165	36	which	which	PRON
iajs-2916	165	37	diagnosed	diagnose	VERB
iajs-2916	165	38	the	the	DET
iajs-2916	165	39	patient	patient	NOUN
iajs-2916	165	40	has	have	VERB
iajs-2916	165	41	peripheral	peripheral	ADJ
iajs-2916	165	42	neuropathy	neuropathy	ADJ
iajs-2916	165	43	if	if	SCONJ
iajs-2916	165	44	the	the	DET
iajs-2916	165	45	score	score	NOUN
iajs-2916	165	46	after	after	ADP
iajs-2916	165	47	the	the	DET
iajs-2916	165	48	examination	examination	NOUN
iajs-2916	165	49	≥6	≥6	PROPN
iajs-2916	165	50	.	.	PROPN
iajs-2916	165	51	5	5	NUM
iajs-2916	165	52	.	.	X
iajs-2916	165	53	conclusion	conclusion	NOUN
iajs-2916	165	54	the	the	DET
iajs-2916	165	55	present	present	ADJ
iajs-2916	165	56	study	study	NOUN
iajs-2916	165	57	has	have	AUX
iajs-2916	165	58	reported	report	VERB
iajs-2916	165	59	the	the	DET
iajs-2916	165	60	improvement	improvement	NOUN
iajs-2916	165	61	in	in	ADP
iajs-2916	165	62	insulin	insulin	NOUN
iajs-2916	165	63	resistance	resistance	NOUN
iajs-2916	165	64	in	in	ADP
iajs-2916	165	65	treated	treat	VERB
iajs-2916	165	66	diabetic	diabetic	ADJ
iajs-2916	165	67	and	and	CCONJ
iajs-2916	165	68	neuropathy	neuropathy	ADJ
iajs-2916	165	69	patients	patient	NOUN
iajs-2916	165	70	with	with	ADP
iajs-2916	165	71	metformin	metformin	NOUN
iajs-2916	165	72	and	and	CCONJ
iajs-2916	165	73	sulfonylureas	sulfonylurea	NOUN
iajs-2916	165	74	or	or	CCONJ
iajs-2916	165	75	together	together	ADV
iajs-2916	165	76	.	.	PUNCT
iajs-2916	166	1	these	these	DET
iajs-2916	166	2	drugs	drug	NOUN
iajs-2916	166	3	are	be	AUX
iajs-2916	166	4	a	a	DET
iajs-2916	166	5	promising	promising	ADJ
iajs-2916	166	6	treatment	treatment	NOUN
iajs-2916	166	7	for	for	ADP
iajs-2916	166	8	patients	patient	NOUN
iajs-2916	166	9	with	with	ADP
iajs-2916	166	10	type	type	NOUN
iajs-2916	166	11	2	2	NUM
iajs-2916	166	12	diabetes	diabetes	NOUN
iajs-2916	166	13	and	and	CCONJ
iajs-2916	166	14	also	also	ADV
iajs-2916	166	15	for	for	ADP
iajs-2916	166	16	those	those	PRON
iajs-2916	166	17	with	with	ADP
iajs-2916	166	18	peripheral	peripheral	ADJ
iajs-2916	166	19	neuropathy	neuropathy	ADJ
iajs-2916	166	20	.	.	PUNCT
iajs-2916	167	1	the	the	DET
iajs-2916	167	2	present	present	ADJ
iajs-2916	167	3	study	study	NOUN
iajs-2916	167	4	has	have	AUX
iajs-2916	167	5	also	also	ADV
iajs-2916	167	6	shown	show	VERB
iajs-2916	167	7	that	that	SCONJ
iajs-2916	167	8	oxidative	oxidative	ADJ
iajs-2916	167	9	stress	stress	NOUN
iajs-2916	167	10	is	be	AUX
iajs-2916	167	11	a	a	DET
iajs-2916	167	12	risk	risk	NOUN
iajs-2916	167	13	factor	factor	NOUN
iajs-2916	167	14	for	for	ADP
iajs-2916	167	15	diabetes	diabetes	NOUN
iajs-2916	167	16	and	and	CCONJ
iajs-2916	167	17	peripheral	peripheral	ADJ
iajs-2916	167	18	neuropathy	neuropathy	ADJ
iajs-2916	167	19	.	.	PUNCT
iajs-2916	168	1	ethical	ethical	ADJ
iajs-2916	168	2	approval	approval	NOUN
iajs-2916	168	3	:	:	PUNCT
iajs-2916	168	4	this	this	DET
iajs-2916	168	5	study	study	NOUN
iajs-2916	168	6	was	be	AUX
iajs-2916	168	7	approved	approve	VERB
iajs-2916	168	8	by	by	ADP
iajs-2916	168	9	the	the	DET
iajs-2916	168	10	scientific	scientific	ADJ
iajs-2916	168	11	committee	committee	NOUN
iajs-2916	168	12	in	in	ADP
iajs-2916	168	13	the	the	DET
iajs-2916	168	14	college	college	NOUN
iajs-2916	168	15	of	of	ADP
iajs-2916	168	16	science	science	NOUN
iajs-2916	168	17	for	for	ADP
iajs-2916	168	18	women	woman	NOUN
iajs-2916	168	19	,	,	PUNCT
iajs-2916	168	20	and	and	CCONJ
iajs-2916	168	21	a	a	DET
iajs-2916	168	22	verbal	verbal	ADJ
iajs-2916	168	23	consent	consent	NOUN
iajs-2916	168	24	form	form	NOUN
iajs-2916	168	25	was	be	AUX
iajs-2916	168	26	obtained	obtain	VERB
iajs-2916	168	27	from	from	ADP
iajs-2916	168	28	each	each	DET
iajs-2916	168	29	participant	participant	NOUN
iajs-2916	168	30	enrolled	enrol	VERB
iajs-2916	168	31	in	in	ADP
iajs-2916	168	32	the	the	DET
iajs-2916	168	33	study	study	NOUN
iajs-2916	168	34	.	.	PUNCT
iajs-2916	169	1	conflict	conflict	NOUN
iajs-2916	169	2	of	of	ADP
iajs-2916	169	3	interest	interest	NOUN
iajs-2916	169	4	:	:	PUNCT
iajs-2916	169	5	none	none	NOUN
iajs-2916	169	6	.	.	PUNCT
iajs-2916	170	1	source	source	NOUN
iajs-2916	170	2	of	of	ADP
iajs-2916	170	3	funding	funding	NOUN
iajs-2916	170	4	:	:	PUNCT
iajs-2916	170	5	none	none	NOUN
iajs-2916	170	6	.	.	PUNCT
iajs-2916	171	1	ihjpas	ihjpas	PROPN
iajs-2916	171	2	.	.	PUNCT
iajs-2916	172	1	53	53	NUM
iajs-2916	172	2	(	(	PUNCT
iajs-2916	172	3	4)2022	4)2022	NOUN
iajs-2916	172	4	202	202	NUM
iajs-2916	172	5	references	reference	NOUN
iajs-2916	172	6	1	1	NUM
iajs-2916	172	7	.	.	X
iajs-2916	172	8	yang	yang	PROPN
iajs-2916	172	9	,	,	PUNCT
iajs-2916	172	10	q.q	q.q	PROPN
iajs-2916	172	11	.	.	PROPN
iajs-2916	172	12	;	;	PUNCT
iajs-2916	172	13	sun	sun	PROPN
iajs-2916	172	14	,	,	PUNCT
iajs-2916	172	15	j.w	j.w	PROPN
iajs-2916	172	16	.	.	PROPN
iajs-2916	172	17	;	;	PUNCT
iajs-2916	172	18	shao	shao	PROPN
iajs-2916	172	19	,	,	PUNCT
iajs-2916	172	20	d.	d.	PROPN
iajs-2916	172	21	;	;	PUNCT
iajs-2916	172	22	zhang	zhang	PROPN
iajs-2916	172	23	,	,	PUNCT
iajs-2916	172	24	h.h	h.h	PROPN
iajs-2916	172	25	.	.	PROPN
iajs-2916	172	26	;	;	PUNCT
iajs-2916	172	27	bai	bai	PROPN
iajs-2916	172	28	,	,	PUNCT
iajs-2916	172	29	c.f	c.f	PROPN
iajs-2916	172	30	.	.	PROPN
iajs-2916	172	31	;	;	PUNCT
iajs-2916	172	32	cao	cao	PROPN
iajs-2916	172	33	,	,	PUNCT
iajs-2916	172	34	f.l	f.l	PROPN
iajs-2916	172	35	.	.	PUNCT
iajs-2916	173	1	the	the	DET
iajs-2916	173	2	association	association	NOUN
iajs-2916	173	3	between	between	ADP
iajs-2916	173	4	diabetes	diabetes	NOUN
iajs-2916	173	5	complications	complication	NOUN
iajs-2916	173	6	,	,	PUNCT
iajs-2916	173	7	diabetes	diabetes	NOUN
iajs-2916	173	8	distress	distress	NOUN
iajs-2916	173	9	,	,	PUNCT
iajs-2916	173	10	and	and	CCONJ
iajs-2916	173	11	depressive	depressive	ADJ
iajs-2916	173	12	symptoms	symptom	NOUN
iajs-2916	173	13	in	in	ADP
iajs-2916	173	14	patients	patient	NOUN
iajs-2916	173	15	with	with	ADP
iajs-2916	173	16	type	type	NOUN
iajs-2916	173	17	2	2	NUM
iajs-2916	173	18	diabetes	diabetes	NOUN
iajs-2916	173	19	mellitus	mellitus	NOUN
iajs-2916	173	20	.	.	PUNCT
iajs-2916	174	1	clin	clin	PROPN
iajs-2916	174	2	.	.	PUNCT
iajs-2916	175	1	nurs	nur	VERB
iajs-2916	175	2	.	.	PUNCT
iajs-2916	176	1	res	re	NOUN
iajs-2916	176	2	.	.	PROPN
iajs-2916	176	3	2021	2021	NUM
iajs-2916	176	4	,	,	PUNCT
iajs-2916	176	5	30	30	NUM
iajs-2916	176	6	,	,	PUNCT
iajs-2916	176	7	293	293	NUM
iajs-2916	176	8	-	-	SYM
iajs-2916	176	9	301	301	NUM
iajs-2916	176	10	.	.	NOUN
iajs-2916	177	1	2	2	NUM
iajs-2916	177	2	.	.	NUM
iajs-2916	177	3	abed	abe	VERB
iajs-2916	177	4	,	,	PUNCT
iajs-2916	177	5	b.a	b.a	PROPN
iajs-2916	177	6	.	.	PROPN
iajs-2916	177	7	;	;	PUNCT
iajs-2916	178	1	al	al	PROPN
iajs-2916	178	2	-	-	PUNCT
iajs-2916	178	3	aaraji	aaraji	PROPN
iajs-2916	178	4	,	,	PUNCT
iajs-2916	178	5	s.b	s.b	PROPN
iajs-2916	178	6	.	.	PROPN
iajs-2916	178	7	;	;	PUNCT
iajs-2916	178	8	salman	salman	PROPN
iajs-2916	178	9	,	,	PUNCT
iajs-2916	178	10	i.n	i.n	PROPN
iajs-2916	178	11	.	.	PROPN
iajs-2916	178	12	estimation	estimation	NOUN
iajs-2916	178	13	of	of	ADP
iajs-2916	178	14	galanin	galanin	ADJ
iajs-2916	178	15	hormone	hormone	NOUN
iajs-2916	178	16	in	in	ADP
iajs-2916	178	17	patients	patient	NOUN
iajs-2916	178	18	with	with	ADP
iajs-2916	178	19	newly	newly	ADV
iajs-2916	178	20	thyroid	thyroid	NOUN
iajs-2916	178	21	dysfunction	dysfunction	NOUN
iajs-2916	178	22	in	in	ADP
iajs-2916	178	23	type	type	NOUN
iajs-2916	178	24	2	2	NUM
iajs-2916	178	25	diabetes	diabetes	NOUN
iajs-2916	178	26	mellitus	mellitus	NOUN
iajs-2916	178	27	.	.	PUNCT
iajs-2916	179	1	biochem	biochem	PROPN
iajs-2916	179	2	cell	cell	PROPN
iajs-2916	179	3	arch.2021	arch.2021	PROPN
iajs-2916	179	4	,	,	PUNCT
iajs-2916	179	5	21	21	NUM
iajs-2916	179	6	,	,	PUNCT
iajs-2916	179	7	1317	1317	NUM
iajs-2916	179	8	.	.	PUNCT
iajs-2916	180	1	3	3	X
iajs-2916	180	2	.	.	X
iajs-2916	180	3	salih	salih	PROPN
iajs-2916	180	4	,	,	PUNCT
iajs-2916	180	5	y.a	y.a	PROPN
iajs-2916	180	6	.	.	PROPN
iajs-2916	180	7	;	;	PUNCT
iajs-2916	180	8	rasool	rasool	PROPN
iajs-2916	180	9	,	,	PUNCT
iajs-2916	180	10	m.t	m.t	PROPN
iajs-2916	180	11	.	.	PROPN
iajs-2916	180	12	;	;	PUNCT
iajs-2916	180	13	ahmed	ahmed	PROPN
iajs-2916	180	14	,	,	PUNCT
iajs-2916	180	15	i.h	i.h	PROPN
iajs-2916	180	16	.	.	PROPN
iajs-2916	180	17	;	;	PUNCT
iajs-2916	180	18	mohammed	mohammed	PROPN
iajs-2916	180	19	,	,	PUNCT
iajs-2916	180	20	a.a	a.a	PROPN
iajs-2916	180	21	.	.	PROPN
iajs-2916	180	22	impact	impact	NOUN
iajs-2916	180	23	of	of	ADP
iajs-2916	180	24	vitamin	vitamin	NOUN
iajs-2916	180	25	d	d	NOUN
iajs-2916	180	26	level	level	NOUN
iajs-2916	180	27	on	on	ADP
iajs-2916	180	28	glycemic	glycemic	ADJ
iajs-2916	180	29	control	control	NOUN
iajs-2916	180	30	in	in	ADP
iajs-2916	180	31	diabetes	diabetes	NOUN
iajs-2916	180	32	mellitus	mellitus	NOUN
iajs-2916	180	33	type	type	VERB
iajs-2916	180	34	2	2	NUM
iajs-2916	180	35	in	in	ADP
iajs-2916	180	36	duhok	duhok	NOUN
iajs-2916	180	37	.	.	PUNCT
iajs-2916	181	1	ann	ann	PROPN
iajs-2916	181	2	.	.	PROPN
iajs-2916	181	3	med	med	PROPN
iajs-2916	181	4	.	.	PUNCT
iajs-2916	181	5	surg	surg	PROPN
iajs-2916	181	6	.	.	PUNCT
iajs-2916	182	1	2021	2021	NUM
iajs-2916	182	2	,	,	PUNCT
iajs-2916	182	3	64,102208	64,102208	NOUN
iajs-2916	182	4	.	.	PUNCT
iajs-2916	183	1	4	4	X
iajs-2916	183	2	.	.	X
iajs-2916	183	3	diabetes	diabetes	NOUN
iajs-2916	183	4	mellitus	mellitus	NOUN
iajs-2916	183	5	:	:	PUNCT
iajs-2916	183	6	report	report	NOUN
iajs-2916	183	7	of	of	ADP
iajs-2916	183	8	a	a	DET
iajs-2916	183	9	who	who	PRON
iajs-2916	183	10	study	study	VERB
iajs-2916	183	11	group	group	NOUN
iajs-2916	183	12	.	.	PUNCT
iajs-2916	184	1	technical	technical	ADJ
iajs-2916	184	2	report	report	PROPN
iajs-2916	184	3	series	series	PROPN
iajs-2916	184	4	727.geneva	727.geneva	NOUN
iajs-2916	184	5	,	,	PUNCT
iajs-2916	184	6	world	world	NOUN
iajs-2916	184	7	health	health	NOUN
iajs-2916	184	8	organization	organization	NOUN
iajs-2916	184	9	,	,	PUNCT
iajs-2916	184	10	1985	1985	NUM
iajs-2916	184	11	.	.	PUNCT
iajs-2916	185	1	5	5	NUM
iajs-2916	185	2	.	.	X
iajs-2916	185	3	world	world	PROPN
iajs-2916	185	4	health	health	PROPN
iajs-2916	185	5	organization	organization	PROPN
iajs-2916	185	6	.	.	PUNCT
iajs-2916	186	1	use	use	NOUN
iajs-2916	186	2	of	of	ADP
iajs-2916	186	3	glycated	glycate	VERB
iajs-2916	186	4	haemoglobin	haemoglobin	NOUN
iajs-2916	186	5	(	(	PUNCT
iajs-2916	186	6	hba1c	hba1c	PROPN
iajs-2916	186	7	)	)	PUNCT
iajs-2916	186	8	in	in	ADP
iajs-2916	186	9	diagnosis	diagnosis	NOUN
iajs-2916	186	10	of	of	ADP
iajs-2916	186	11	diabetes	diabetes	NOUN
iajs-2916	186	12	mellitus	mellitus	NOUN
iajs-2916	186	13	:	:	PUNCT
iajs-2916	186	14	abbreviated	abbreviate	VERB
iajs-2916	186	15	report	report	NOUN
iajs-2916	186	16	of	of	ADP
iajs-2916	186	17	a	a	DET
iajs-2916	186	18	who	who	PRON
iajs-2916	186	19	consultation	consultation	NOUN
iajs-2916	186	20	.	.	PUNCT
iajs-2916	187	1	world	world	PROPN
iajs-2916	187	2	health	health	PROPN
iajs-2916	187	3	organization	organization	NOUN
iajs-2916	187	4	;	;	PUNCT
iajs-2916	187	5	2011	2011	NUM
iajs-2916	187	6	,	,	PUNCT
iajs-2916	187	7	no	no	INTJ
iajs-2916	187	8	.	.	PUNCT
iajs-2916	188	1	who	who	PRON
iajs-2916	188	2	/	/	SYM
iajs-2916	188	3	nmh	nmh	NOUN
iajs-2916	188	4	/	/	SYM
iajs-2916	188	5	chp	chp	NOUN
iajs-2916	188	6	/	/	SYM
iajs-2916	188	7	cpm/11.1	cpm/11.1	NOUN
iajs-2916	188	8	.	.	PUNCT
iajs-2916	188	9	6	6	NUM
iajs-2916	188	10	.	.	X
iajs-2916	188	11	branch	branch	NOUN
iajs-2916	188	12	,	,	PUNCT
iajs-2916	188	13	o.	o.	NOUN
iajs-2916	188	14	the	the	DET
iajs-2916	188	15	impact	impact	NOUN
iajs-2916	188	16	of	of	ADP
iajs-2916	188	17	diabetes	diabetes	NOUN
iajs-2916	188	18	mellitus	mellitus	NOUN
iajs-2916	188	19	on	on	ADP
iajs-2916	188	20	length	length	NOUN
iajs-2916	188	21	of	of	ADP
iajs-2916	188	22	stay	stay	NOUN
iajs-2916	188	23	and	and	CCONJ
iajs-2916	188	24	mechanical	mechanical	ADJ
iajs-2916	188	25	ventilation	ventilation	NOUN
iajs-2916	188	26	among	among	ADP
iajs-2916	188	27	motor	motor	NOUN
iajs-2916	188	28	vehicle	vehicle	NOUN
iajs-2916	188	29	accident	accident	NOUN
iajs-2916	188	30	patients	patient	NOUN
iajs-2916	188	31	in	in	ADP
iajs-2916	188	32	a	a	DET
iajs-2916	188	33	level-1	level-1	NUM
iajs-2916	188	34	trauma	trauma	NOUN
iajs-2916	188	35	center	center	NOUN
iajs-2916	188	36	2021	2021	NUM
iajs-2916	188	37	,	,	PUNCT
iajs-2916	188	38	georgia	georgia	PROPN
iajs-2916	188	39	state	state	PROPN
iajs-2916	188	40	university	university	PROPN
iajs-2916	188	41	,	,	PUNCT
iajs-2916	188	42	https://scholarworks.gsu.edu/rt_theses	https://scholarworks.gsu.edu/rt_theses	PROPN
iajs-2916	188	43	7	7	X
iajs-2916	188	44	.	.	X
iajs-2916	188	45	wolosowicz	wolosowicz	NOUN
iajs-2916	188	46	,	,	PUNCT
iajs-2916	188	47	m.	m.	NOUN
iajs-2916	188	48	;	;	PUNCT
iajs-2916	188	49	lukaszuk	lukaszuk	PROPN
iajs-2916	188	50	,	,	PUNCT
iajs-2916	188	51	b.	b.	PROPN
iajs-2916	188	52	;	;	PUNCT
iajs-2916	188	53	chabowski	chabowski	ADV
iajs-2916	188	54	,	,	PUNCT
iajs-2916	188	55	a.	a.	NOUN
iajs-2916	188	56	the	the	DET
iajs-2916	188	57	causes	cause	NOUN
iajs-2916	188	58	of	of	ADP
iajs-2916	188	59	insulin	insulin	NOUN
iajs-2916	188	60	resistance	resistance	NOUN
iajs-2916	188	61	in	in	ADP
iajs-2916	188	62	type	type	NOUN
iajs-2916	188	63	1	1	NUM
iajs-2916	188	64	diabetes	diabetes	NOUN
iajs-2916	188	65	mellitus	mellitus	NOUN
iajs-2916	188	66	:	:	PUNCT
iajs-2916	188	67	is	be	AUX
iajs-2916	188	68	there	there	PRON
iajs-2916	188	69	a	a	DET
iajs-2916	188	70	place	place	NOUN
iajs-2916	188	71	for	for	ADP
iajs-2916	188	72	quaternary	quaternary	ADJ
iajs-2916	188	73	prevention	prevention	NOUN
iajs-2916	188	74	?	?	PUNCT
iajs-2916	189	1	int	int	NOUN
iajs-2916	189	2	.	.	PUNCT
iajs-2916	190	1	j.	j.	PROPN
iajs-2916	190	2	environ	environ	PROPN
iajs-2916	190	3	.	.	PUNCT
iajs-2916	191	1	res	re	NOUN
iajs-2916	191	2	.	.	PUNCT
iajs-2916	192	1	public	public	ADJ
iajs-2916	192	2	health	health	NOUN
iajs-2916	192	3	.	.	PUNCT
iajs-2916	193	1	2020	2020	NUM
iajs-2916	193	2	,	,	PUNCT
iajs-2916	193	3	17	17	NUM
iajs-2916	193	4	,	,	PUNCT
iajs-2916	193	5	8651	8651	NUM
iajs-2916	193	6	.	.	PUNCT
iajs-2916	194	1	8	8	NUM
iajs-2916	194	2	.	.	X
iajs-2916	194	3	dahik	dahik	NOUN
iajs-2916	194	4	,	,	PUNCT
iajs-2916	194	5	v.d	v.d	PROPN
iajs-2916	194	6	.	.	PROPN
iajs-2916	194	7	;	;	PUNCT
iajs-2916	194	8	frisdal	frisdal	PROPN
iajs-2916	194	9	,	,	PUNCT
iajs-2916	194	10	e.	e.	PROPN
iajs-2916	194	11	;	;	PUNCT
iajs-2916	194	12	le	le	PROPN
iajs-2916	194	13	goff	goff	PROPN
iajs-2916	194	14	,	,	PUNCT
iajs-2916	194	15	w.	w.	PROPN
iajs-2916	194	16	rewiring	rewiring	PROPN
iajs-2916	194	17	of	of	ADP
iajs-2916	194	18	lipid	lipid	ADJ
iajs-2916	194	19	metabolism	metabolism	NOUN
iajs-2916	194	20	in	in	ADP
iajs-2916	194	21	adipose	adipose	ADJ
iajs-2916	194	22	tissue	tissue	NOUN
iajs-2916	194	23	macrophages	macrophage	NOUN
iajs-2916	194	24	in	in	ADP
iajs-2916	194	25	obesity	obesity	NOUN
iajs-2916	194	26	:	:	PUNCT
iajs-2916	194	27	impact	impact	NOUN
iajs-2916	194	28	on	on	ADP
iajs-2916	194	29	insulin	insulin	NOUN
iajs-2916	194	30	resistance	resistance	NOUN
iajs-2916	194	31	and	and	CCONJ
iajs-2916	194	32	type	type	NOUN
iajs-2916	194	33	2	2	NUM
iajs-2916	194	34	diabetes	diabetes	NOUN
iajs-2916	194	35	.	.	PUNCT
iajs-2916	195	1	int	int	NOUN
iajs-2916	195	2	.	.	PUNCT
iajs-2916	196	1	j.	j.	PROPN
iajs-2916	196	2	mol	mol	PROPN
iajs-2916	196	3	.	.	PUNCT
iajs-2916	197	1	sci	sci	PROPN
iajs-2916	197	2	.	.	PROPN
iajs-2916	197	3	2020	2020	NUM
iajs-2916	197	4	,	,	PUNCT
iajs-2916	197	5	21	21	NUM
iajs-2916	197	6	,	,	PUNCT
iajs-2916	197	7	5505	5505	NUM
iajs-2916	197	8	.	.	PUNCT
iajs-2916	198	1	9	9	NUM
iajs-2916	198	2	.	.	X
iajs-2916	198	3	hammi	hammi	PROPN
iajs-2916	198	4	,	,	PUNCT
iajs-2916	198	5	c.	c.	PROPN
iajs-2916	198	6	;	;	PUNCT
iajs-2916	198	7	yeung	yeung	PROPN
iajs-2916	198	8	,	,	PUNCT
iajs-2916	198	9	b.	b.	PROPN
iajs-2916	198	10	neuropathy.in	neuropathy.in	PROPN
iajs-2916	198	11	:	:	PUNCT
iajs-2916	198	12	statpearls	statpearl	NOUN
iajs-2916	199	1	[	[	X
iajs-2916	199	2	internet	internet	NOUN
iajs-2916	199	3	]	]	PUNCT
iajs-2916	199	4	,	,	PUNCT
iajs-2916	199	5	treasure	treasure	NOUN
iajs-2916	199	6	island	island	NOUN
iajs-2916	199	7	(	(	PUNCT
iajs-2916	199	8	fl	fl	NOUN
iajs-2916	199	9	)	)	PUNCT
iajs-2916	199	10	,	,	PUNCT
iajs-2916	199	11	statpearls	statpearls	PROPN
iajs-2916	199	12	publishing	publishing	NOUN
iajs-2916	199	13	;	;	PUNCT
iajs-2916	199	14	2021	2021	NUM
iajs-2916	199	15	,	,	PUNCT
iajs-2916	199	16	nbk542220	nbk542220	NOUN
iajs-2916	199	17	,	,	PUNCT
iajs-2916	199	18	https://www.ncbi.nlm.nih.gov/books/nbk542220/.	https://www.ncbi.nlm.nih.gov/books/nbk542220/.	PROPN
iajs-2916	199	19	10	10	NUM
iajs-2916	199	20	.	.	PUNCT
iajs-2916	200	1	ighodaro	ighodaro	NOUN
iajs-2916	200	2	,	,	PUNCT
iajs-2916	200	3	o.m	o.m	PROPN
iajs-2916	200	4	.	.	PUNCT
iajs-2916	201	1	molecular	molecular	ADJ
iajs-2916	201	2	pathways	pathway	NOUN
iajs-2916	201	3	associated	associate	VERB
iajs-2916	201	4	with	with	ADP
iajs-2916	201	5	oxidative	oxidative	ADJ
iajs-2916	201	6	stress	stress	NOUN
iajs-2916	201	7	in	in	ADP
iajs-2916	201	8	diabetes	diabetes	NOUN
iajs-2916	201	9	mellitus	mellitus	NOUN
iajs-2916	201	10	.	.	PUNCT
iajs-2916	201	11	biomed	biome	VERB
iajs-2916	201	12	.	.	PUNCT
iajs-2916	202	1	pharmacother	pharmacother	ADJ
iajs-2916	202	2	.	.	PUNCT
iajs-2916	203	1	2018	2018	NUM
iajs-2916	203	2	,	,	PUNCT
iajs-2916	203	3	108	108	NUM
iajs-2916	203	4	,	,	PUNCT
iajs-2916	203	5	656	656	NUM
iajs-2916	203	6	-	-	SYM
iajs-2916	203	7	62	62	NUM
iajs-2916	203	8	.	.	PUNCT
iajs-2916	204	1	11	11	NUM
iajs-2916	204	2	.	.	PUNCT
iajs-2916	205	1	forouhi	forouhi	PROPN
iajs-2916	205	2	,	,	PUNCT
iajs-2916	205	3	n.g	n.g	PROPN
iajs-2916	205	4	.	.	PROPN
iajs-2916	205	5	;	;	PUNCT
iajs-2916	205	6	misra	misra	NUM
iajs-2916	205	7	,	,	PUNCT
iajs-2916	205	8	a.	a.	NOUN
iajs-2916	205	9	;	;	PUNCT
iajs-2916	205	10	mohan	mohan	PROPN
iajs-2916	205	11	,	,	PUNCT
iajs-2916	205	12	v.	v.	PROPN
iajs-2916	205	13	;	;	PUNCT
iajs-2916	205	14	taylor	taylor	PROPN
iajs-2916	205	15	,	,	PUNCT
iajs-2916	205	16	r.	r.	PROPN
iajs-2916	205	17	;	;	PUNCT
iajs-2916	205	18	yancy	yancy	PROPN
iajs-2916	205	19	,	,	PUNCT
iajs-2916	205	20	w.	w.	PROPN
iajs-2916	205	21	dietary	dietary	ADJ
iajs-2916	205	22	and	and	CCONJ
iajs-2916	205	23	nutritional	nutritional	ADJ
iajs-2916	205	24	approaches	approach	NOUN
iajs-2916	205	25	for	for	ADP
iajs-2916	205	26	prevention	prevention	NOUN
iajs-2916	205	27	and	and	CCONJ
iajs-2916	205	28	management	management	NOUN
iajs-2916	205	29	of	of	ADP
iajs-2916	205	30	type	type	NOUN
iajs-2916	205	31	2	2	NUM
iajs-2916	205	32	diabetes	diabetes	NOUN
iajs-2916	205	33	.	.	PUNCT
iajs-2916	206	1	bmj	bmj	PROPN
iajs-2916	206	2	2018	2018	NUM
iajs-2916	206	3	,	,	PUNCT
iajs-2916	206	4	361	361	NUM
iajs-2916	206	5	,	,	PUNCT
iajs-2916	206	6	k2234	k2234	PROPN
iajs-2916	206	7	12	12	NUM
iajs-2916	206	8	.	.	PUNCT
iajs-2916	207	1	langhans	langhan	NOUN
iajs-2916	207	2	,	,	PUNCT
iajs-2916	207	3	w.	w.	PROPN
iajs-2916	207	4	food	food	NOUN
iajs-2916	207	5	components	component	NOUN
iajs-2916	207	6	in	in	ADP
iajs-2916	207	7	health	health	NOUN
iajs-2916	207	8	promotion	promotion	NOUN
iajs-2916	207	9	and	and	CCONJ
iajs-2916	207	10	disease	disease	NOUN
iajs-2916	207	11	prevention	prevention	NOUN
iajs-2916	207	12	.	.	PUNCT
iajs-2916	208	1	j.	j.	PROPN
iajs-2916	208	2	agric	agric	PROPN
iajs-2916	208	3	.	.	PUNCT
iajs-2916	208	4	food	food	NOUN
iajs-2916	208	5	chem	chem	NOUN
iajs-2916	208	6	.	.	PUNCT
iajs-2916	209	1	2017	2017	NUM
iajs-2916	209	2	,	,	PUNCT
iajs-2916	209	3	66	66	NUM
iajs-2916	209	4	,	,	PUNCT
iajs-2916	209	5	2287	2287	NUM
iajs-2916	209	6	-	-	SYM
iajs-2916	209	7	94	94	NUM
iajs-2916	209	8	.	.	PUNCT
iajs-2916	210	1	13	13	NUM
iajs-2916	210	2	.	.	X
iajs-2916	211	1	sari	sari	PROPN
iajs-2916	211	2	,	,	PUNCT
iajs-2916	211	3	m.i	m.i	PROPN
iajs-2916	211	4	.	.	PROPN
iajs-2916	211	5	;	;	PUNCT
iajs-2916	211	6	tala	tala	PROPN
iajs-2916	211	7	,	,	PUNCT
iajs-2916	211	8	z.z	z.z	PROPN
iajs-2916	211	9	.	.	PROPN
iajs-2916	211	10	;	;	PUNCT
iajs-2916	211	11	daulay	daulay	PROPN
iajs-2916	211	12	,	,	PUNCT
iajs-2916	211	13	m.	m.	NOUN
iajs-2916	211	14	dietary	dietary	ADJ
iajs-2916	211	15	intake	intake	NOUN
iajs-2916	211	16	and	and	CCONJ
iajs-2916	211	17	glutathione	glutathione	NOUN
iajs-2916	211	18	s	s	NOUN
iajs-2916	211	19	-	-	NOUN
iajs-2916	211	20	transferase	transferase	NOUN
iajs-2916	211	21	(	(	PUNCT
iajs-2916	211	22	m1	m1	PROPN
iajs-2916	211	23	and	and	CCONJ
iajs-2916	211	24	t1	t1	PROPN
iajs-2916	211	25	)	)	PUNCT
iajs-2916	211	26	variants	variant	NOUN
iajs-2916	211	27	in	in	ADP
iajs-2916	211	28	type	type	NOUN
iajs-2916	211	29	2	2	NUM
iajs-2916	211	30	diabetes	diabetes	NOUN
iajs-2916	211	31	mellitus	mellitus	NOUN
iajs-2916	211	32	at	at	ADP
iajs-2916	211	33	usu	usu	PROPN
iajs-2916	211	34	hospital	hospital	PROPN
iajs-2916	211	35	,	,	PUNCT
iajs-2916	211	36	medan	medan	PROPN
iajs-2916	211	37	,	,	PUNCT
iajs-2916	211	38	indonesia	indonesia	PROPN
iajs-2916	211	39	.	.	PUNCT
iajs-2916	212	1	j	j	PROPN
iajs-2916	212	2	diabetes	diabetes	PROPN
iajs-2916	212	3	nutr	nutr	PROPN
iajs-2916	212	4	metab	metab	PROPN
iajs-2916	212	5	dis	dis	PROPN
iajs-2916	212	6	.	.	PUNCT
iajs-2916	212	7	2021	2021	NUM
iajs-2916	212	8	,	,	PUNCT
iajs-2916	212	9	28	28	NUM
iajs-2916	212	10	,	,	PUNCT
iajs-2916	212	11	77	77	NUM
iajs-2916	212	12	-	-	SYM
iajs-2916	212	13	83	83	NUM
iajs-2916	212	14	.	.	PUNCT
iajs-2916	213	1	14	14	NUM
iajs-2916	213	2	.	.	PUNCT
iajs-2916	213	3	senhaji	senhaji	NOUN
iajs-2916	213	4	,	,	PUNCT
iajs-2916	213	5	n.	n.	NOUN
iajs-2916	213	6	;	;	PUNCT
iajs-2916	213	7	kassogue	kassogue	PROPN
iajs-2916	213	8	,	,	PUNCT
iajs-2916	213	9	y.	y.	PROPN
iajs-2916	213	10	;	;	PUNCT
iajs-2916	213	11	fahimi	fahimi	PROPN
iajs-2916	213	12	,	,	PUNCT
iajs-2916	213	13	m.	m.	NOUN
iajs-2916	213	14	;	;	PUNCT
iajs-2916	213	15	serbati	serbati	NOUN
iajs-2916	213	16	,	,	PUNCT
iajs-2916	213	17	n.	n.	NOUN
iajs-2916	213	18	;	;	PUNCT
iajs-2916	213	19	badre	badre	PROPN
iajs-2916	213	20	,	,	PUNCT
iajs-2916	213	21	w.	w.	PROPN
iajs-2916	213	22	;	;	PUNCT
iajs-2916	213	23	nadifi	nadifi	PROPN
iajs-2916	213	24	,	,	PUNCT
iajs-2916	213	25	s.	s.	PROPN
iajs-2916	213	26	genetic	genetic	ADJ
iajs-2916	213	27	polymorphisms	polymorphism	NOUN
iajs-2916	213	28	of	of	ADP
iajs-2916	213	29	multidrug	multidrug	NOUN
iajs-2916	213	30	resistance	resistance	NOUN
iajs-2916	213	31	gene-1	gene-1	PROPN
iajs-2916	213	32	(	(	PUNCT
iajs-2916	213	33	mdr1	mdr1	PROPN
iajs-2916	213	34	/	/	SYM
iajs-2916	213	35	abcb1	abcb1	NOUN
iajs-2916	213	36	)	)	PUNCT
iajs-2916	213	37	and	and	CCONJ
iajs-2916	213	38	glutathione	glutathione	NOUN
iajs-2916	213	39	stransferase	stransferase	NOUN
iajs-2916	213	40	gene	gene	NOUN
iajs-2916	213	41	and	and	CCONJ
iajs-2916	213	42	the	the	DET
iajs-2916	213	43	risk	risk	NOUN
iajs-2916	213	44	of	of	ADP
iajs-2916	213	45	inflammatory	inflammatory	ADJ
iajs-2916	213	46	bowel	bowel	NOUN
iajs-2916	213	47	disease	disease	NOUN
iajs-2916	213	48	among	among	ADP
iajs-2916	213	49	moroccan	moroccan	ADJ
iajs-2916	213	50	patients	patient	NOUN
iajs-2916	213	51	.	.	PUNCT
iajs-2916	214	1	mediators	mediator	NOUN
iajs-2916	214	2	inflamm	inflamm	NOUN
iajs-2916	214	3	.	.	PUNCT
iajs-2916	215	1	2015	2015	NUM
iajs-2916	215	2	,	,	PUNCT
iajs-2916	215	3	i	i	PROPN
iajs-2916	215	4	d	d	PROPN
iajs-2916	215	5	248060	248060	NUM
iajs-2916	215	6	.	.	PUNCT
iajs-2916	216	1	https://scholarworks.gsu.edu/rt_theses	https://scholarworks.gsu.edu/rt_theses	PRON
iajs-2916	216	2	https://www.ncbi.nlm.nih.gov/books/nbk542220/	https://www.ncbi.nlm.nih.gov/books/nbk542220/	PROPN
iajs-2916	216	3	ihjpas	ihjpa	VERB
iajs-2916	216	4	.	.	PUNCT
iajs-2916	217	1	53	53	NUM
iajs-2916	217	2	(	(	PUNCT
iajs-2916	217	3	4)2022	4)2022	NOUN
iajs-2916	217	4	203	203	NUM
iajs-2916	217	5	15	15	NUM
iajs-2916	217	6	.	.	PUNCT
iajs-2916	218	1	shihab	shihab	PROPN
iajs-2916	218	2	,	,	PUNCT
iajs-2916	218	3	b.a	b.a	PROPN
iajs-2916	218	4	.	.	PROPN
iajs-2916	218	5	;	;	PUNCT
iajs-2916	218	6	al	al	PROPN
iajs-2916	218	7	-	-	PUNCT
iajs-2916	218	8	essa	essa	PROPN
iajs-2916	218	9	,	,	PUNCT
iajs-2916	218	10	n.e	n.e	PROPN
iajs-2916	218	11	.	.	PROPN
iajs-2916	218	12	;	;	PUNCT
iajs-2916	218	13	rasheed	rasheed	NOUN
iajs-2916	218	14	,	,	PUNCT
iajs-2916	218	15	r.h	r.h	PROPN
iajs-2916	218	16	.	.	PROPN
iajs-2916	218	17	association	association	NOUN
iajs-2916	218	18	of	of	ADP
iajs-2916	218	19	glutathione	glutathione	NOUN
iajs-2916	218	20	–	–	PUNCT
iajs-2916	218	21	s	s	NOUN
iajs-2916	218	22	-	-	NOUN
iajs-2916	218	23	transferase	transferase	NOUN
iajs-2916	218	24	(	(	PUNCT
iajs-2916	218	25	gstp1	gstp1	NOUN
iajs-2916	218	26	)	)	PUNCT
iajs-2916	218	27	genetic	genetic	ADJ
iajs-2916	218	28	polymorphism	polymorphism	NOUN
iajs-2916	218	29	in	in	ADP
iajs-2916	218	30	iraqi	iraqi	ADJ
iajs-2916	218	31	patients	patient	NOUN
iajs-2916	218	32	with	with	ADP
iajs-2916	218	33	diabetes	diabetes	NOUN
iajs-2916	218	34	mellitus	mellitus	PROPN
iajs-2916	218	35	type2	type2	PROPN
iajs-2916	218	36	.	.	PUNCT
iajs-2916	219	1	baghdad	baghdad	PROPN
iajs-2916	219	2	sci	sci	PROPN
iajs-2916	219	3	j.	j.	PROPN
iajs-2916	219	4	2016	2016	NUM
iajs-2916	219	5	,	,	PUNCT
iajs-2916	219	6	13	13	NUM
iajs-2916	219	7	,	,	PUNCT
iajs-2916	219	8	36	36	NUM
iajs-2916	219	9	-	-	SYM
iajs-2916	219	10	43	43	NUM
iajs-2916	219	11	.	.	PUNCT
iajs-2916	220	1	16	16	NUM
iajs-2916	220	2	.	.	PUNCT
iajs-2916	221	1	turner	turner	PROPN
iajs-2916	221	2	,	,	PUNCT
iajs-2916	221	3	r.c	r.c	PROPN
iajs-2916	221	4	.	.	PROPN
iajs-2916	221	5	;	;	PUNCT
iajs-2916	221	6	levy	levy	NOUN
iajs-2916	221	7	,	,	PUNCT
iajs-2916	221	8	j.;c	j.;c	PROPN
iajs-2916	221	9	,	,	PUNCT
iajs-2916	221	10	rudenski	rudenski	NOUN
iajs-2916	221	11	,	,	PUNCT
iajs-2916	221	12	a.s	a.s	PROPN
iajs-2916	221	13	.	.	PROPN
iajs-2916	221	14	;	;	PUNCT
iajs-2916	221	15	hammersley	hammersley	NOUN
iajs-2916	221	16	,	,	PUNCT
iajs-2916	221	17	m.	m.	NOUN
iajs-2916	221	18	;	;	PUNCT
iajs-2916	221	19	page	page	NOUN
iajs-2916	221	20	,	,	PUNCT
iajs-2916	221	21	r.	r.	PROPN
iajs-2916	221	22	measurement	measurement	PROPN
iajs-2916	221	23	of	of	ADP
iajs-2916	221	24	insulin	insulin	NOUN
iajs-2916	221	25	resistance	resistance	NOUN
iajs-2916	221	26	and	and	CCONJ
iajs-2916	221	27	beta	beta	NOUN
iajs-2916	221	28	-	-	PUNCT
iajs-2916	221	29	cell	cell	NOUN
iajs-2916	221	30	function	function	NOUN
iajs-2916	221	31	:	:	PUNCT
iajs-2916	221	32	the	the	DET
iajs-2916	221	33	homa	homa	PROPN
iajs-2916	221	34	and	and	CCONJ
iajs-2916	221	35	cigma	cigma	PROPN
iajs-2916	221	36	approach	approach	NOUN
iajs-2916	221	37	.	.	PUNCT
iajs-2916	222	1	current	current	ADJ
iajs-2916	222	2	topics	topic	NOUN
iajs-2916	222	3	in	in	ADP
iajs-2916	222	4	diabetes	diabetes	NOUN
iajs-2916	222	5	research	research	NOUN
iajs-2916	222	6	.	.	PUNCT
iajs-2916	223	1	1993	1993	NUM
iajs-2916	223	2	,	,	PUNCT
iajs-2916	223	3	12	12	NUM
iajs-2916	223	4	,	,	PUNCT
iajs-2916	223	5	66	66	NUM
iajs-2916	223	6	-	-	SYM
iajs-2916	223	7	75	75	NUM
iajs-2916	223	8	.	.	PUNCT
iajs-2916	224	1	17	17	NUM
iajs-2916	224	2	.	.	PUNCT
iajs-2916	225	1	ubah	ubah	PROPN
iajs-2916	225	2	jc	jc	PROPN
iajs-2916	225	3	,	,	PUNCT
iajs-2916	225	4	nnolim	nnolim	PROPN
iajs-2916	225	5	ua	ua	PROPN
iajs-2916	225	6	,	,	PUNCT
iajs-2916	225	7	onyeidu	onyeidu	ADP
iajs-2916	225	8	bu	bu	ADP
iajs-2916	225	9	.	.	PUNCT
iajs-2916	225	10	image	image	NOUN
iajs-2916	225	11	-	-	PUNCT
iajs-2916	225	12	based	base	VERB
iajs-2916	225	13	waist	waist	NOUN
iajs-2916	225	14	-	-	PUNCT
iajs-2916	225	15	to	to	ADP
iajs-2916	225	16	-	-	PUNCT
iajs-2916	225	17	hip	hip	NOUN
iajs-2916	225	18	ratio	ratio	NOUN
iajs-2916	225	19	determinant	determinant	ADJ
iajs-2916	225	20	.	.	PUNCT
iajs-2916	226	1	iosr	iosr	PROPN
iajs-2916	226	2	j.	j.	PROPN
iajs-2916	226	3	comput	comput	PROPN
iajs-2916	226	4	.	.	PUNCT
iajs-2916	227	1	eng	eng	PROPN
iajs-2916	227	2	.	.	PROPN
iajs-2916	227	3	2020	2020	NUM
iajs-2916	227	4	,	,	PUNCT
iajs-2916	227	5	22	22	NUM
iajs-2916	227	6	,	,	PUNCT
iajs-2916	227	7	28	28	NUM
iajs-2916	227	8	-	-	SYM
iajs-2916	227	9	35	35	NUM
iajs-2916	227	10	.	.	NOUN
iajs-2916	227	11	18	18	NUM
iajs-2916	227	12	.	.	X
iajs-2916	227	13	noh	noh	PROPN
iajs-2916	227	14	,	,	PUNCT
iajs-2916	227	15	h.	h.	PROPN
iajs-2916	227	16	;	;	PUNCT
iajs-2916	227	17	lee	lee	PROPN
iajs-2916	227	18	,	,	PUNCT
iajs-2916	227	19	h.	h.	PROPN
iajs-2916	227	20	;	;	PUNCT
iajs-2916	227	21	kim	kim	PROPN
iajs-2916	227	22	,	,	PUNCT
iajs-2916	227	23	s.	s.	PROPN
iajs-2916	227	24	;	;	PUNCT
iajs-2916	227	25	joo	joo	PROPN
iajs-2916	227	26	,	,	PUNCT
iajs-2916	227	27	j.	j.	PROPN
iajs-2916	227	28	;	;	PUNCT
iajs-2916	227	29	suh	suh	PROPN
iajs-2916	227	30	,	,	PUNCT
iajs-2916	227	31	d.	d.	PROPN
iajs-2916	227	32	;	;	PUNCT
iajs-2916	227	33	kim	kim	PROPN
iajs-2916	227	34	,	,	PUNCT
iajs-2916	227	35	k.	k.	PROPN
iajs-2916	227	36	et	et	PROPN
iajs-2916	227	37	al	al	PROPN
iajs-2916	227	38	.	.	PUNCT
iajs-2916	228	1	the	the	DET
iajs-2916	228	2	efficacy	efficacy	NOUN
iajs-2916	228	3	of	of	ADP
iajs-2916	228	4	body	body	NOUN
iajs-2916	228	5	mass	mass	NOUN
iajs-2916	228	6	index	index	NOUN
iajs-2916	228	7	and	and	CCONJ
iajs-2916	228	8	total	total	ADJ
iajs-2916	228	9	body	body	NOUN
iajs-2916	228	10	fat	fat	ADJ
iajs-2916	228	11	percent	percent	NOUN
iajs-2916	228	12	in	in	ADP
iajs-2916	228	13	diagnosis	diagnosis	NOUN
iajs-2916	228	14	obesity	obesity	NOUN
iajs-2916	228	15	according	accord	VERB
iajs-2916	228	16	to	to	ADP
iajs-2916	228	17	menopausal	menopausal	ADJ
iajs-2916	228	18	status	status	NOUN
iajs-2916	228	19	.	.	PUNCT
iajs-2916	229	1	j	j	PROPN
iajs-2916	229	2	menopausal	menopausal	PROPN
iajs-2916	229	3	med	med	PROPN
iajs-2916	229	4	.	.	PROPN
iajs-2916	229	5	2019	2019	NUM
iajs-2916	229	6	,	,	PUNCT
iajs-2916	229	7	25	25	NUM
iajs-2916	229	8	,	,	PUNCT
iajs-2916	229	9	55	55	NUM
iajs-2916	229	10	-	-	SYM
iajs-2916	229	11	62	62	NUM
iajs-2916	229	12	.	.	PUNCT
iajs-2916	230	1	19	19	NUM
iajs-2916	230	2	.	.	NOUN
iajs-2916	230	3	babic	babic	NOUN
iajs-2916	230	4	,	,	PUNCT
iajs-2916	230	5	n.	n.	NOUN
iajs-2916	230	6	;	;	PUNCT
iajs-2916	230	7	valjevac	valjevac	NOUN
iajs-2916	230	8	,	,	PUNCT
iajs-2916	230	9	a.	a.	NOUN
iajs-2916	230	10	;	;	PUNCT
iajs-2916	230	11	zaciragic	zaciragic	NOUN
iajs-2916	230	12	,	,	PUNCT
iajs-2916	230	13	a.	a.	NOUN
iajs-2916	230	14	;	;	PUNCT
iajs-2916	230	15	avdagic	avdagic	ADJ
iajs-2916	230	16	,	,	PUNCT
iajs-2916	230	17	n.	n.	NOUN
iajs-2916	230	18	;	;	PUNCT
iajs-2916	230	19	zukic	zukic	NUM
iajs-2916	230	20	,	,	PUNCT
iajs-2916	230	21	s.	s.	PROPN
iajs-2916	230	22	;	;	PUNCT
iajs-2916	230	23	hasic	hasic	ADJ
iajs-2916	230	24	,	,	PUNCT
iajs-2916	230	25	s.	s.	PROPN
iajs-2916	230	26	;	;	PUNCT
iajs-2916	230	27	the	the	DET
iajs-2916	230	28	triglyceride	triglyceride	PROPN
iajs-2916	230	29	/	/	SYM
iajs-2916	230	30	hdl	hdl	PROPN
iajs-2916	230	31	ratio	ratio	NOUN
iajs-2916	230	32	and	and	CCONJ
iajs-2916	230	33	triglyceride	triglyceride	ADJ
iajs-2916	230	34	glucose	glucose	NOUN
iajs-2916	230	35	index	index	NOUN
iajs-2916	230	36	as	as	ADP
iajs-2916	230	37	predictors	predictor	NOUN
iajs-2916	230	38	of	of	ADP
iajs-2916	230	39	glycemic	glycemic	ADJ
iajs-2916	230	40	control	control	NOUN
iajs-2916	230	41	in	in	ADP
iajs-2916	230	42	patients	patient	NOUN
iajs-2916	230	43	with	with	ADP
iajs-2916	230	44	diabetes	diabetes	NOUN
iajs-2916	230	45	mellitus	mellitus	NOUN
iajs-2916	230	46	type	type	VERB
iajs-2916	230	47	2	2	NUM
iajs-2916	230	48	.	.	PUNCT
iajs-2916	230	49	medical	medical	ADJ
iajs-2916	230	50	archives	archive	NOUN
iajs-2916	230	51	.	.	PUNCT
iajs-2916	231	1	2019	2019	NUM
iajs-2916	231	2	,	,	PUNCT
iajs-2916	231	3	73,163	73,163	NUM
iajs-2916	231	4	.	.	NOUN
iajs-2916	232	1	20	20	NUM
iajs-2916	232	2	.	.	PUNCT
iajs-2916	233	1	borle	borle	PROPN
iajs-2916	233	2	,	,	PUNCT
iajs-2916	233	3	a.l	a.l	PROPN
iajs-2916	233	4	.	.	PROPN
iajs-2916	233	5	;	;	PUNCT
iajs-2916	233	6	chhari	chhari	ADJ
iajs-2916	233	7	,	,	PUNCT
iajs-2916	233	8	n.	n.	NOUN
iajs-2916	233	9	;	;	PUNCT
iajs-2916	233	10	gupta	gupta	PROPN
iajs-2916	233	11	,	,	PUNCT
iajs-2916	233	12	g.	g.	PROPN
iajs-2916	233	13	;	;	PUNCT
iajs-2916	233	14	bathma	bathma	NOUN
iajs-2916	233	15	,	,	PUNCT
iajs-2916	233	16	v.	v.	ADP
iajs-2916	233	17	study	study	NOUN
iajs-2916	233	18	of	of	ADP
iajs-2916	233	19	prevalence	prevalence	NOUN
iajs-2916	233	20	and	and	CCONJ
iajs-2916	233	21	pattern	pattern	NOUN
iajs-2916	233	22	of	of	ADP
iajs-2916	233	23	dyslipidaemia	dyslipidaemia	NOUN
iajs-2916	233	24	in	in	ADP
iajs-2916	233	25	type	type	NOUN
iajs-2916	233	26	2	2	NUM
iajs-2916	233	27	diabetes	diabetes	NOUN
iajs-2916	233	28	mellitus	mellitus	NOUN
iajs-2916	233	29	patients	patient	NOUN
iajs-2916	233	30	attending	attend	VERB
iajs-2916	233	31	rural	rural	ADJ
iajs-2916	233	32	health	health	NOUN
iajs-2916	233	33	training	training	NOUN
iajs-2916	233	34	centre	centre	NOUN
iajs-2916	233	35	of	of	ADP
iajs-2916	233	36	medical	medical	ADJ
iajs-2916	233	37	college	college	PROPN
iajs-2916	233	38	in	in	ADP
iajs-2916	233	39	bhopal	bhopal	PROPN
iajs-2916	233	40	,	,	PUNCT
iajs-2916	233	41	madhya	madhya	PROPN
iajs-2916	233	42	pradesh	pradesh	PROPN
iajs-2916	233	43	,	,	PUNCT
iajs-2916	233	44	india	india	PROPN
iajs-2916	233	45	.	.	PUNCT
iajs-2916	234	1	int	int	PROPN
iajs-2916	234	2	j	j	PROPN
iajs-2916	234	3	community	community	NOUN
iajs-2916	234	4	med	me	VERB
iajs-2916	234	5	public	public	ADJ
iajs-2916	234	6	health	health	NOUN
iajs-2916	234	7	.	.	PUNCT
iajs-2916	235	1	2016	2016	NUM
iajs-2916	235	2	,	,	PUNCT
iajs-2916	235	3	3	3	NUM
iajs-2916	235	4	,	,	PUNCT
iajs-2916	235	5	140	140	NUM
iajs-2916	235	6	-	-	SYM
iajs-2916	235	7	4	4	NUM
iajs-2916	235	8	.	.	NUM
iajs-2916	235	9	21	21	NUM
iajs-2916	235	10	.	.	PUNCT
iajs-2916	236	1	thapa	thapa	PROPN
iajs-2916	236	2	,	,	PUNCT
iajs-2916	236	3	s.d	s.d	PROPN
iajs-2916	236	4	.	.	PROPN
iajs-2916	236	5	;	;	PUNCT
iajs-2916	236	6	kc	kc	PROPN
iajs-2916	236	7	,	,	PUNCT
iajs-2916	236	8	sr	sr	PROPN
iajs-2916	236	9	.	.	PUNCT
iajs-2916	236	10	;	;	PUNCT
iajs-2916	236	11	gautam	gautam	PROPN
iajs-2916	236	12	,	,	PUNCT
iajs-2916	236	13	s.	s.	PROPN
iajs-2916	236	14	;	;	PUNCT
iajs-2916	236	15	gyawali	gyawali	VERB
iajs-2916	236	16	,	,	PUNCT
iajs-2916	236	17	d.	d.	PROPN
iajs-2916	236	18	dyslipidemia	dyslipidemia	VERB
iajs-2916	236	19	in	in	ADP
iajs-2916	236	20	type	type	NOUN
iajs-2916	236	21	2	2	NUM
iajs-2916	236	22	diabetes	diabetes	NOUN
iajs-2916	236	23	mellitus	mellitus	NOUN
iajs-2916	236	24	.	.	PUNCT
iajs-2916	237	1	j.	j.	PROPN
iajs-2916	237	2	pathol	pathol	PROPN
iajs-2916	237	3	.	.	PUNCT
iajs-2916	238	1	nepal	nepal	PROPN
iajs-2916	238	2	.	.	PUNCT
iajs-2916	239	1	2017	2017	NUM
iajs-2916	239	2	,	,	PUNCT
iajs-2916	239	3	7	7	NUM
iajs-2916	239	4	,	,	PUNCT
iajs-2916	239	5	1149	1149	NUM
iajs-2916	239	6	-	-	SYM
iajs-2916	239	7	54	54	NUM
iajs-2916	239	8	.	.	PUNCT
iajs-2916	240	1	22	22	NUM
iajs-2916	240	2	.	.	PUNCT
iajs-2916	241	1	kane	kane	PROPN
iajs-2916	241	2	,	,	PUNCT
iajs-2916	241	3	j.p	j.p	PROPN
iajs-2916	241	4	.	.	PROPN
iajs-2916	241	5	;	;	PUNCT
iajs-2916	241	6	pullinger	pullinger	NOUN
iajs-2916	241	7	,	,	PUNCT
iajs-2916	241	8	c.r	c.r	PROPN
iajs-2916	241	9	.	.	PROPN
iajs-2916	241	10	;	;	PUNCT
iajs-2916	241	11	goldfine	goldfine	NOUN
iajs-2916	241	12	,	,	PUNCT
iajs-2916	241	13	i.d	i.d	PROPN
iajs-2916	241	14	.	.	PROPN
iajs-2916	241	15	;	;	PUNCT
iajs-2916	241	16	malloy	malloy	PROPN
iajs-2916	241	17	,	,	PUNCT
iajs-2916	241	18	mj	mj	PROPN
iajs-2916	241	19	.	.	PROPN
iajs-2916	241	20	dyslipidemia	dyslipidemia	NOUN
iajs-2916	241	21	and	and	CCONJ
iajs-2916	241	22	diabetes	diabete	VERB
iajs-2916	241	23	mellitus	mellitus	NOUN
iajs-2916	241	24	:	:	PUNCT
iajs-2916	241	25	role	role	NOUN
iajs-2916	241	26	of	of	ADP
iajs-2916	241	27	lipoprotein	lipoprotein	ADJ
iajs-2916	241	28	species	specie	NOUN
iajs-2916	241	29	and	and	CCONJ
iajs-2916	241	30	interrelated	interrelated	ADJ
iajs-2916	241	31	pathways	pathway	NOUN
iajs-2916	241	32	of	of	ADP
iajs-2916	241	33	lipid	lipid	ADJ
iajs-2916	241	34	metabolism	metabolism	NOUN
iajs-2916	241	35	in	in	ADP
iajs-2916	241	36	diabetes	diabetes	NOUN
iajs-2916	241	37	mellitus	mellitus	NOUN
iajs-2916	241	38	.	.	PUNCT
iajs-2916	242	1	curr	curr	PROPN
iajs-2916	242	2	opin	opin	PROPN
iajs-2916	242	3	pharmacol	pharmacol	PROPN
iajs-2916	242	4	.	.	PROPN
iajs-2916	242	5	2021	2021	NUM
iajs-2916	242	6	,	,	PUNCT
iajs-2916	242	7	61	61	NUM
iajs-2916	242	8	,	,	PUNCT
iajs-2916	242	9	21	21	NUM
iajs-2916	242	10	-	-	SYM
iajs-2916	242	11	7	7	NUM
iajs-2916	242	12	.	.	NOUN
iajs-2916	242	13	23	23	NUM
iajs-2916	242	14	.	.	PUNCT
iajs-2916	243	1	srivastava	srivastava	PROPN
iajs-2916	243	2	,	,	PUNCT
iajs-2916	243	3	ra	ra	PROPN
iajs-2916	243	4	.	.	PROPN
iajs-2916	243	5	dysfunctional	dysfunctional	PROPN
iajs-2916	243	6	hdl	hdl	PROPN
iajs-2916	243	7	in	in	ADP
iajs-2916	243	8	diabetes	diabetes	NOUN
iajs-2916	243	9	mellitus	mellitus	NOUN
iajs-2916	243	10	and	and	CCONJ
iajs-2916	243	11	its	its	PRON
iajs-2916	243	12	role	role	NOUN
iajs-2916	243	13	in	in	ADP
iajs-2916	243	14	the	the	DET
iajs-2916	243	15	pathogenesis	pathogenesis	NOUN
iajs-2916	243	16	of	of	ADP
iajs-2916	243	17	cardiovascular	cardiovascular	ADJ
iajs-2916	243	18	disease	disease	NOUN
iajs-2916	243	19	.	.	PUNCT
iajs-2916	244	1	mol	mol	PROPN
iajs-2916	244	2	.	.	PROPN
iajs-2916	244	3	cell	cell	NOUN
iajs-2916	244	4	.	.	PUNCT
iajs-2916	245	1	biochem	biochem	PROPN
iajs-2916	245	2	.	.	PUNCT
iajs-2916	246	1	2018	2018	NUM
iajs-2916	246	2	,	,	PUNCT
iajs-2916	246	3	440	440	NUM
iajs-2916	246	4	,	,	PUNCT
iajs-2916	246	5	167	167	NUM
iajs-2916	246	6	-	-	SYM
iajs-2916	246	7	87	87	NUM
iajs-2916	246	8	.	.	PUNCT
iajs-2916	247	1	24	24	NUM
iajs-2916	247	2	.	.	PUNCT
iajs-2916	247	3	temple	temple	PROPN
iajs-2916	247	4	,	,	PUNCT
iajs-2916	247	5	r.	r.	PROPN
iajs-2916	247	6	;	;	PUNCT
iajs-2916	247	7	luzio	luzio	PROPN
iajs-2916	247	8	,	,	PUNCT
iajs-2916	247	9	s.	s.	PROPN
iajs-2916	247	10	;	;	PUNCT
iajs-2916	247	11	schneider	schneider	PROPN
iajs-2916	247	12	,	,	PUNCT
iajs-2916	247	13	a.	a.	PROPN
iajs-2916	247	14	;	;	PUNCT
iajs-2916	247	15	carrington	carrington	PROPN
iajs-2916	247	16	,	,	PUNCT
iajs-2916	247	17	c.	c.	PROPN
iajs-2916	247	18	;	;	PUNCT
iajs-2916	247	19	owens	owens	PROPN
iajs-2916	247	20	,	,	PUNCT
iajs-2916	247	21	d.	d.	PROPN
iajs-2916	247	22	;	;	PUNCT
iajs-2916	247	23	sobey	sobey	PROPN
iajs-2916	247	24	,	,	PUNCT
iajs-2916	247	25	w.	w.	PROPN
iajs-2916	247	26	;	;	PUNCT
iajs-2916	247	27	hales	hales	PROPN
iajs-2916	247	28	,	,	PUNCT
iajs-2916	247	29	cn	cn	PROPN
iajs-2916	247	30	.	.	PUNCT
iajs-2916	247	31	insulin	insulin	NOUN
iajs-2916	247	32	deficiency	deficiency	NOUN
iajs-2916	247	33	in	in	ADP
iajs-2916	247	34	non	non	ADJ
iajs-2916	247	35	-	-	ADJ
iajs-2916	247	36	insulin	insulin	ADJ
iajs-2916	247	37	-	-	PUNCT
iajs-2916	247	38	dependent	dependent	ADJ
iajs-2916	247	39	diabetes	diabetes	NOUN
iajs-2916	247	40	.	.	PUNCT
iajs-2916	248	1	the	the	DET
iajs-2916	248	2	lancet	lancet	PROPN
iajs-2916	248	3	.	.	PUNCT
iajs-2916	249	1	1989	1989	NUM
iajs-2916	249	2	,	,	PUNCT
iajs-2916	249	3	333	333	NUM
iajs-2916	249	4	,	,	PUNCT
iajs-2916	249	5	293	293	NUM
iajs-2916	249	6	-	-	SYM
iajs-2916	249	7	5	5	NUM
iajs-2916	249	8	.	.	NUM
iajs-2916	249	9	25	25	NUM
iajs-2916	249	10	.	.	PUNCT
iajs-2916	250	1	weyer	weyer	PROPN
iajs-2916	250	2	,	,	PUNCT
iajs-2916	250	3	c.	c.	PROPN
iajs-2916	250	4	;	;	PUNCT
iajs-2916	250	5	bogardus	bogardus	PROPN
iajs-2916	250	6	,	,	PUNCT
iajs-2916	250	7	c.	c.	PROPN
iajs-2916	250	8	;	;	PUNCT
iajs-2916	250	9	mott	mott	PROPN
iajs-2916	250	10	,	,	PUNCT
iajs-2916	250	11	dm	dm	PROPN
iajs-2916	250	12	.	.	PUNCT
iajs-2916	250	13	;	;	PUNCT
iajs-2916	250	14	pratley	pratley	PROPN
iajs-2916	250	15	,	,	PUNCT
iajs-2916	250	16	r.e	r.e	PROPN
iajs-2916	250	17	.	.	PROPN
iajs-2916	251	1	the	the	DET
iajs-2916	251	2	natural	natural	ADJ
iajs-2916	251	3	history	history	NOUN
iajs-2916	251	4	of	of	ADP
iajs-2916	251	5	insulin	insulin	NOUN
iajs-2916	251	6	secretory	secretory	ADJ
iajs-2916	251	7	dysfunction	dysfunction	NOUN
iajs-2916	251	8	and	and	CCONJ
iajs-2916	251	9	insulin	insulin	NOUN
iajs-2916	251	10	resistance	resistance	NOUN
iajs-2916	251	11	in	in	ADP
iajs-2916	251	12	the	the	DET
iajs-2916	251	13	pathogenesis	pathogenesis	NOUN
iajs-2916	251	14	of	of	ADP
iajs-2916	251	15	type	type	NOUN
iajs-2916	251	16	2	2	NUM
iajs-2916	251	17	diabetes	diabetes	NOUN
iajs-2916	251	18	mellitus	mellitus	NOUN
iajs-2916	251	19	.	.	PUNCT
iajs-2916	252	1	j.	j.	PROPN
iajs-2916	252	2	clin	clin	PROPN
iajs-2916	252	3	.	.	PUNCT
iajs-2916	253	1	investig	investig	PROPN
iajs-2916	253	2	.	.	PROPN
iajs-2916	253	3	1999	1999	NUM
iajs-2916	253	4	,	,	PUNCT
iajs-2916	253	5	104	104	NUM
iajs-2916	253	6	,	,	PUNCT
iajs-2916	253	7	787	787	NUM
iajs-2916	253	8	-	-	SYM
iajs-2916	253	9	94	94	NUM
iajs-2916	253	10	.	.	PUNCT
iajs-2916	254	1	26	26	NUM
iajs-2916	254	2	.	.	PUNCT
iajs-2916	255	1	nolan	nolan	PROPN
iajs-2916	255	2	,	,	PUNCT
iajs-2916	255	3	cj	cj	PROPN
iajs-2916	255	4	.	.	PUNCT
iajs-2916	255	5	;	;	PUNCT
iajs-2916	255	6	madiraju	madiraju	PROPN
iajs-2916	255	7	,	,	PUNCT
iajs-2916	255	8	ms	ms	PROPN
iajs-2916	255	9	.	.	PROPN
iajs-2916	255	10	;	;	PUNCT
iajs-2916	255	11	delghingaro	delghingaro	NOUN
iajs-2916	255	12	-	-	PUNCT
iajs-2916	255	13	augusto	augusto	NOUN
iajs-2916	255	14	,	,	PUNCT
iajs-2916	255	15	v.	v.	ADP
iajs-2916	255	16	;	;	PUNCT
iajs-2916	255	17	peyot	peyot	NOUN
iajs-2916	255	18	,	,	PUNCT
iajs-2916	255	19	ml	ml	X
iajs-2916	255	20	.	.	PUNCT
iajs-2916	255	21	;	;	PUNCT
iajs-2916	255	22	prentki	prentki	NOUN
iajs-2916	255	23	,	,	PUNCT
iajs-2916	255	24	m.	m.	NOUN
iajs-2916	255	25	fatty	fatty	NOUN
iajs-2916	255	26	acid	acid	NOUN
iajs-2916	255	27	signaling	signal	VERB
iajs-2916	255	28	in	in	ADP
iajs-2916	255	29	the	the	DET
iajs-2916	255	30	β	β	NOUN
iajs-2916	255	31	-	-	NOUN
iajs-2916	255	32	cell	cell	NOUN
iajs-2916	255	33	and	and	CCONJ
iajs-2916	255	34	insulin	insulin	NOUN
iajs-2916	255	35	secretion	secretion	NOUN
iajs-2916	255	36	.	.	PUNCT
iajs-2916	256	1	diabetes	diabetes	NOUN
iajs-2916	256	2	.	.	PUNCT
iajs-2916	257	1	2006	2006	NUM
iajs-2916	257	2	,	,	PUNCT
iajs-2916	257	3	55	55	NUM
iajs-2916	257	4	,	,	PUNCT
iajs-2916	257	5	s16	s16	NOUN
iajs-2916	257	6	-	-	PUNCT
iajs-2916	257	7	23	23	NUM
iajs-2916	257	8	.	.	PUNCT
iajs-2916	258	1	27	27	NUM
iajs-2916	258	2	.	.	PUNCT
iajs-2916	259	1	el	el	NOUN
iajs-2916	259	2	-	-	PUNCT
iajs-2916	259	3	assaad	assaad	PROPN
iajs-2916	259	4	,	,	PUNCT
iajs-2916	259	5	w.	w.	PROPN
iajs-2916	259	6	;	;	PUNCT
iajs-2916	259	7	buteau	buteau	PROPN
iajs-2916	259	8	,	,	PUNCT
iajs-2916	259	9	j.	j.	PROPN
iajs-2916	259	10	;	;	PUNCT
iajs-2916	259	11	peyot	peyot	NOUN
iajs-2916	259	12	,	,	PUNCT
iajs-2916	259	13	ml	ml	X
iajs-2916	259	14	.	.	PUNCT
iajs-2916	259	15	;	;	PUNCT
iajs-2916	259	16	nolan	nolan	PROPN
iajs-2916	259	17	,	,	PUNCT
iajs-2916	259	18	c.	c.	PROPN
iajs-2916	259	19	;	;	PUNCT
iajs-2916	259	20	roduit	roduit	PROPN
iajs-2916	259	21	,	,	PUNCT
iajs-2916	259	22	r.	r.	PROPN
iajs-2916	259	23	;	;	PUNCT
iajs-2916	259	24	hardy	hardy	ADJ
iajs-2916	259	25	,	,	PUNCT
iajs-2916	259	26	s.	s.	PROPN
iajs-2916	259	27	;	;	PUNCT
iajs-2916	259	28	joly	joly	PROPN
iajs-2916	259	29	,	,	PUNCT
iajs-2916	259	30	e.	e.	PROPN
iajs-2916	259	31	;	;	PUNCT
iajs-2916	259	32	dbaibo	dbaibo	ADJ
iajs-2916	259	33	,	,	PUNCT
iajs-2916	259	34	g.	g.	PROPN
iajs-2916	259	35	;	;	PUNCT
iajs-2916	260	1	rosenberg	rosenberg	PROPN
iajs-2916	260	2	,	,	PUNCT
iajs-2916	260	3	l.	l.	PROPN
iajs-2916	260	4	;	;	PUNCT
iajs-2916	260	5	prentki	prentki	PROPN
iajs-2916	260	6	,	,	PUNCT
iajs-2916	260	7	m.	m.	NOUN
iajs-2916	260	8	saturated	saturate	VERB
iajs-2916	260	9	fatty	fatty	NOUN
iajs-2916	260	10	acids	acid	NOUN
iajs-2916	260	11	synergize	synergize	VERB
iajs-2916	260	12	with	with	ADP
iajs-2916	260	13	elevated	elevated	ADJ
iajs-2916	260	14	glucose	glucose	NOUN
iajs-2916	260	15	to	to	PART
iajs-2916	260	16	cause	cause	VERB
iajs-2916	260	17	pancreatic	pancreatic	ADJ
iajs-2916	260	18	β	β	NOUN
iajs-2916	260	19	-	-	NOUN
iajs-2916	260	20	cell	cell	NOUN
iajs-2916	260	21	death	death	NOUN
iajs-2916	260	22	.	.	PUNCT
iajs-2916	261	1	endocrinol	endocrinol	NOUN
iajs-2916	261	2	.	.	PUNCT
iajs-2916	262	1	2003	2003	NUM
iajs-2916	262	2	,	,	PUNCT
iajs-2916	262	3	144	144	NUM
iajs-2916	262	4	,	,	PUNCT
iajs-2916	262	5	4154	4154	NUM
iajs-2916	262	6	-	-	SYM
iajs-2916	262	7	63	63	NUM
iajs-2916	262	8	.	.	PUNCT
iajs-2916	263	1	28	28	NUM
iajs-2916	263	2	.	.	PUNCT
iajs-2916	264	1	hu	hu	PROPN
iajs-2916	264	2	,	,	PUNCT
iajs-2916	264	3	y.	y.	PROPN
iajs-2916	264	4	;	;	PUNCT
iajs-2916	264	5	liu	liu	PROPN
iajs-2916	264	6	,	,	PUNCT
iajs-2916	264	7	j	j	PROPN
iajs-2916	264	8	,	,	PUNCT
iajs-2916	264	9	.	.	PUNCT
iajs-2916	264	10	;	;	PUNCT
iajs-2916	264	11	wang	wang	PROPN
iajs-2916	264	12	,	,	PUNCT
iajs-2916	264	13	g.	g.	PROPN
iajs-2916	264	14	,	,	PUNCT
iajs-2916	264	15	xu	xu	PROPN
iajs-2916	264	16	,	,	PUNCT
iajs-2916	264	17	y.	y.	NOUN
iajs-2916	264	18	the	the	DET
iajs-2916	264	19	effects	effect	NOUN
iajs-2916	264	20	of	of	ADP
iajs-2916	264	21	exenatide	exenatide	NOUN
iajs-2916	264	22	and	and	CCONJ
iajs-2916	264	23	metformin	metformin	NOUN
iajs-2916	264	24	on	on	ADP
iajs-2916	264	25	endothelial	endothelial	ADJ
iajs-2916	264	26	function	function	NOUN
iajs-2916	264	27	in	in	ADP
iajs-2916	264	28	newly	newly	ADV
iajs-2916	264	29	diagnosed	diagnose	VERB
iajs-2916	264	30	type	type	NOUN
iajs-2916	264	31	2	2	NUM
iajs-2916	264	32	diabetes	diabetes	NOUN
iajs-2916	264	33	mellitus	mellitus	NOUN
iajs-2916	264	34	patients	patient	NOUN
iajs-2916	264	35	:	:	PUNCT
iajs-2916	264	36	a	a	DET
iajs-2916	264	37	case	case	NOUN
iajs-2916	264	38	–	–	PUNCT
iajs-2916	264	39	control	control	NOUN
iajs-2916	264	40	study	study	NOUN
iajs-2916	264	41	.	.	PUNCT
iajs-2916	265	1	diabetes	diabetes	NOUN
iajs-2916	265	2	ther	ther	ADV
iajs-2916	265	3	.	.	PUNCT
iajs-2916	266	1	2018	2018	NUM
iajs-2916	266	2	,	,	PUNCT
iajs-2916	266	3	9	9	NUM
iajs-2916	266	4	,	,	PUNCT
iajs-2916	266	5	1295	1295	NUM
iajs-2916	266	6	-	-	SYM
iajs-2916	266	7	305	305	NUM
iajs-2916	266	8	.	.	PUNCT
iajs-2916	267	1	29	29	NUM
iajs-2916	267	2	.	.	PUNCT
iajs-2916	268	1	bermudez	bermudez	PROPN
iajs-2916	268	2	-	-	PUNCT
iajs-2916	268	3	pirela	pirela	PROPN
iajs-2916	268	4	,	,	PUNCT
iajs-2916	268	5	vj	vj	PROPN
iajs-2916	268	6	.	.	PROPN
iajs-2916	268	7	;	;	PUNCT
iajs-2916	268	8	cano	cano	PROPN
iajs-2916	268	9	,	,	PUNCT
iajs-2916	268	10	c.	c.	PROPN
iajs-2916	268	11	;	;	PUNCT
iajs-2916	268	12	medina	medina	PROPN
iajs-2916	268	13	,	,	PUNCT
iajs-2916	268	14	mt	mt	PROPN
iajs-2916	268	15	.	.	PROPN
iajs-2916	268	16	;	;	PUNCT
iajs-2916	268	17	souki	souki	PROPN
iajs-2916	268	18	,	,	PUNCT
iajs-2916	268	19	a.	a.	NOUN
iajs-2916	268	20	;	;	PUNCT
iajs-2916	268	21	lemus	lemus	PROPN
iajs-2916	268	22	,	,	PUNCT
iajs-2916	268	23	ma	ma	PROPN
iajs-2916	268	24	.	.	PROPN
iajs-2916	268	25	;	;	PUNCT
iajs-2916	268	26	leal	leal	PROPN
iajs-2916	268	27	,	,	PUNCT
iajs-2916	268	28	em	em	PRON
iajs-2916	268	29	.	.	PUNCT
iajs-2916	268	30	;	;	PUNCT
iajs-2916	268	31	seyfi	seyfi	PROPN
iajs-2916	268	32	,	,	PUNCT
iajs-2916	268	33	ha	ha	INTJ
iajs-2916	268	34	.	.	PUNCT
iajs-2916	268	35	;	;	PUNCT
iajs-2916	268	36	cano	cano	PROPN
iajs-2916	268	37	,	,	PUNCT
iajs-2916	268	38	r.	r.	PROPN
iajs-2916	268	39	;	;	PUNCT
iajs-2916	268	40	ciscek	ciscek	PROPN
iajs-2916	268	41	,	,	PUNCT
iajs-2916	268	42	a.	a.	NOUN
iajs-2916	268	43	;	;	PUNCT
iajs-2916	268	44	bermúdez	bermúdez	NOUN
iajs-2916	268	45	-	-	PUNCT
iajs-2916	268	46	arias	aria	NOUN
iajs-2916	268	47	,	,	PUNCT
iajs-2916	268	48	f.	f.	PROPN
iajs-2916	268	49	;	;	PUNCT
iajs-2916	268	50	contreras	contreras	PROPN
iajs-2916	268	51	,	,	PUNCT
iajs-2916	268	52	f.	f.	PROPN
iajs-2916	268	53	metformin	metformin	PROPN
iajs-2916	268	54	plus	plus	CCONJ
iajs-2916	268	55	low	low	ADV
iajs-2916	268	56	-	-	PUNCT
iajs-2916	268	57	dose	dose	NOUN
iajs-2916	268	58	glimeperide	glimeperide	NOUN
iajs-2916	268	59	significantly	significantly	ADV
iajs-2916	268	60	improves	improve	VERB
iajs-2916	268	61	homeostasis	homeostasis	NOUN
iajs-2916	268	62	model	model	NOUN
iajs-2916	268	63	assessment	assessment	NOUN
iajs-2916	268	64	for	for	ADP
iajs-2916	268	65	insulin	insulin	NOUN
iajs-2916	268	66	resistance	resistance	NOUN
iajs-2916	268	67	ihjpas	ihjpa	VERB
iajs-2916	268	68	.	.	PUNCT
iajs-2916	269	1	53	53	NUM
iajs-2916	269	2	(	(	PUNCT
iajs-2916	269	3	4)2022	4)2022	NOUN
iajs-2916	269	4	204	204	NUM
iajs-2916	269	5	(	(	PUNCT
iajs-2916	269	6	homair	homair	NOUN
iajs-2916	269	7	)	)	PUNCT
iajs-2916	269	8	and	and	CCONJ
iajs-2916	269	9	β	β	NOUN
iajs-2916	269	10	-	-	NOUN
iajs-2916	269	11	cell	cell	NOUN
iajs-2916	269	12	function	function	NOUN
iajs-2916	269	13	(	(	PUNCT
iajs-2916	269	14	homaβ	homaβ	ADJ
iajs-2916	269	15	-	-	PUNCT
iajs-2916	269	16	cell	cell	NOUN
iajs-2916	269	17	)	)	PUNCT
iajs-2916	269	18	without	without	ADP
iajs-2916	269	19	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-2916	269	20	in	in	ADP
iajs-2916	269	21	patients	patient	NOUN
iajs-2916	269	22	with	with	ADP
iajs-2916	269	23	type	type	NOUN
iajs-2916	269	24	2	2	NUM
iajs-2916	269	25	diabetes	diabetes	NOUN
iajs-2916	269	26	mellitus	mellitus	NOUN
iajs-2916	269	27	.	.	PUNCT
iajs-2916	270	1	am	be	AUX
iajs-2916	270	2	.	.	PUNCT
iajs-2916	271	1	j.	j.	PROPN
iajs-2916	271	2	ther	ther	PROPN
iajs-2916	271	3	.	.	PUNCT
iajs-2916	272	1	2007	2007	NUM
iajs-2916	272	2	,	,	PUNCT
iajs-2916	272	3	14	14	NUM
iajs-2916	272	4	,	,	PUNCT
iajs-2916	272	5	194	194	NUM
iajs-2916	272	6	-	-	SYM
iajs-2916	272	7	202	202	NUM
iajs-2916	272	8	.	.	PUNCT
iajs-2916	273	1	30	30	NUM
iajs-2916	273	2	.	.	PUNCT
iajs-2916	274	1	katsuki	katsuki	PROPN
iajs-2916	274	2	,	,	PUNCT
iajs-2916	274	3	a.	a.	NOUN
iajs-2916	274	4	;	;	PUNCT
iajs-2916	274	5	sumida	sumida	PROPN
iajs-2916	274	6	,	,	PUNCT
iajs-2916	274	7	y.	y.	PROPN
iajs-2916	274	8	;	;	PUNCT
iajs-2916	274	9	gabazza	gabazza	PROPN
iajs-2916	274	10	,	,	PUNCT
iajs-2916	274	11	ec	ec	PROPN
iajs-2916	274	12	.	.	PUNCT
iajs-2916	274	13	;	;	PUNCT
iajs-2916	275	1	murashima	murashima	PROPN
iajs-2916	275	2	,	,	PUNCT
iajs-2916	275	3	s.	s.	PROPN
iajs-2916	275	4	;	;	PUNCT
iajs-2916	275	5	furuta	furuta	PROPN
iajs-2916	275	6	,	,	PUNCT
iajs-2916	275	7	m.	m.	NOUN
iajs-2916	275	8	;	;	PUNCT
iajs-2916	275	9	araki	araki	PROPN
iajs-2916	275	10	-	-	PUNCT
iajs-2916	275	11	sasaki	sasaki	PROPN
iajs-2916	275	12	,	,	PUNCT
iajs-2916	275	13	r.	r.	PROPN
iajs-2916	275	14	;	;	PUNCT
iajs-2916	275	15	hori	hori	PROPN
iajs-2916	275	16	,	,	PUNCT
iajs-2916	275	17	y.	y.	PROPN
iajs-2916	275	18	;	;	PUNCT
iajs-2916	275	19	yano	yano	PROPN
iajs-2916	275	20	,	,	PUNCT
iajs-2916	275	21	y.	y.	PROPN
iajs-2916	275	22	;	;	PUNCT
iajs-2916	275	23	adachi	adachi	PROPN
iajs-2916	275	24	,	,	PUNCT
iajs-2916	275	25	y.	y.	NOUN
iajs-2916	275	26	homeostasis	homeostasis	NOUN
iajs-2916	275	27	model	model	NOUN
iajs-2916	275	28	assessment	assessment	NOUN
iajs-2916	275	29	is	be	AUX
iajs-2916	275	30	a	a	DET
iajs-2916	275	31	reliable	reliable	ADJ
iajs-2916	275	32	indicator	indicator	NOUN
iajs-2916	275	33	of	of	ADP
iajs-2916	275	34	insulin	insulin	NOUN
iajs-2916	275	35	resistance	resistance	NOUN
iajs-2916	275	36	during	during	ADP
iajs-2916	275	37	follow	follow	NOUN
iajs-2916	275	38	-	-	PUNCT
iajs-2916	275	39	up	up	NOUN
iajs-2916	275	40	of	of	ADP
iajs-2916	275	41	patients	patient	NOUN
iajs-2916	275	42	with	with	ADP
iajs-2916	275	43	type	type	NOUN
iajs-2916	275	44	2	2	NUM
iajs-2916	275	45	diabetes	diabetes	NOUN
iajs-2916	275	46	.	.	PUNCT
iajs-2916	276	1	diabetes	diabetes	NOUN
iajs-2916	276	2	care	care	NOUN
iajs-2916	276	3	.	.	PUNCT
iajs-2916	277	1	2001	2001	NUM
iajs-2916	277	2	,	,	PUNCT
iajs-2916	277	3	24	24	NUM
iajs-2916	277	4	,	,	PUNCT
iajs-2916	277	5	3625	3625	NUM
iajs-2916	277	6	.	.	PUNCT
iajs-2916	278	1	31	31	NUM
iajs-2916	278	2	.	.	PUNCT
iajs-2916	279	1	naghiaee	naghiaee	PROPN
iajs-2916	279	2	,	,	PUNCT
iajs-2916	279	3	y.	y.	PROPN
iajs-2916	279	4	;	;	PUNCT
iajs-2916	279	5	didehdar	didehdar	PROPN
iajs-2916	279	6	,	,	PUNCT
iajs-2916	279	7	r.	r.	PROPN
iajs-2916	279	8	;	;	PUNCT
iajs-2916	279	9	pourrajab	pourrajab	PROPN
iajs-2916	279	10	,	,	PUNCT
iajs-2916	279	11	f.	f.	PROPN
iajs-2916	279	12	;	;	PUNCT
iajs-2916	279	13	rahmanian	rahmanian	PROPN
iajs-2916	279	14	,	,	PUNCT
iajs-2916	279	15	m.	m.	NOUN
iajs-2916	279	16	;	;	PUNCT
iajs-2916	279	17	heiranizadeh	heiranizadeh	ADV
iajs-2916	279	18	,	,	PUNCT
iajs-2916	279	19	n.	n.	NOUN
iajs-2916	279	20	;	;	PUNCT
iajs-2916	279	21	mohiti	mohiti	PROPN
iajs-2916	279	22	,	,	PUNCT
iajs-2916	279	23	a.	a.	NOUN
iajs-2916	279	24	;	;	PUNCT
iajs-2916	279	25	mohiti	mohiti	NOUN
iajs-2916	279	26	-	-	PUNCT
iajs-2916	279	27	ardakani	ardakani	PROPN
iajs-2916	279	28	,	,	PUNCT
iajs-2916	279	29	j.	j.	PROPN
iajs-2916	279	30	metformin	metformin	PROPN
iajs-2916	279	31	downregulates	downregulate	VERB
iajs-2916	279	32	mir223	mir223	PROPN
iajs-2916	279	33	expression	expression	NOUN
iajs-2916	279	34	in	in	ADP
iajs-2916	279	35	insulin	insulin	NOUN
iajs-2916	279	36	-	-	PUNCT
iajs-2916	279	37	resistant	resistant	ADJ
iajs-2916	279	38	3t3l1	3t3l1	NUM
iajs-2916	279	39	cells	cell	NOUN
iajs-2916	279	40	and	and	CCONJ
iajs-2916	279	41	human	human	ADJ
iajs-2916	279	42	diabetic	diabetic	NOUN
iajs-2916	279	43	adipose	adipose	PRON
iajs-2916	279	44	tissue	tissue	NOUN
iajs-2916	279	45	.	.	PUNCT
iajs-2916	280	1	endocrine	endocrine	NOUN
iajs-2916	280	2	.	.	PUNCT
iajs-2916	281	1	2020	2020	NUM
iajs-2916	281	2	,	,	PUNCT
iajs-2916	281	3	70	70	NUM
iajs-2916	281	4	,	,	PUNCT
iajs-2916	281	5	498	498	NUM
iajs-2916	281	6	-	-	SYM
iajs-2916	281	7	508	508	NUM
iajs-2916	281	8	.	.	PUNCT
iajs-2916	282	1	32	32	NUM
iajs-2916	282	2	.	.	PUNCT
iajs-2916	282	3	adeva	adeva	VERB
iajs-2916	282	4	-	-	PUNCT
iajs-2916	282	5	andany	andany	ADJ
iajs-2916	282	6	,	,	PUNCT
iajs-2916	282	7	mm	mm	INTJ
iajs-2916	282	8	.	.	PUNCT
iajs-2916	282	9	;	;	PUNCT
iajs-2916	282	10	martínez	martínez	PROPN
iajs-2916	282	11	-	-	PUNCT
iajs-2916	282	12	rodríguez	rodríguez	PROPN
iajs-2916	282	13	,	,	PUNCT
iajs-2916	282	14	j.	j.	PROPN
iajs-2916	282	15	;	;	PUNCT
iajs-2916	282	16	gonzález	gonzález	PROPN
iajs-2916	282	17	-	-	PUNCT
iajs-2916	282	18	lucán	lucán	PROPN
iajs-2916	282	19	,	,	PUNCT
iajs-2916	282	20	m.	m.	NOUN
iajs-2916	282	21	;	;	PUNCT
iajs-2916	282	22	fernándezfernández	fernándezfernández	PROPN
iajs-2916	282	23	,	,	PUNCT
iajs-2916	282	24	c.	c.	PROPN
iajs-2916	282	25	;	;	PUNCT
iajs-2916	282	26	castro	castro	PROPN
iajs-2916	282	27	-	-	PUNCT
iajs-2916	282	28	quintela	quintela	PROPN
iajs-2916	282	29	,	,	PUNCT
iajs-2916	282	30	e.	e.	PROPN
iajs-2916	282	31	insulin	insulin	PROPN
iajs-2916	282	32	resistance	resistance	NOUN
iajs-2916	282	33	is	be	AUX
iajs-2916	282	34	a	a	DET
iajs-2916	282	35	cardiovascular	cardiovascular	ADJ
iajs-2916	282	36	risk	risk	NOUN
iajs-2916	282	37	factor	factor	NOUN
iajs-2916	282	38	in	in	ADP
iajs-2916	282	39	humans	human	NOUN
iajs-2916	282	40	.	.	PUNCT
iajs-2916	283	1	diabetes	diabete	VERB
iajs-2916	283	2	metab	metab	NOUN
iajs-2916	283	3	syndr	syndr	NOUN
iajs-2916	283	4	.	.	PUNCT
iajs-2916	284	1	2019	2019	NUM
iajs-2916	284	2	,	,	PUNCT
iajs-2916	284	3	13	13	NUM
iajs-2916	284	4	,	,	PUNCT
iajs-2916	284	5	1449	1449	NUM
iajs-2916	284	6	-	-	SYM
iajs-2916	284	7	55	55	NUM
iajs-2916	284	8	.	.	PUNCT
iajs-2916	285	1	33	33	NUM
iajs-2916	285	2	.	.	PUNCT
iajs-2916	286	1	giebułtowicz	giebułtowicz	PROPN
iajs-2916	286	2	,	,	PUNCT
iajs-2916	286	3	j.	j.	PROPN
iajs-2916	286	4	;	;	PUNCT
iajs-2916	286	5	sołobodowska	sołobodowska	PROPN
iajs-2916	286	6	,	,	PUNCT
iajs-2916	286	7	s.	s.	PROPN
iajs-2916	286	8	;	;	PUNCT
iajs-2916	286	9	bobilewicz	bobilewicz	NOUN
iajs-2916	286	10	,	,	PUNCT
iajs-2916	286	11	d.	d.	PROPN
iajs-2916	286	12	;	;	PUNCT
iajs-2916	286	13	wroczyński	wroczyński	ADJ
iajs-2916	286	14	,	,	PUNCT
iajs-2916	286	15	p.	p.	NOUN
iajs-2916	286	16	blood	blood	NOUN
iajs-2916	287	1	aldh1	aldh1	PROPN
iajs-2916	287	2	and	and	CCONJ
iajs-2916	287	3	gst	gst	NOUN
iajs-2916	287	4	activity	activity	NOUN
iajs-2916	287	5	in	in	ADP
iajs-2916	287	6	diabetes	diabetes	NOUN
iajs-2916	287	7	type	type	NOUN
iajs-2916	287	8	2	2	NUM
iajs-2916	287	9	and	and	CCONJ
iajs-2916	287	10	its	its	PRON
iajs-2916	287	11	correlation	correlation	NOUN
iajs-2916	287	12	with	with	ADP
iajs-2916	287	13	glycated	glycate	VERB
iajs-2916	287	14	hemoglobin	hemoglobin	NOUN
iajs-2916	287	15	.	.	PUNCT
iajs-2916	288	1	exp	exp	PROPN
iajs-2916	288	2	.	.	PUNCT
iajs-2916	289	1	clin	clin	PROPN
iajs-2916	289	2	.	.	PUNCT
iajs-2916	290	1	endocrinol	endocrinol	NOUN
iajs-2916	290	2	.	.	PUNCT
iajs-2916	291	1	diabetes	diabetes	NOUN
iajs-2916	291	2	.	.	PUNCT
iajs-2916	292	1	2014	2014	NUM
iajs-2916	292	2	,	,	PUNCT
iajs-2916	292	3	122	122	NUM
iajs-2916	292	4	,	,	PUNCT
iajs-2916	292	5	55	55	NUM
iajs-2916	292	6	-	-	SYM
iajs-2916	292	7	9	9	NUM
iajs-2916	292	8	.	.	NUM
iajs-2916	293	1	34	34	NUM
iajs-2916	293	2	.	.	PUNCT
iajs-2916	293	3	sharma	sharma	PROPN
iajs-2916	293	4	,	,	PUNCT
iajs-2916	293	5	m.	m.	NOUN
iajs-2916	293	6	;	;	PUNCT
iajs-2916	293	7	gupta	gupta	PROPN
iajs-2916	293	8	,	,	PUNCT
iajs-2916	293	9	s.	s.	PROPN
iajs-2916	293	10	;	;	PUNCT
iajs-2916	293	11	singh	singh	PROPN
iajs-2916	293	12	,	,	PUNCT
iajs-2916	293	13	k.	k.	PROPN
iajs-2916	293	14	;	;	PUNCT
iajs-2916	293	15	mehndiratta	mehndiratta	PROPN
iajs-2916	293	16	,	,	PUNCT
iajs-2916	293	17	m.	m.	NOUN
iajs-2916	293	18	;	;	PUNCT
iajs-2916	293	19	gautam	gautam	PROPN
iajs-2916	293	20	,	,	PUNCT
iajs-2916	293	21	a.	a.	NOUN
iajs-2916	293	22	;	;	PUNCT
iajs-2916	293	23	kalra	kalra	NOUN
iajs-2916	293	24	,	,	PUNCT
iajs-2916	293	25	op	op	NOUN
iajs-2916	293	26	.	.	PUNCT
iajs-2916	293	27	;	;	PUNCT
iajs-2916	293	28	shukla	shukla	NOUN
iajs-2916	293	29	,	,	PUNCT
iajs-2916	293	30	r.	r.	PROPN
iajs-2916	293	31	;	;	PUNCT
iajs-2916	293	32	gambhir	gambhir	PROPN
iajs-2916	293	33	,	,	PUNCT
iajs-2916	293	34	jk	jk	PROPN
iajs-2916	293	35	.	.	PROPN
iajs-2916	293	36	association	association	PROPN
iajs-2916	293	37	of	of	ADP
iajs-2916	293	38	glutathione	glutathione	NOUN
iajs-2916	293	39	-	-	PUNCT
iajs-2916	293	40	s	s	NOUN
iajs-2916	293	41	-	-	NOUN
iajs-2916	293	42	transferase	transferase	NOUN
iajs-2916	293	43	with	with	ADP
iajs-2916	293	44	patients	patient	NOUN
iajs-2916	293	45	of	of	ADP
iajs-2916	293	46	type	type	NOUN
iajs-2916	293	47	2	2	NUM
iajs-2916	293	48	diabetes	diabetes	NOUN
iajs-2916	293	49	mellitus	mellitus	NOUN
iajs-2916	293	50	with	with	ADP
iajs-2916	293	51	and	and	CCONJ
iajs-2916	293	52	without	without	ADP
iajs-2916	293	53	nephropathy	nephropathy	NOUN
iajs-2916	293	54	.	.	PUNCT
iajs-2916	294	1	diabetes	diabete	VERB
iajs-2916	294	2	metab	metab	ADJ
iajs-2916	294	3	syndr	syndr	NOUN
iajs-2916	294	4	.	.	PUNCT
iajs-2916	295	1	2016	2016	NUM
iajs-2916	295	2	,	,	PUNCT
iajs-2916	295	3	10	10	NUM
iajs-2916	295	4	,	,	PUNCT
iajs-2916	295	5	194	194	NUM
iajs-2916	295	6	-	-	SYM
iajs-2916	295	7	7	7	NUM
iajs-2916	295	8	.	.	NOUN
iajs-2916	295	9	35	35	NUM
iajs-2916	295	10	.	.	PUNCT
iajs-2916	296	1	sarkar	sarkar	PROPN
iajs-2916	296	2	,	,	PUNCT
iajs-2916	296	3	a.	a.	NOUN
iajs-2916	296	4	;	;	PUNCT
iajs-2916	296	5	dash	dash	NOUN
iajs-2916	296	6	,	,	PUNCT
iajs-2916	296	7	s.	s.	PROPN
iajs-2916	296	8	;	;	PUNCT
iajs-2916	296	9	barik	barik	NOUN
iajs-2916	296	10	,	,	PUNCT
iajs-2916	296	11	bk	bk	PROPN
iajs-2916	296	12	.	.	PUNCT
iajs-2916	296	13	;	;	PUNCT
iajs-2916	296	14	muttigi	muttigi	PROPN
iajs-2916	296	15	,	,	PUNCT
iajs-2916	296	16	ms	ms	PROPN
iajs-2916	296	17	.	.	PROPN
iajs-2916	296	18	;	;	PUNCT
iajs-2916	297	1	kedage	kedage	NOUN
iajs-2916	297	2	,	,	PUNCT
iajs-2916	297	3	v.	v.	PROPN
iajs-2916	297	4	;	;	PUNCT
iajs-2916	297	5	shetty	shetty	PROPN
iajs-2916	297	6	,	,	PUNCT
iajs-2916	297	7	jk	jk	PROPN
iajs-2916	297	8	.	.	PROPN
iajs-2916	297	9	;	;	PUNCT
iajs-2916	297	10	prakash	prakash	PROPN
iajs-2916	297	11	,	,	PUNCT
iajs-2916	297	12	m.	m.	NOUN
iajs-2916	297	13	copper	copper	PROPN
iajs-2916	297	14	and	and	CCONJ
iajs-2916	297	15	ceruloplasmin	ceruloplasmin	NOUN
iajs-2916	297	16	levels	level	NOUN
iajs-2916	297	17	in	in	ADP
iajs-2916	297	18	relation	relation	NOUN
iajs-2916	297	19	to	to	ADP
iajs-2916	297	20	total	total	ADJ
iajs-2916	297	21	thiols	thiol	NOUN
iajs-2916	297	22	and	and	CCONJ
iajs-2916	297	23	gst	gst	NOUN
iajs-2916	297	24	in	in	ADP
iajs-2916	297	25	type	type	NOUN
iajs-2916	297	26	2	2	NUM
iajs-2916	297	27	diabetes	diabetes	NOUN
iajs-2916	297	28	mellitus	mellitus	NOUN
iajs-2916	297	29	patients	patient	NOUN
iajs-2916	297	30	.	.	PUNCT
iajs-2916	298	1	indian	indian	PROPN
iajs-2916	298	2	j	j	PROPN
iajs-2916	298	3	clin	clin	PROPN
iajs-2916	298	4	biochem	biochem	PROPN
iajs-2916	298	5	.	.	PUNCT
iajs-2916	299	1	2010	2010	NUM
iajs-2916	299	2	,	,	PUNCT
iajs-2916	299	3	25	25	NUM
iajs-2916	299	4	,	,	PUNCT
iajs-2916	299	5	74	74	NUM
iajs-2916	299	6	-	-	SYM
iajs-2916	299	7	6	6	NUM
iajs-2916	299	8	.	.	NUM
iajs-2916	299	9	36	36	NUM
iajs-2916	299	10	.	.	PUNCT
iajs-2916	300	1	babizhayev	babizhayev	PROPN
iajs-2916	300	2	,	,	PUNCT
iajs-2916	300	3	ma	ma	PROPN
iajs-2916	300	4	.	.	PROPN
iajs-2916	300	5	;	;	PUNCT
iajs-2916	300	6	strokov	strokov	PROPN
iajs-2916	300	7	,	,	PUNCT
iajs-2916	300	8	ia	ia	PROPN
iajs-2916	300	9	.	.	PROPN
iajs-2916	300	10	;	;	PUNCT
iajs-2916	300	11	nosikov	nosikov	NOUN
iajs-2916	300	12	,	,	PUNCT
iajs-2916	300	13	vv	vv	PROPN
iajs-2916	300	14	.	.	PUNCT
iajs-2916	300	15	;	;	PUNCT
iajs-2916	300	16	savel’yeva	savel’yeva	X
iajs-2916	300	17	,	,	PUNCT
iajs-2916	300	18	el	el	PROPN
iajs-2916	300	19	.	.	PROPN
iajs-2916	300	20	;	;	PUNCT
iajs-2916	300	21	sitnikov	sitnikov	PROPN
iajs-2916	300	22	,	,	PUNCT
iajs-2916	300	23	vf	vf	X
iajs-2916	300	24	.	.	PROPN
iajs-2916	300	25	;	;	PUNCT
iajs-2916	300	26	yegorov	yegorov	PROPN
iajs-2916	300	27	,	,	PUNCT
iajs-2916	300	28	ye	ye	PROPN
iajs-2916	300	29	.	.	PROPN
iajs-2916	300	30	;	;	PUNCT
iajs-2916	300	31	lankin	lankin	PROPN
iajs-2916	300	32	,	,	PUNCT
iajs-2916	300	33	vz	vz	PROPN
iajs-2916	300	34	.	.	PUNCT
iajs-2916	301	1	the	the	DET
iajs-2916	301	2	role	role	NOUN
iajs-2916	301	3	of	of	ADP
iajs-2916	301	4	oxidative	oxidative	ADJ
iajs-2916	301	5	stress	stress	NOUN
iajs-2916	301	6	in	in	ADP
iajs-2916	301	7	diabetic	diabetic	ADJ
iajs-2916	301	8	neuropathy	neuropathy	ADJ
iajs-2916	301	9	:	:	PUNCT
iajs-2916	301	10	generation	generation	NOUN
iajs-2916	301	11	of	of	ADP
iajs-2916	301	12	free	free	ADJ
iajs-2916	301	13	radical	radical	ADJ
iajs-2916	301	14	species	specie	NOUN
iajs-2916	301	15	in	in	ADP
iajs-2916	301	16	the	the	DET
iajs-2916	301	17	glycation	glycation	NOUN
iajs-2916	301	18	reaction	reaction	NOUN
iajs-2916	301	19	and	and	CCONJ
iajs-2916	301	20	gene	gene	NOUN
iajs-2916	301	21	polymorphisms	polymorphism	NOUN
iajs-2916	301	22	encoding	encode	VERB
iajs-2916	301	23	antioxidant	antioxidant	ADJ
iajs-2916	301	24	enzymes	enzyme	NOUN
iajs-2916	301	25	to	to	ADP
iajs-2916	301	26	genetic	genetic	ADJ
iajs-2916	301	27	susceptibility	susceptibility	NOUN
iajs-2916	301	28	to	to	PART
iajs-2916	301	29	diabetic	diabetic	VERB
iajs-2916	301	30	neuropathy	neuropathy	ADJ
iajs-2916	301	31	in	in	ADP
iajs-2916	301	32	population	population	NOUN
iajs-2916	301	33	of	of	ADP
iajs-2916	301	34	type	type	NOUN
iajs-2916	301	35	i	i	PRON
iajs-2916	301	36	diabetic	diabetic	ADJ
iajs-2916	301	37	patients	patient	NOUN
iajs-2916	301	38	.	.	PUNCT
iajs-2916	302	1	cell	cell	NOUN
iajs-2916	302	2	biochem	biochem	PROPN
iajs-2916	302	3	.	.	PUNCT
iajs-2916	303	1	biophys	biophy	NOUN
iajs-2916	303	2	.	.	PUNCT
iajs-2916	304	1	2015	2015	NUM
iajs-2916	304	2	,	,	PUNCT
iajs-2916	304	3	71	71	NUM
iajs-2916	304	4	,	,	PUNCT
iajs-2916	304	5	1425	1425	NUM
iajs-2916	304	6	-	-	SYM
iajs-2916	304	7	43	43	NUM
iajs-2916	304	8	.	.	PUNCT
iajs-2916	305	1	37	37	NUM
iajs-2916	305	2	.	.	PUNCT
iajs-2916	306	1	hashemi	hashemi	PROPN
iajs-2916	306	2	-	-	PUNCT
iajs-2916	306	3	soteh	soteh	PROPN
iajs-2916	306	4	,	,	PUNCT
iajs-2916	306	5	mb	mb	PROPN
iajs-2916	306	6	.	.	PROPN
iajs-2916	306	7	,	,	PUNCT
iajs-2916	306	8	ahmadzadeh	ahmadzadeh	PROPN
iajs-2916	306	9	amiri	amiri	PROPN
iajs-2916	306	10	,	,	PUNCT
iajs-2916	306	11	a.	a.	NOUN
iajs-2916	306	12	;	;	PUNCT
iajs-2916	306	13	sheikh	sheikh	PROPN
iajs-2916	306	14	rezaee	rezaee	PROPN
iajs-2916	306	15	mr	mr	PROPN
iajs-2916	306	16	,	,	PUNCT
iajs-2916	306	17	ahmadzadeh	ahmadzadeh	PROPN
iajs-2916	306	18	amiri	amiri	PROPN
iajs-2916	306	19	a	a	PRON
iajs-2916	306	20	,	,	PUNCT
iajs-2916	306	21	ahrari	ahrari	ADJ
iajs-2916	306	22	r	r	NOUN
iajs-2916	306	23	,	,	PUNCT
iajs-2916	306	24	ahmadzadeh	ahmadzadeh	X
iajs-2916	306	25	amiri	amiri	PROPN
iajs-2916	306	26	a	a	PRON
iajs-2916	306	27	,	,	PUNCT
iajs-2916	306	28	daneshvar	daneshvar	NOUN
iajs-2916	306	29	f.	f.	PROPN
iajs-2916	306	30	evaluation	evaluation	NOUN
iajs-2916	306	31	of	of	ADP
iajs-2916	306	32	glutathione	glutathione	NOUN
iajs-2916	306	33	s	s	NOUN
iajs-2916	306	34	-	-	PUNCT
iajs-2916	306	35	transferase	transferase	NOUN
iajs-2916	306	36	polymorphism	polymorphism	NOUN
iajs-2916	306	37	in	in	ADP
iajs-2916	306	38	iranian	iranian	ADJ
iajs-2916	306	39	patients	patient	NOUN
iajs-2916	306	40	with	with	ADP
iajs-2916	306	41	type	type	NOUN
iajs-2916	306	42	2	2	NUM
iajs-2916	306	43	diabetic	diabetic	NOUN
iajs-2916	306	44	microangiopathy	microangiopathy	PROPN
iajs-2916	306	45	.	.	PUNCT
iajs-2916	307	1	egypt	egypt	PROPN
iajs-2916	307	2	.	.	PUNCT
iajs-2916	308	1	j.	j.	PROPN
iajs-2916	308	2	med	med	PROPN
iajs-2916	308	3	.	.	PUNCT
iajs-2916	308	4	hum	hum	PROPN
iajs-2916	308	5	.	.	PUNCT
iajs-2916	309	1	genet	genet	NOUN
iajs-2916	309	2	.	.	PUNCT
iajs-2916	310	1	2020	2020	NUM
iajs-2916	310	2	,	,	PUNCT
iajs-2916	310	3	21	21	NUM
iajs-2916	310	4	,	,	PUNCT
iajs-2916	310	5	1	1	NUM
iajs-2916	310	6	-	-	SYM
iajs-2916	310	7	8	8	NUM
iajs-2916	310	8	.	.	PUNCT
iajs-2916	310	9	38	38	NUM
iajs-2916	310	10	.	.	PUNCT
iajs-2916	311	1	moller	moller	PROPN
iajs-2916	311	2	,	,	PUNCT
iajs-2916	311	3	d.e	d.e	PROPN
iajs-2916	311	4	.	.	PROPN
iajs-2916	311	5	;	;	PUNCT
iajs-2916	311	6	flier	flier	NOUN
iajs-2916	311	7	,	,	PUNCT
iajs-2916	311	8	js	js	PROPN
iajs-2916	311	9	.	.	PUNCT
iajs-2916	312	1	insulin	insulin	NOUN
iajs-2916	312	2	resistance	resistance	NOUN
iajs-2916	312	3	—	—	PUNCT
iajs-2916	312	4	mechanisms	mechanism	NOUN
iajs-2916	312	5	,	,	PUNCT
iajs-2916	312	6	syndromes	syndrome	NOUN
iajs-2916	312	7	,	,	PUNCT
iajs-2916	312	8	and	and	CCONJ
iajs-2916	312	9	implications	implication	NOUN
iajs-2916	312	10	.	.	PUNCT
iajs-2916	313	1	n.	n.	PROPN
iajs-2916	313	2	engl	engl	PROPN
iajs-2916	313	3	.	.	PUNCT
iajs-2916	314	1	j.	j.	PROPN
iajs-2916	314	2	med	med	PROPN
iajs-2916	314	3	.	.	PROPN
iajs-2916	314	4	1991	1991	NUM
iajs-2916	314	5	,	,	PUNCT
iajs-2916	314	6	325	325	NUM
iajs-2916	314	7	,	,	PUNCT
iajs-2916	314	8	938	938	NUM
iajs-2916	314	9	-	-	SYM
iajs-2916	314	10	48	48	NUM
iajs-2916	314	11	.	.	PUNCT
iajs-2916	314	12	39	39	NUM
iajs-2916	314	13	.	.	PUNCT
iajs-2916	315	1	waldman	waldman	PROPN
iajs-2916	315	2	,	,	PUNCT
iajs-2916	315	3	b.	b.	PROPN
iajs-2916	315	4	;	;	PUNCT
iajs-2916	315	5	jenkins	jenkins	PROPN
iajs-2916	315	6	,	,	PUNCT
iajs-2916	315	7	aj	aj	PROPN
iajs-2916	315	8	.	.	PROPN
iajs-2916	315	9	;	;	PUNCT
iajs-2916	315	10	davis	davis	PROPN
iajs-2916	315	11	,	,	PUNCT
iajs-2916	315	12	tm	tm	PROPN
iajs-2916	315	13	.	.	PROPN
iajs-2916	315	14	;	;	PUNCT
iajs-2916	315	15	taskinen	taskinen	PROPN
iajs-2916	315	16	,	,	PUNCT
iajs-2916	315	17	mr	mr	PROPN
iajs-2916	315	18	.	.	PROPN
iajs-2916	315	19	;	;	PUNCT
iajs-2916	315	20	scott	scott	PROPN
iajs-2916	315	21	,	,	PUNCT
iajs-2916	315	22	r.	r.	PROPN
iajs-2916	315	23	;	;	PUNCT
iajs-2916	315	24	o’connell	o’connell	INTJ
iajs-2916	315	25	,	,	PUNCT
iajs-2916	315	26	rl	rl	PROPN
iajs-2916	315	27	.	.	PUNCT
iajs-2916	315	28	;	;	PUNCT
iajs-2916	315	29	gebski	gebski	PROPN
iajs-2916	315	30	,	,	PUNCT
iajs-2916	315	31	vj	vj	PROPN
iajs-2916	315	32	.	.	PROPN
iajs-2916	315	33	;	;	PUNCT
iajs-2916	315	34	ng	ng	PROPN
iajs-2916	315	35	mk	mk	PROPN
iajs-2916	315	36	,	,	PUNCT
iajs-2916	315	37	keech	keech	PROPN
iajs-2916	315	38	,	,	PUNCT
iajs-2916	315	39	ac	ac	PROPN
iajs-2916	315	40	.	.	PUNCT
iajs-2916	315	41	hdl	hdl	PROPN
iajs-2916	315	42	-	-	PUNCT
iajs-2916	315	43	c	c	PROPN
iajs-2916	315	44	and	and	CCONJ
iajs-2916	315	45	hdl	hdl	PROPN
iajs-2916	315	46	-	-	PUNCT
iajs-2916	315	47	c	c	NOUN
iajs-2916	315	48	/	/	SYM
iajs-2916	315	49	apoa	apoa	NOUN
iajs-2916	315	50	-	-	PUNCT
iajs-2916	315	51	i	i	PRON
iajs-2916	315	52	predict	predict	VERB
iajs-2916	315	53	long	long	ADJ
iajs-2916	315	54	-	-	PUNCT
iajs-2916	315	55	term	term	NOUN
iajs-2916	315	56	progression	progression	NOUN
iajs-2916	315	57	of	of	ADP
iajs-2916	315	58	glycemia	glycemia	NOUN
iajs-2916	315	59	in	in	ADP
iajs-2916	315	60	established	established	ADJ
iajs-2916	315	61	type	type	NOUN
iajs-2916	315	62	2	2	NUM
iajs-2916	315	63	diabetes	diabetes	NOUN
iajs-2916	315	64	.	.	PUNCT
iajs-2916	316	1	diabetes	diabetes	NOUN
iajs-2916	316	2	care	care	NOUN
iajs-2916	316	3	.	.	PUNCT
iajs-2916	317	1	2014	2014	NUM
iajs-2916	317	2	,	,	PUNCT
iajs-2916	317	3	37	37	NUM
iajs-2916	317	4	,	,	PUNCT
iajs-2916	317	5	2351	2351	NUM
iajs-2916	317	6	-	-	SYM
iajs-2916	317	7	8	8	NUM
iajs-2916	317	8	.	.	NUM
iajs-2916	317	9	40	40	NUM
iajs-2916	317	10	.	.	PUNCT
iajs-2916	318	1	rutti	rutti	PROPN
iajs-2916	318	2	,	,	PUNCT
iajs-2916	318	3	s.	s.	PROPN
iajs-2916	318	4	;	;	PUNCT
iajs-2916	318	5	ehses	ehse	NOUN
iajs-2916	318	6	,	,	PUNCT
iajs-2916	318	7	ja	ja	PROPN
iajs-2916	318	8	.	.	PUNCT
iajs-2916	318	9	;	;	PUNCT
iajs-2916	318	10	sibler	sibler	NOUN
iajs-2916	318	11	,	,	PUNCT
iajs-2916	318	12	ra	ra	PROPN
iajs-2916	318	13	.	.	PUNCT
iajs-2916	318	14	;	;	PUNCT
iajs-2916	319	1	prazak	prazak	PROPN
iajs-2916	319	2	,	,	PUNCT
iajs-2916	319	3	r.	r.	PROPN
iajs-2916	319	4	;	;	PUNCT
iajs-2916	319	5	rohrer	rohrer	NOUN
iajs-2916	319	6	,	,	PUNCT
iajs-2916	319	7	l.	l.	PROPN
iajs-2916	319	8	;	;	PUNCT
iajs-2916	319	9	georgopoulos	georgopoulo	NOUN
iajs-2916	319	10	,	,	PUNCT
iajs-2916	319	11	s.	s.	PROPN
iajs-2916	319	12	;	;	PUNCT
iajs-2916	319	13	meier	meier	PROPN
iajs-2916	319	14	,	,	PUNCT
iajs-2916	319	15	dt	dt	PROPN
iajs-2916	319	16	.	.	PROPN
iajs-2916	319	17	,	,	PUNCT
iajs-2916	319	18	niclauss	niclauss	ADJ
iajs-2916	319	19	,	,	PUNCT
iajs-2916	319	20	n.	n.	NOUN
iajs-2916	319	21	;	;	PUNCT
iajs-2916	319	22	berney	berney	NOUN
iajs-2916	319	23	,	,	PUNCT
iajs-2916	319	24	t.	t.	PROPN
iajs-2916	319	25	;	;	PUNCT
iajs-2916	319	26	donath	donath	PROPN
iajs-2916	319	27	,	,	PUNCT
iajs-2916	319	28	my	my	PRON
iajs-2916	319	29	.	.	PUNCT
iajs-2916	319	30	;	;	PUNCT
iajs-2916	319	31	von	von	PROPN
iajs-2916	319	32	eckardstein	eckardstein	AUX
iajs-2916	319	33	,	,	PUNCT
iajs-2916	319	34	a.	a.	PROPN
iajs-2916	319	35	low	low	PROPN
iajs-2916	319	36	-	-	PUNCT
iajs-2916	319	37	and	and	CCONJ
iajs-2916	319	38	high	high	ADJ
iajs-2916	319	39	-	-	PUNCT
iajs-2916	319	40	density	density	NOUN
iajs-2916	319	41	lipoproteins	lipoprotein	NOUN
iajs-2916	319	42	modulate	modulate	VERB
iajs-2916	319	43	function	function	NOUN
iajs-2916	319	44	,	,	PUNCT
iajs-2916	319	45	apoptosis	apoptosis	NOUN
iajs-2916	319	46	,	,	PUNCT
iajs-2916	319	47	and	and	CCONJ
iajs-2916	319	48	proliferation	proliferation	NOUN
iajs-2916	319	49	of	of	ADP
iajs-2916	319	50	primary	primary	ADJ
iajs-2916	319	51	human	human	ADJ
iajs-2916	319	52	and	and	CCONJ
iajs-2916	319	53	murine	murine	ADJ
iajs-2916	319	54	pancreatic	pancreatic	ADJ
iajs-2916	319	55	β	β	NOUN
iajs-2916	319	56	-	-	NOUN
iajs-2916	319	57	cells	cell	NOUN
iajs-2916	319	58	.	.	PUNCT
iajs-2916	320	1	endocrinol	endocrinol	NOUN
iajs-2916	320	2	.	.	PUNCT
iajs-2916	321	1	2009	2009	NUM
iajs-2916	321	2	,	,	PUNCT
iajs-2916	321	3	150	150	NUM
iajs-2916	321	4	,	,	PUNCT
iajs-2916	321	5	4521	4521	NUM
iajs-2916	321	6	-	-	SYM
iajs-2916	321	7	30	30	NUM
iajs-2916	321	8	.	.	PUNCT
iajs-2916	322	1	41	41	NUM
iajs-2916	322	2	.	.	PUNCT
iajs-2916	323	1	brunham	brunham	VERB
iajs-2916	323	2	,	,	PUNCT
iajs-2916	323	3	 	 	SPACE
iajs-2916	323	4	lr	lr	PROPN
iajs-2916	323	5	.	.	PROPN
iajs-2916	323	6	;	;	PUNCT
iajs-2916	323	7	kruit	kruit	PROPN
iajs-2916	323	8	,	,	PUNCT
iajs-2916	323	9	 	 	SPACE
iajs-2916	323	10	jk	jk	PROPN
iajs-2916	323	11	.	.	PROPN
iajs-2916	323	12	;	;	PUNCT
iajs-2916	323	13	pape	pape	NOUN
iajs-2916	323	14	,	,	PUNCT
iajs-2916	323	15	 	 	SPACE
iajs-2916	323	16	td	td	NOUN
iajs-2916	323	17	.	.	PUNCT
iajs-2916	323	18	;	;	PUNCT
iajs-2916	324	1	et	et	PROPN
iajs-2916	324	2	al	al	PROPN
iajs-2916	324	3	.	.	PUNCT
iajs-2916	324	4	beta	beta	NOUN
iajs-2916	324	5	-	-	PUNCT
iajs-2916	324	6	cell	cell	NOUN
iajs-2916	324	7	abca1	abca1	NOUN
iajs-2916	324	8	influences	influence	VERB
iajs-2916	324	9	insulin	insulin	NOUN
iajs-2916	324	10	secretion	secretion	NOUN
iajs-2916	324	11	,	,	PUNCT
iajs-2916	324	12	glucose	glucose	NOUN
iajs-2916	324	13	homeostasis	homeostasis	NOUN
iajs-2916	324	14	and	and	CCONJ
iajs-2916	324	15	response	response	NOUN
iajs-2916	324	16	to	to	ADP
iajs-2916	324	17	thiazolidinedione	thiazolidinedione	ADJ
iajs-2916	324	18	treatment	treatment	NOUN
iajs-2916	324	19	.	.	PUNCT
iajs-2916	325	1	nat	nat	PROPN
iajs-2916	325	2	.	.	PUNCT
iajs-2916	326	1	med	med	PROPN
iajs-2916	326	2	.	.	PUNCT
iajs-2916	326	3	 	 	SPACE
iajs-2916	327	1	2007	2007	NUM
iajs-2916	327	2	,	,	PUNCT
iajs-2916	327	3	13	13	NUM
iajs-2916	327	4	,	,	PUNCT
iajs-2916	327	5	340	340	NUM
iajs-2916	327	6	–	–	SYM
iajs-2916	327	7	347	347	NUM
iajs-2916	327	8	.	.	PUNCT
iajs-2916	327	9	ihjpas	ihjpas	PROPN
iajs-2916	327	10	.	.	PUNCT
iajs-2916	328	1	53	53	NUM
iajs-2916	328	2	(	(	PUNCT
iajs-2916	328	3	4)2022	4)2022	NOUN
iajs-2916	328	4	205	205	NUM
iajs-2916	328	5	42	42	NUM
iajs-2916	328	6	.	.	PUNCT
iajs-2916	328	7	drew	draw	VERB
iajs-2916	328	8	,	,	PUNCT
iajs-2916	328	9	bg	bg	PROPN
iajs-2916	328	10	.	.	PROPN
iajs-2916	328	11	;	;	PUNCT
iajs-2916	329	1	rye	rye	PROPN
iajs-2916	329	2	,	,	PUNCT
iajs-2916	329	3	ka	ka	PROPN
iajs-2916	329	4	.	.	PROPN
iajs-2916	329	5	;	;	PUNCT
iajs-2916	329	6	duffy	duffy	PROPN
iajs-2916	329	7	,	,	PUNCT
iajs-2916	329	8	sj	sj	PROPN
iajs-2916	329	9	.	.	PUNCT
iajs-2916	329	10	;	;	PUNCT
iajs-2916	329	11	barter	barter	NOUN
iajs-2916	329	12	,	,	PUNCT
iajs-2916	329	13	p.	p.	NOUN
iajs-2916	329	14	;	;	PUNCT
iajs-2916	330	1	kingwell	kingwell	PROPN
iajs-2916	330	2	,	,	PUNCT
iajs-2916	330	3	ba	ba	PROPN
iajs-2916	330	4	.	.	PUNCT
iajs-2916	331	1	the	the	DET
iajs-2916	331	2	emerging	emerge	VERB
iajs-2916	331	3	role	role	NOUN
iajs-2916	331	4	of	of	ADP
iajs-2916	331	5	hdl	hdl	PROPN
iajs-2916	331	6	in	in	ADP
iajs-2916	331	7	glucose	glucose	NOUN
iajs-2916	331	8	metabolism	metabolism	NOUN
iajs-2916	331	9	.	.	PUNCT
iajs-2916	332	1	nat	nat	PROPN
iajs-2916	332	2	.	.	PUNCT
iajs-2916	333	1	rev	rev	PROPN
iajs-2916	333	2	.	.	PROPN
iajs-2916	333	3	endocrinol	endocrinol	NOUN
iajs-2916	333	4	.	.	PUNCT
iajs-2916	334	1	2012	2012	NUM
iajs-2916	334	2	,	,	PUNCT
iajs-2916	334	3	8	8	NUM
iajs-2916	334	4	,	,	PUNCT
iajs-2916	334	5	237	237	NUM
iajs-2916	334	6	-	-	SYM
iajs-2916	334	7	45	45	NUM
iajs-2916	334	8	.	.	NOUN
iajs-2916	335	1	43	43	NUM
iajs-2916	335	2	.	.	PUNCT
iajs-2916	336	1	morley	morley	PROPN
iajs-2916	336	2	,	,	PUNCT
iajs-2916	336	3	gk	gk	PROPN
iajs-2916	336	4	.	.	PROPN
iajs-2916	336	5	;	;	PUNCT
iajs-2916	336	6	mooradian	mooradian	NOUN
iajs-2916	336	7	,	,	PUNCT
iajs-2916	336	8	ad	ad	NOUN
iajs-2916	336	9	.	.	PUNCT
iajs-2916	336	10	;	;	PUNCT
iajs-2916	336	11	levine	levine	PROPN
iajs-2916	336	12	,	,	PUNCT
iajs-2916	336	13	as	as	ADP
iajs-2916	336	14	.	.	PROPN
iajs-2916	336	15	;	;	PUNCT
iajs-2916	336	16	morley	morley	PROPN
iajs-2916	336	17	,	,	PUNCT
iajs-2916	336	18	je	je	PROPN
iajs-2916	336	19	.	.	PUNCT
iajs-2916	336	20	mechanism	mechanism	NOUN
iajs-2916	336	21	of	of	ADP
iajs-2916	336	22	pain	pain	NOUN
iajs-2916	336	23	in	in	ADP
iajs-2916	336	24	diabetic	diabetic	ADJ
iajs-2916	336	25	peripheral	peripheral	ADJ
iajs-2916	336	26	neuropathy	neuropathy	ADJ
iajs-2916	336	27	:	:	PUNCT
iajs-2916	336	28	effect	effect	NOUN
iajs-2916	336	29	of	of	ADP
iajs-2916	336	30	glucose	glucose	NOUN
iajs-2916	336	31	on	on	ADP
iajs-2916	336	32	pain	pain	NOUN
iajs-2916	336	33	perception	perception	NOUN
iajs-2916	336	34	in	in	ADP
iajs-2916	336	35	humans	human	NOUN
iajs-2916	336	36	.	.	PUNCT
iajs-2916	337	1	am	be	AUX
iajs-2916	337	2	.	.	PUNCT
iajs-2916	338	1	j.	j.	PROPN
iajs-2916	338	2	med.1984	med.1984	PROPN
iajs-2916	338	3	,	,	PUNCT
iajs-2916	338	4	77	77	NUM
iajs-2916	338	5	,	,	PUNCT
iajs-2916	338	6	79	79	NUM
iajs-2916	338	7	-	-	SYM
iajs-2916	338	8	82	82	NUM
iajs-2916	338	9	.	.	PROPN
iajs-2916	338	10	44	44	NUM
iajs-2916	338	11	.	.	PUNCT
iajs-2916	339	1	hall	hall	PROPN
iajs-2916	339	2	,	,	PUNCT
iajs-2916	339	3	je	je	PROPN
iajs-2916	339	4	;	;	PUNCT
iajs-2916	339	5	hall	hall	PROPN
iajs-2916	339	6	,	,	PUNCT
iajs-2916	339	7	me	i	PRON
iajs-2916	339	8	.	.	PUNCT
iajs-2916	340	1	guyton	guyton	PROPN
iajs-2916	340	2	and	and	CCONJ
iajs-2916	340	3	hall	hall	PROPN
iajs-2916	340	4	textbook	textbook	NOUN
iajs-2916	340	5	of	of	ADP
iajs-2916	340	6	medical	medical	ADJ
iajs-2916	340	7	physiology	physiology	NOUN
iajs-2916	340	8	e	e	NOUN
iajs-2916	340	9	-	-	NOUN
iajs-2916	340	10	book	book	NOUN
iajs-2916	340	11	.	.	PUNCT
iajs-2916	341	1	elsevier	elsevier	PROPN
iajs-2916	341	2	,	,	PUNCT
iajs-2916	341	3	health	health	NOUN
iajs-2916	341	4	sciences	science	NOUN
iajs-2916	341	5	,	,	PUNCT
iajs-2916	341	6	2020	2020	NUM
iajs-2916	341	7	;	;	PUNCT
iajs-2916	341	8	isbn	isbn	ADJ
iajs-2916	341	9	9780323640039	9780323640039	NUM
iajs-2916	341	10	.	.	PUNCT
iajs-2916	342	1	45	45	NUM
iajs-2916	342	2	.	.	PUNCT
iajs-2916	342	3	huang	huang	PROPN
iajs-2916	342	4	,	,	PUNCT
iajs-2916	342	5	s.	s.	PROPN
iajs-2916	342	6	;	;	PUNCT
iajs-2916	342	7	czech	czech	PROPN
iajs-2916	342	8	,	,	PUNCT
iajs-2916	342	9	mp	mp	PROPN
iajs-2916	342	10	.	.	PUNCT
iajs-2916	343	1	the	the	DET
iajs-2916	343	2	glut4	glut4	NOUN
iajs-2916	343	3	glucose	glucose	NOUN
iajs-2916	343	4	transporter	transporter	NOUN
iajs-2916	343	5	.	.	PUNCT
iajs-2916	344	1	cell	cell	NOUN
iajs-2916	344	2	metab	metab	NOUN
iajs-2916	344	3	.	.	PUNCT
iajs-2916	345	1	2007	2007	NUM
iajs-2916	345	2	,	,	PUNCT
iajs-2916	345	3	5	5	NUM
iajs-2916	345	4	,	,	PUNCT
iajs-2916	345	5	237	237	NUM
iajs-2916	345	6	-	-	SYM
iajs-2916	345	7	252	252	NUM
iajs-2916	345	8	.	.	PUNCT
iajs-2916	346	1	46	46	NUM
iajs-2916	346	2	.	.	PUNCT
iajs-2916	347	1	kavanagh	kavanagh	PROPN
iajs-2916	347	2	williamson	williamson	PROPN
iajs-2916	347	3	,	,	PUNCT
iajs-2916	347	4	m.	m.	NOUN
iajs-2916	347	5	;	;	PUNCT
iajs-2916	347	6	coombes	coombe	NOUN
iajs-2916	347	7	,	,	PUNCT
iajs-2916	347	8	n.	n.	NOUN
iajs-2916	347	9	;	;	PUNCT
iajs-2916	347	10	juszczak	juszczak	PROPN
iajs-2916	347	11	,	,	PUNCT
iajs-2916	347	12	f.	f.	PROPN
iajs-2916	347	13	;	;	PUNCT
iajs-2916	347	14	athanasopoulos	athanasopoulo	NOUN
iajs-2916	347	15	,	,	PUNCT
iajs-2916	347	16	m.	m.	NOUN
iajs-2916	347	17	;	;	PUNCT
iajs-2916	347	18	khan	khan	PROPN
iajs-2916	347	19	,	,	PUNCT
iajs-2916	347	20	mb	mb	PROPN
iajs-2916	347	21	.	.	PROPN
iajs-2916	347	22	;	;	PUNCT
iajs-2916	347	23	eykyn	eykyn	NOUN
iajs-2916	347	24	,	,	PUNCT
iajs-2916	347	25	tr	tr	VERB
iajs-2916	347	26	.	.	PUNCT
iajs-2916	347	27	;	;	PUNCT
iajs-2916	347	28	srenathan	srenathan	PROPN
iajs-2916	347	29	,	,	PUNCT
iajs-2916	347	30	u.	u.	PROPN
iajs-2916	347	31	;	;	PUNCT
iajs-2916	347	32	taams	taam	NOUN
iajs-2916	347	33	,	,	PUNCT
iajs-2916	347	34	ls	ls	PROPN
iajs-2916	347	35	.	.	PUNCT
iajs-2916	347	36	;	;	PUNCT
iajs-2916	347	37	dias	dias	PROPN
iajs-2916	347	38	zeidler	zeidler	NOUN
iajs-2916	347	39	,	,	PUNCT
iajs-2916	347	40	j.	j.	PROPN
iajs-2916	347	41	;	;	PUNCT
iajs-2916	347	42	da	da	PROPN
iajs-2916	347	43	poian	poian	PROPN
iajs-2916	347	44	,	,	PUNCT
iajs-2916	347	45	at	at	ADP
iajs-2916	347	46	.	.	PUNCT
iajs-2916	347	47	;	;	PUNCT
iajs-2916	347	48	huthoff	huthoff	NOUN
iajs-2916	347	49	,	,	PUNCT
iajs-2916	347	50	h.	h.	PROPN
iajs-2916	347	51	upregulation	upregulation	NOUN
iajs-2916	347	52	of	of	ADP
iajs-2916	347	53	glucose	glucose	NOUN
iajs-2916	347	54	uptake	uptake	ADJ
iajs-2916	347	55	and	and	CCONJ
iajs-2916	347	56	hexokinase	hexokinase	NOUN
iajs-2916	347	57	activity	activity	NOUN
iajs-2916	347	58	of	of	ADP
iajs-2916	347	59	primary	primary	ADJ
iajs-2916	347	60	human	human	PROPN
iajs-2916	347	61	cd4	cd4	PROPN
iajs-2916	347	62	+	+	PROPN
iajs-2916	347	63	t	t	NOUN
iajs-2916	347	64	cells	cell	NOUN
iajs-2916	347	65	in	in	ADP
iajs-2916	347	66	response	response	NOUN
iajs-2916	347	67	to	to	ADP
iajs-2916	347	68	infection	infection	NOUN
iajs-2916	347	69	with	with	ADP
iajs-2916	347	70	hiv-1	hiv-1	NOUN
iajs-2916	347	71	.	.	PUNCT
iajs-2916	347	72	viruses	virus	NOUN
iajs-2916	347	73	.	.	PUNCT
iajs-2916	348	1	2018	2018	NUM
iajs-2916	348	2	,	,	PUNCT
iajs-2916	348	3	10	10	NUM
iajs-2916	348	4	,	,	PUNCT
iajs-2916	348	5	114	114	NUM
iajs-2916	348	6	.	.	PUNCT
iajs-2916	349	1	47	47	NUM
iajs-2916	349	2	.	.	PUNCT
iajs-2916	350	1	mohamed	mohamed	PROPN
iajs-2916	350	2	,	,	PUNCT
iajs-2916	350	3	ma	ma	PROPN
iajs-2916	350	4	.	.	PROPN
iajs-2916	350	5	;	;	PUNCT
iajs-2916	350	6	ahmed	ahmed	PROPN
iajs-2916	350	7	,	,	PUNCT
iajs-2916	350	8	ma	ma	PROPN
iajs-2916	350	9	.	.	PROPN
iajs-2916	350	10	;	;	PUNCT
iajs-2916	351	1	el	el	PROPN
iajs-2916	351	2	sayed	sayed	PROPN
iajs-2916	351	3	,	,	PUNCT
iajs-2916	351	4	ra	ra	PROPN
iajs-2916	351	5	.	.	PUNCT
iajs-2916	352	1	molecular	molecular	ADJ
iajs-2916	352	2	effects	effect	NOUN
iajs-2916	352	3	of	of	ADP
iajs-2916	352	4	moringa	moringa	NOUN
iajs-2916	352	5	leaf	leaf	NOUN
iajs-2916	352	6	extract	extract	NOUN
iajs-2916	352	7	on	on	ADP
iajs-2916	352	8	insulin	insulin	NOUN
iajs-2916	352	9	resistance	resistance	NOUN
iajs-2916	352	10	and	and	CCONJ
iajs-2916	352	11	reproductive	reproductive	ADJ
iajs-2916	352	12	function	function	NOUN
iajs-2916	352	13	in	in	ADP
iajs-2916	352	14	hyperinsulinemic	hyperinsulinemic	ADJ
iajs-2916	352	15	male	male	ADJ
iajs-2916	352	16	rats	rat	NOUN
iajs-2916	352	17	.	.	PUNCT
iajs-2916	353	1	j.	j.	PROPN
iajs-2916	353	2	diabetes	diabetes	PROPN
iajs-2916	353	3	metab	metab	PROPN
iajs-2916	353	4	.	.	PUNCT
iajs-2916	354	1	disord	disord	NOUN
iajs-2916	354	2	.	.	PUNCT
iajs-2916	355	1	2019	2019	NUM
iajs-2916	355	2	,	,	PUNCT
iajs-2916	355	3	18	18	NUM
iajs-2916	355	4	,	,	PUNCT
iajs-2916	355	5	487	487	NUM
iajs-2916	355	6	-	-	SYM
iajs-2916	355	7	94	94	NUM
iajs-2916	355	8	.	.	PUNCT